United States
Securities and Exchange Commission
Washington, D.C. 20549

Form 10-K

x
Annual Report pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934:
  For the fiscal year ended: December 31, 2009 
   
o
Transition report pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934: 
  For the transition period from:
000-50081
(Commission File Number)
 
Invisa, Inc.
(Exact name of small business issuer as specified in its charter) 
   
Nevada
(State or other jurisdiction of incorporation or organization)
   
65-1005398
(I.R.S. employer identification number)
   
1800 2 nd Street Suite 965
Sarasota, Florida 34236
(Address of principal executive offices)
   
  (941) 870-3950
(Issuer’s telephone number)

Securities registered under Section 12(b) of the Act: None.

Securities registered under Section 12(g) of the Act: Common Stock, $0.001 par value per share.

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes  o   No x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act. o

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the issuer was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  o   No x

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes o   No o
 
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained in herein, and will not be contained, to the best of the registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes o   No x
 
1


Indicate by check mark whether the registrant is a large accelerated filer, and accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” I Rule 12b-2 of the Exchange Act.

Large accelerated filer   o
Accelerated filer   o
Non-accelerated filer (Do not check if a smaller reporting company)   o
Smaller reporting company   x
 
As of June 30, 2009, the aggregate market value of the registrant’s common stock held by non-affiliates of the registrant was approximately $20,546.00, based on the closing price of the registrant’s common stock of $0.001 per share on June 30, 2009.

On March 24, 2010, 35,156,081 shares of Invisa Common Stock, $0.001 par value, were outstanding  
 
 
 


2


TABLE OF CONTENTS
 
   
Page
 
Part I
 
     
4
7
9
10
10
10
     
 
Part II
 
     
10
11
11
Item 7A
Quantitative and Qualitative Disclosures about Market Risk
12
13
13
14
     
 
Part III
     
15
17
20
21
21
     
 
Part IV
 
     
22
     
 
Financial Statements
 
     
 
F-1
 
F-2
 
F-3
 
F-4
 
F-5
 
F-7
     
 
27
     
 
Index to Exhibits
 
 
3

 
PART I

Note regarding forward-looking statements: Except for statements of historical fact, certain information contained herein constitutes forward-looking statements including, without limitation, statements containing the words believes, anticipates, intends, expects, and words of similar import, as well as all projections of future results. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results or achievements of Invisa, Inc. to be materially different from any future results or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the following: risks involved in  implementing our business strategy; our ability to obtain financing on acceptable terms; competition; our ability to manage growth; risks of technological change; our dependence on key personnel;  our ability to protect our intellectual property rights; risks of new technology and new products; and government regulation.

Item 1 - Description of Business
 
Invisa, Inc. is a Nevada corporation that manufactures and sells a line of SmartGate ® brand safety sensors used in or with parking gates to protect life and property.   Parking gates are motorized barriers used to control the flow of vehicular traffic in areas such as parking facilities, vehicle storage facilities, tollbooths, and metered entry points for highways. Our SmartGate sensors are based on presence sensing technology that we call InvisaShield. While we believe that our InvisaShield technology may have additional applications for safety products, to date all of our revenue has been derived from the sale of SmartGate sensors used in parking gates.    
 
We acquired the InvisaShield™ presence-sensing technology in 2004.  Presence sensing is the repeatable detection of people and conductive objects within a certain perimeter of the sensor.   InvisaShield technology detects objects at a distance of typically less than one meter.  Invisa currently owns the patent and patent applications, as well as the sole rights to the InvisaShield technology in all markets worldwide.
 
Our offices are located at 1800 2 nd Street, Suite 765, Sarasota, FL 34236, telephone (941) 870-3950.

Our SmartGate Product

Many products use presence-sensing technology; however, we believe that our InvisaShield technology is particularly suited to safety sensors for use in the parking gate market.   In 2008 and 2009, all of our revenues were derived from the sale of SmartGate safety sensors used with powered parking gates. These gates typically have a power-operated barrier arm made of metal, wood or PVC. This arm moves vertically between an open and a closed position. Our device places an invisible presence-sensing field around the potentially dangerous barrier arm to detect people and vehicles in its path. Our device signals the powered gate to trigger a predetermined response, such as stopping and reversing the barrier arm.  The retail price for our SmartGate™ sensors allow us to realize an acceptable gross profit margin, however, we continue to look for ways to decrease our cost of goods and increase our distribution to improve our profit margins.
 
Marketing and Sales

We sell our safety products to manufacturers, dealers and end-users.   As part of our current sales efforts, we have attended trade shows and have continued our relationships with our customer list which comprises manufacturers, dealers and end users.  We also receive unsolicited orders either by telephone, fax or internet.  In addition, during fiscal year 2009, we have sought relationships with architectural engineering firms and municipalities that are implementing projects requiring parking barrier gates, such as municipal parking lots and airport reconstruction.  Although we do not maintain a full-time sales force, we do engage outside sales consultants.

During fiscal year ended December 31, 2008, Magnetic Automation Corp. was our largest customer, comprising approximately 21% of our total sales revenue for that year.  However, in 2009, Magnetic discontinued our product line, which resulted in a reduction in direct sales to Magnetic.  Currently, Magnetic instructs their customers to contact us directly for the purchase of our products.  We believe that a significant portion of those sales would have otherwise been made to Magnetic.

In 2009, Automatic Systems America was our largest customer, responsible for 11% of our product revenues.  The sales to Automatic Systems in 2009 include a project that Automatic Systems is administering for a large governmental end user and no assurance can be given that we will continue to sell products to Automatic Systems at the same level once the project is complete.
 
 
Technology

InvisaShield technology uses electronic circuitry that emits, controls, and monitors changes in an invisible energy field. The field is based, in part, upon low energy radio waves oscillating within a controlled frequency range. The field that is monitored can be varied in sensitivity from a distance of approximately one meter to a centimeter or less, depending upon the selected application. Circuitry constantly checks the field to test for the presence of people, vehicles or other conductive objects (objects that conduct electricity) that would disturb the monitored field.

We believe that the InvisaShield technology is a novel and proprietary way to provide presence sensing. At the core of the technology is the ability to project a field or zone capable of detecting most conductive objects that enter the field. The field is projected from a metallic substance, referred to as an antenna, which may consist of wire, self-adhesive metallic tape or other metallic items. The technology allows flexibility in designing and locating the antenna. This may offer unique opportunities to place presence-sensing fields where they can be used more efficiently or effectively. This adaptability may permit the InvisaShield technology to perform non-contact presence-sensing tasks not currently possible with competing technologies and/or it may perform presence-sensing tasks similar to those performed by competing technologies, but in a more efficient, effective, and reliable manner.

InvisaShield technology does not depend upon lenses, beams or reflectors, which may require replacement, cleaning and aligning. Its operating environment, including electronic noise, mechanical noise, temperature, dust, frost, snow, ice or other operating conditions, generally does not disrupt the non-intrusive, non-contact presence-sensing capability of our technology.
 
We have, in the past, sought to develop additional products based on our InvisaShield technology. We have developed pre-production prototypes of safety products for various power doors such as slide-gates, commercial overhead doors, powered industrial doors (which are used in commercial, manufacturing and industrial facilities) and residential garage doors and pre-production prototypes of security products  various applications in museums,  retail and industrial. We have indefinitely delayed such development projects
 
Competing Technologies - The presence-sensing business is highly competitive, consisting of numerous manufacturers of presence-sensing products based on various technologies, including infrared, ultrasonic, laser, microwave, and similar technologies. For the most part, these technologies have been in use for a number of years and, in many cases, may not be proprietary.  Our competitors provide a variety of presence-sensing and other safety and security alternatives such as motion detectors, CCTV-based movement detection systems, infrared and visible light beam detectors, light curtains, on/off switching mats and pads, tape switches, contact edges, as well as others.

In the safety and/or security sectors we compete with many companies, including MillerEdge, Stanley, Optex, Napco, Pelco, and DMP, along with other large and well-established firms such as Honeywell, Tyco, General Electric, Bosch, and Siemens.  Many of our competitors have substantially greater development, technical, marketing, sales and financial capabilities than we have. As a result of these factors, competitors and potential competitors may be able to respond more quickly to new or emerging technologies and changes in customer requirements and/or to devote greater resources to the development, promotion and sale of their products and services than we can.
 
 
Patents and Trademarks - We own five Patents issued by the U.S. Patent Office, three of which were issued in the year 2006 or the first quarter of 2007: Patent No. 5,337,039 issued on August 9, 1994, Patent No. 6,819,242 issued on November 16, 2004, Patent No. 7,023,222, B2 issued on April 4, 2006; Patent No. 7,167,093 B2 issued on January 23, 2007 and Patent No. 7,187,282 issued on March 6, 2007.  In addition, we have filed for two patents (as PCT, or Patent Cooperation Treaty filings), one provisional patent application and have one application pending, all of which cover improvements to the InvisaShield technology.

We have a trademark on the trade name “SmartGate” which we use in our safety products category. We have filed trademark applications for the following: “Invisa”, “InvisaShield” and the tagline “Safe. Secure. No Question.” We believe that our patent and trademark position will be useful in our efforts to protect our perceived competitive advantages.

Materials and Manufacturing

All components and parts are modified or manufactured by third parties to our specifications or are otherwise generally available as off-the-shelf materials. Our products have a number of components including proprietary electronic circuitry manufactured to our specifications by third party manufacturers and a standard power supply available in the marketplace. The antenna is standard wire, tape or other metallic materials, which can generally be purchased in bulk. Whenever possible, we use fixed price manufacturing for our electronic circuitry, placing the responsibility for component supply on the manufacturer. We believe that there are multiple manufacturers and suppliers for each component and that adequate components and materials will be available to support our business plan. We perform some final assembly and predetermined quality control procedures in our facility using contractors, including contract piece work in connection with the assembly when needed.  All shipping is done directly from our facility.

Government Regulation

The Federal Communications Commission regulates the use of radio frequency or “RF”, such as that used by our safety products. We currently have FCC Certification for our product. We will endeavor to continue satisfying all requirements of the FCC to maintain our FCC Certification.

On March 1, 2001, Underwriters Laboratory (UL) implemented a new safety standard for the powered gate, door and window industry. This rule, UL-325, while not a governmental regulation, is considered an indication of reasonable safety for powered gates, doors and windows, and is a requirement for UL certification for certain powered gate, door and window operators. Gate and operator manufacturers that rely upon UL certification or consider UL certification important for components most likely will require that our products be UL certified before incorporating our products as original equipment. We do not have a UL certification and the absence of UL certification for our products may represent a sales or marketing barrier in certain market categories and to certain customers.

Our products have also earned the Conformité Européenne   marking (also known as CE mark) which is a mandatory conformity mark placed on many products used in the single market in the European Economic Area. The CE mark certifies that a  product has met EU consumer safety, health or environmental requirements.  This marking is mandatory for sales of products in approximately 27 European countries but is usually preferred by customers whether or not required in their respective countries.

In addition to gaining the CE mark, our products are now RoHS compliant and have been since late 2008.  The directive on the restriction of the use of certain hazardous substances in electrical and electronic equipment 2002/95/EC; commonly referred to as the Restriction of Hazardous Substances Directive or RoHS) was adopted in February 2003 by the European Union and took effect in July 2006.  This directive restricts the use of six hazardous materials (lead, mercury, cadmium, hexavalent chromium, polybrominated biphenyls and polybrominated diphenyl ether), in the manufacture of various types of electronic and electrical equipment. By complying with the RoHS directive, our customers are assured that our products are free of these hazardous substances.

Warranty

Our safety products are sold with a 90-day limited warranty against manufactures parts and defects. We have had no significant claims expensed under the warranty in 2008 or 2009.

Employees

We have no full time employees.  Our Chief Financial Officer, who is currently our Acting President, serves in both capacities on a part-time basis.  We support our operations by using consultants and third party contract piece workers as required
 
 
Research and Development

We are not conducting any research and development with respect to our technology at this time.  Therefore, during the years ended December 31, 2008 and 2009 we incurred no research and development expenses.
 
Item 1A – Risk Factors
 
You should carefully consider the risks and uncertainties described below and the other information in this filing before deciding to purchase our common stock. If any of these risks or uncertainties occurs, our business, financial condition or operating results could be materially harmed. In that case, the trading price of our common stock could decline and you could lose all or part of your investment. The risks and uncertainties described below are not the only ones we may face.  . We have historically incurred losses and losses are expected to continue in the future, which means that we may not be able to continue operations unless we obtain additional funding.

We continue to incur losses.

In the twelve months ended December 31, 2009, we sustained a net loss from operations of $171,970,  including a gain of $24,714 to reflect the favorable settlement of certain debt.  Absent a dramatic increase in our market share or demand for our products, future losses are expected to continue. Accordingly, we will experience significant liquidity and cash flow problems if we are not successful in increasing our sales and lowering costs.  No assurances can be given that we will be successful in reaching or maintaining profitable operations. Our ability to generate revenue and achieve profitability depends upon our ability to manufacture and sell our products in sufficient volume to cover our fixed and variable costs of operations.

We will need to continue financing our operations through third party sources or we may be unable to fund our operations, promote our products or develop our technology.

In recent years, our operations have relied almost entirely on external financing to fund our operations; however, in 2009 sales revenues satisfied approximately 51% of our operational costs and expenses.   During 2008 and 2009, we funded our operations with funds borrowed under short term notes which, for the most part, were secured with the Company’s assets.  We anticipate, based on our current proposed plans and assumptions relating to our operations, that the line of credit established by our senior lender will provide adequate funding to continue to operate our business through December 31, 2010. Unless our sales increase significantly, we will need to raise additional capital to fund our operating expenses beyond December 31, 2010.  We cannot assure you that financing, whether from external sources or related parties, will be available if needed or on favorable terms beyond December 31, 2010. If additional financing is not available when required or is not available on acceptable terms, we may be unable to support our secured debt, fund our operations and planned growth, take advantage of business opportunities or respond to competitive market pressures, any of which could have a material adverse affect on our long term business plan.

Our financing requirements could result in dilution to existing stockholders.

The additional financings we will require may be obtained through one or more transactions, which effectively dilute the ownership interests of our stockholders. Further, we may not be able to secure such additional financing on terms acceptable to us, if at all. We have the authority to issue additional shares of common stock, as well as additional classes or series of ownership interests or debt obligations that may be convertible into any one or more classes or series of ownership interests. We are authorized to issue 95,000,000 shares of common stock and 5,000,000 shares of preferred stock. Such securities may be issued without the approval or other consent of our stockholders.

Our revenues.

We anticipate that we will encounter difficulties and risks relating to our sales revenues, which include, but are  not limited to, the introduction of new products, the ability to hire full time personnel, access to required capital, management issues, increasing our manufacturing capacity, and other similar aspects of operations which  are important to our business operations.
 

We will be required to compete with larger, more established, and better financed companies.

There are a number of well-established companies that are well known in the manufacture and/or distribution of products for the security and life-safety markets. Such companies include Honeywell, Tyco, General Electric, Bosch, Siemens and others. Accordingly, we are subject to the difficult challenge of introducing and commercializing our new technology and products in a strong competitive environment. Additionally, our technology and products based thereon will have to compete with other technologies such as passive infrared and various types of motion detection that are well known and well accepted.

We continue to experience uncertainty and risks related to market acceptance.

We continue our efforts to expand the market for our safety sensor product, to gain broader market acceptance and to demonstrate competitive advantages. Our success is dependent, to a large degree, upon our ability to successfully market our technology and its perceived competitive advantages. Accordingly, our prospects must be considered in light of the risks, expenses and difficulties frequently encountered in connection with the operation of a small business in a highly competitive industry, characterized by frequent new product introductions. We anticipate that we will continue to be disadvantaged by our limited revenues as they will inhibit our ability to expand our marketing and sales efforts in the domestic and international marketplace.

The limits of our of product liability insurance coverage may affect our Business.

We may be exposed to potential product liability claims by consumers. Although we maintain product liability insurance, there can be no assurance that such insurance will be sufficient to cover all possible liabilities to which we may be exposed. Any product liability claim, even one that was not in excess of our insurance coverage or one that is meritless and/or unsuccessful, could adversely affect our cash available for other purposes, such as research and development. In addition, the existence of a product liability claim could affect the market price of our common stock.  Also, certain vendors may require minimum product liability insurance coverage as a condition precedent to purchasing or accepting products for retail distribution. Product liability insurance coverage includes various deductibles, limitations and exclusions from coverage, and in any event might not fully cover any potential claims. Failure to satisfy such insurance requirements could impede our ability or our distributors or licensees ability to achieve broad retail distribution of our proposed products, which could have a material adverse effect on us.

We may not be able to effectively protect our intellectual property rights, the foundation of our business, which could harm our business by making it easier for our competitors to duplicate our services.

We regard certain aspects of our products, processes, services and technology as proprietary. We have taken steps to protect them with patents, copyrights, trademarks, restrictions on disclosure and other methods. Despite these precautions, we cannot be certain that third parties will not infringe or misappropriate our proprietary rights or that third parties will not independently develop similar products, services and technology. Any infringement, misappropriation or independent development could cause us to cease operations.

We have issued patents and have filed patent applications with respect to various aspects of our technology. The pending patent applications may not be issued to us, and if issued, may not protect our intellectual property from competition, which could seek to design around or invalidate these patents. Our failure to adequately protect our proprietary rights in our products, services and technology could harm our business by making it easier for our competitors to duplicate our services. We may have to resort to litigation to enforce our intellectual property rights, protect our trade secrets, determine the validity and scope of the proprietary rights of others, or defend ourselves from claims of infringement, invalidity or unenforceability. Litigation may be expensive and divert resources even if we win. This could adversely affect our business, financial condition and operating results such that it could cause us to reduce or cease operations.
 

Other parties may assert that our technology infringes on their Intellectual property rights, which could divert management time and resources and possibly force our Company to redesign our technology.

Technology-based companies, such as ours, have the potential to be involved in litigation related to allegations of patent infringement. Although we have no knowledge of any such claims, from time to time, third parties may assert patent, copyright and other intellectual property rights to technologies that are important to us. While there currently are no outstanding infringement claims pending by or against us, we cannot assure you that third parties will not assert infringement claims against us in the future, that assertion by such parties will not result in costly litigation, or that they will not prevail in any such litigation. In addition, we cannot assure you that we will be able to license any valid and infringed patents from third parties on commercially reasonable terms or, alternatively, be able to redesign products on a cost-effective basis to avoid infringement. Any infringement claim or other litigation against or by us could have a material adverse effect on us and could cause us to reduce or cease operations.

We may not be able to keep up with rapid technological changes, which could render our products less competitive or obsolete.

Changes in technology, changes in customer requirements and preferences, introduction of products and services embodying new or different technologies and the emergence of new industry standards and practices could render our existing technology and products less competitive or obsolete. Our future success will depend on our ability to enhance and improve the responsiveness, functionality, accessibility and features of our technology and products. We expect that our marketplace will require extensive technological upgrades and enhancements to accommodate many of the new products and services that we anticipate will be added to our marketplace. We cannot assure you that we will be able to expand and upgrade our technology and systems, or successfully integrate new technologies or systems we develop in the future, to accommodate such increases in a timely manner.

We may not be able to increase sales or if we succeed in increasing sales and revenue, we may not be able  to effectively manage the growth necessary to execute our business plan, which could adversely affect the quality of our operations and our costs.

In order to successfully execute our business plan, we must significantly increase our sales and revenue. Additionally, we will need to increase the number of strategic partners, manufacturers, dealers, distributors and customers that use our products. Lack of growth in sales and revenue will require that we continue to access financing which will subject us to the risks attendant thereto. On the other hand, if we succeed in increasing sales and revenue, the resulting growth will place significant strain on our systems and resources.  In the event of growth, we may not be able to maintain the quality of our operations, control our costs, continue complying with all applicable regulations and expand our internal management, technical information and accounting systems in order to support our desired growth. We cannot be sure that we will manage our growth effectively, and our failure to do so could cause us to reduce or cease operations.

We are thinly staffed.

We have no full time employees.  Our Chief Financial Officer is also serving as our acting President and is available to the Company on a part time basis.  We also engage consultants and contract piece workers as necessary.  Unless additional employees are hired, the limited size of our staff could restrict the level and/or nature of our business operations.

We have promissory notes payable that are secured by all of our assets and default under these notes could result in the loss of our assets .

In order to fund our operations, we have entered into promissory notes payable that are secured by all of our assets and in some instances by shares of our common stock that were issued to secure the promissory notes. We currently do not have the available cash or other financing resources to pay the interest or principal there under. Default under these promissory notes could result in the loss of all of our assets and business opportunity.  The senior lender has liens on all of our assets and approximately 49% of the common stock and potentially other shares which give it significant influence on our ability to issue stock, get financing, or consummate a business transaction.

Item 1B – Unresolved Staff Comments

None
 

Item 2 - Properties

In the February, 2010, we relocated our operations to approximately 1,277 square feet of office space located at 1800 2 nd Street in Sarasota, Florida. Our monthly base rental is approximately $1,600.  We rent the facilities pursuant to a lease which expires on February 28, 2011.

Item 3 - Legal Proceedings

None.

Item 4 – Removed and Reserved

PART II

Item 5 - Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information

Our Common Stock trades on the NASD OTC BB under the symbol INSA.OB. The following table sets forth the range of high and low bids to purchase our Common Stock during the last two fiscal years. Such prices represent quotations between dealers, without dealer markup, markdown, or commissions, and may not represent actual transactions.

As of December 31, 2009 there were   395 stockholders of record of Invisa Common Stock.
Quarter
High Bid
Low Bid
First Quarter 2008
0.01
0.01
Second Quarter 2008
0.02
0.01
Third Quarter 2008
0.02
0.01
Fourth Quarter 2008
0.02
0.00
First Quarter 2009
0.00
0.00
Second Quarter 2009
0.00
0.00
Third Quarter 2009
0.00
0.00
Fourth Quarter 2009
0.02
0.02
 
On March 15, 2010, the closing bid and closing ask prices for shares of our Common Stock in the over-the-counter market, as reported by NASD OTC BB was $0.022 per share.

We believe that there are presently approximately 6 market makers for our Common Stock. When stock is traded in the public market, characteristics of depth, liquidity and orderliness of the market may depend upon the existence of market makers as well as the presence of willing buyers and sellers. We do not know if these or other market makers will continue to make a market in our Common Stock. Further, the trading volume in our Common Stock has historically been both sporadic and light.

Dividend Policy

With the exception of our Series B Preferred Stock, the payment by the Company of dividends on its capital stock rests within the sole discretion of its Board of Directors. The payment of dividends will depend upon our earnings, our capital requirements and our financial condition, as well as other relevant factors. With the exception of our Series B Preferred Stock, the Company has not been required to or declared any cash dividends since its inception, and has no present intention of paying any cash dividends on its capital stock in the foreseeable future.  Our policy with regard to the Series B Preferred Stock is to base any dividend paid on a rate that varies with the prime interest rate.  The dividend may be paid in either stock or cash at the option of the Company.

Transfer Agent

The Transfer Agent for the Common Stock of the Company is Continental Stock Transfer and Trust Company 17 Battery Place, New York, NY 10004.
 

Recent Sales of Unregistered Securities

We issued 53,333,333 shares of our common stock in through 2008 to collateralize several notes totaling $563,400 evidencing loans made to the Company by a third party lender. The shares were deposited in an escrow account and will only be delivered to such lender in the event of a default under or non-payment of the notes. Upon full repayment of the notes, said shares will be returned to the Company. The shares delivered to the escrow agent as security for the notes are not being treated as outstanding and will only be considered as being issued and outstanding if and when the shares are released by the escrow agent and delivered to the lender as a result of a default under the promissory notes and related security agreement.  (Additionally, see Note G to the accompanying financial statements.)

In 2008 the Company issued 2,667,361 shares of common stock for employee share-based compensation and 7,047,594 shares for settlement of debt.

In 2009 the Company granted 375,000 shares of its common stock as compensation to its Board members.

Item 6 – Selected Financial Data

Not applicable

Item 7 - Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and plan of operations should be read in conjunction with our financial statements and related notes appearing elsewhere in this filing. This discussion and analysis contains forward-looking statements including information about possible or assumed results of our financial conditions, operations, plans, objectives and performance that involve risk, uncertainties and assumptions. The actual results may differ materially from those anticipated in such forward-looking statements. For example, when we indicate that we expect to increase our product sales and potentially establish additional license relationships, these are forward-looking statements. The words expect, anticipate, estimate or similar expressions are also used to indicate forward-looking statements. The cautionary statements made herein should be read as being applicable to all related forward-looking statements in this Annual Report on Form 10-K.

Background of our Company

We manufacture and sell sensors using the Company’s patented InvisaShield™ presence-sensing technology in the safety market.  We market our line of safety sensors under the name of SmartGate ® brand safety sensors used in or with parking barrier gates to protect life and property.  All of our sales revenues are derived from the sale of our SmartGate safety sensors.

We financed our operations in 2008 and 2009 through revenues derived from the sale of our SmartGate ® brand safety sensors and short-term debt financing. We are focusing our efforts on increasing our sales of our products and reducing operating costs, where possible.  In March 2010 the company’s senior lender agreed to extend the maturity date of the Senior Secured Promissory Notes and the related accrued interest until March 1, 2012, and put it place a line of credit which we believe is sufficient to finance our operations through December 31, 2010.  (See Note J)-
.
Year Ended December 31, 2008 Compared to the Year Ended December 31, 2009

Net Sales - During the years ended December 31, 2008 and 2009, product sales totaled $102,297and $147,589, respectively.  We had a gross profit of   $41,739   for the year ended December 31, 2008 and gross profit of $83,476   for the year ended December 31, 2009.   Gross margin was 40 percent during 2008 and 57 percent during 2009.  We attribute the increase in our sales and gross margin in 2009 to an increase in the retail price of our products as well as the success of our new marketing strategy of targeting project work and municipalities while maintaining our current customer relationships.

Selling, General and Administrative Expenses - During the years 2008 and 2009, selling, general and administrative expenses totaled $256,999 and $219,533, respectively.  We were successful in decreasing our expenses in 2009 by reducing our insurance costs through lower premiums, decreasing our leasehold costs and reducing professional services expenses.

Interest (expense) and other, Net - The interest expense during 2008 of $56,348 and during 2009 of $62,202 relates primarily to financing costs and interest due to certain stockholders under lines of credit to the Company.  During 2008 and 2009, the Company settled certain debts for cash and stock resulting in the extinguishment gain of $377,454 and $24,714, respectively.
 
 
Net Income (Loss) applicable to Common Stockholders and Net Income (Loss) Per Share applicable to Common Stockholders - The Company’s net income (loss) applicable to Common Stockholders and net income (loss) per share applicable to Common Stockholders for these periods decreased from net income of $18,096 and $0.00 in 2008 to a net loss of $226,315 and ($0.00) in 2009.

Plan of Development and Operations
    
We obtained funding of $262,730, in the form of short-term debt financing in 2008, and an additional $69,370 in 2009, which together with our cash from sales supported our operations.   We have extended the maturity of our short-term debt to March 1, 2012, and put in place a line of credit which we believe is sufficient to finance our operations through December 31, 2010.  (See Note J)-. In addition,  we will explore other business opportunities such as licensing and business combinations as they may arise.

Liquidity and Capital Resources

At December 31, 2009, we had a cash and cash equivalents totaling $157.
 
As of December 31, 2009, the Company has borrowed $628,320 which includes $64,920 in interest payments due and owing from its senior lender.  The financing arrangements are set forth in a series of Notes having similar terms but varying terms and maturity dates, specifically (i) $128,320 in 2009, (ii) $100,000 in July 2008, (iii) $150,000 in March 2008 and (iv) $250,000 prior to 2008.  Each note bears interest at 10 percent per annum and is secured by all of the assets of the Company.  Additionally, the Company has pledged an aggregate of 53,333,333 shares of its common stock, and has committed additional capital stock, when available, as additional security for the notes.  These shares have been issued and are being held in escrow as additional collateral against the notes.    Upon full repayment of the notes, said shares will be returned to the Company.  The shares delivered to the escrow agent as security for the notes are treated as issued on the stockholder lists of the Company but will not be deemed outstanding  unless the shares are released by the escrow agent and delivered to the lender as a result of a default or non payment under the promissory notes and related security agreement.

In March 2010, as part of a restructure of the senior debt of the Company, the senior lender agreed to extend the maturity date of its $628,320 principal amount of notes and accrued interest to March 1, 2012, through a series of note extension agreements.  With the exception of the extension of the maturity date to March 1, 2012, all of the terms and provisions of the original notes remain in full force and effect, including, without limitation all security thereon.  The senior lender also established a $150,000 line of credit to finance operations of the Company through December 31, 2010.  The revolving credit facility has similar terms and provisions to the previous notes between the Company and the senior lender and is due and payable on March 1, 2012.

                The Company had negative working capital at December 31, 2009, totaling $584,313 including $157 in cash and cash equivalents. To finance planned operations through at least the next 12 months, we will rely upon our sales revenues and the line of $150,000 line of credit established by our senior lender.   We believe that the line of credit facility and our sales revenue will be sufficient to finance our operations through December 31, 2010.  However, we will continue to explore other avenues of financing, such as licensing of our product and/or our technology and potential strategic or business relationships or combinations, and to a lesser degree private equity and debt financing.
 
                While we are confident that the current funding and sales revenue available to us will be sufficient to finance our operations through December 31, 2010, it is important to note that additional funding, if needed, may not be available when required or it may not be available on acceptable terms. Should we require additional funding, we may need to reduce or refocus our operations or obtain funds through arrangements that would be less attractive to us or which may require us to relinquish rights to certain or potential markets, either of which could have a material adverse effect on our business, financial condition and results of operations.

Item 8 - Financial Statements

The Financial Statements of the Company and the accompanying notes thereto, and the Report of Independent Registered Certified Public Accounting Firm are included as part of this Form 10-K beginning on Page F-1.
 

Item 9 - Changes in and Disagreements with Accountants on Accounting and Financial Disclosure  
 
None

Item 9a - Controls and Procedures

Evaluation of Disclosure Controls and Procedures
  
            The Company maintains “disclosure controls and procedures” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Acting President,  Chief Financial Officer, and Board of Directors, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognizes that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable assurance of achieving the desired objectives, and we necessarily are required to apply our judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures.
 
13

 
Our management, including our Acting President and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2009 and concluded that our disclosure controls and procedures were effective as of December 31, 2009.
 
Management’s Annual Report on Internal Control over Financial Reporting
 
Our management is responsible for establishing and maintaining internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. The Company’s internal control system is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes, in accordance with generally accepted accounting principles. Because of inherent limitations, a system of internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate due to change in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
   
Our management, including our Acting President and Chief Financial Officer, conducted an evaluation of the effectiveness of our internal control over financial reporting and concluded that our internal control over financial reporting was effective as of December 31, 2009.
   
This Form 10-K does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to temporary rules of the SEC that permit the Company to provide only management’s report in this annual report.

Changes in Internal Controls over Financial Reporting
  
                During the quarter ended December 31, 2009, there were no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) and 15d–15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
 
Item 9b - Other Information
 
None.
 

PART III

Item 10 - Directors and Executive Officers of the Registrant

The Company’s Directors are elected at the Annual Meeting of Stockholders and hold office until their successors are elected and qualified. The Company’s officers are appointed annually by the Board of Directors and serve at the pleasure of the Board. There are no family relationships between any of the officers, directors or significant employees of the Company.

The directors, executive officers, and significant employees of the Company at December 31, 2009 are as follows:

       
Positions and Offices Presently
Name
 
Age
 
Held with the Company
Edmund C. King
 
75
 
Director, Acting President, Chief Financial Officer, Treasurer
Gregory J. Newell
 
60
 
Director
John E. Scates
 
53
 
Director
 
EDMUND C. KING has served as our Chief Financial Officer and Director since February 9, 2000. In 2007, Mr. King began serving as our Acting President.  Until October 1, 1991, Mr. King was a partner in Ernst & Young, an international accounting and consulting firm. While at Ernst & Young, Mr. King was that firm’s Southern California senior healthcare partner and prior to that directed the Southern California healthcare practice for Arthur Young & Company, one of the predecessor firms of Ernst & Young. During his 30 years with Ernst & Young, Mr. King counseled clients in structuring acquisitions and divestitures; advised on the development of strategic plans; directed the preparation of feasibility studies; assisted with operational and financial restructuring; directed and supervised audits of client financial statements; and provided expert witness testimony and technical SEC consultation. Commencing in 1999, Mr. King became a financial consultant to SmartGate, L.C. that we acquired in February 2000. Mr. King has served as Chief Financial Officer and Director of SmartPlug, Inc. since November 2000 and Chief Financial Officer and Director of FlashPoint International, Inc. since October 2001. From January 1992, Mr. King has been a general partner of Trouver, an investment banking and financial consulting partnership. Mr. King is also a member of the Board of Directors of LTC Properties, Inc., an NYSE listed real estate investment trust. Mr. King is a graduate of Brigham Young University, having served on the National Advisory Council of that school’s Marriott School of Management, and has completed a Harvard University management course sponsored by Ernst & Young. Mr. King also has served as Chairman of the HFMA’s Long-Term Care Committee (Los Angeles Chapter) and is a past member of the National Association of Corporate Directors. He holds CPA certificate in the state of California.

Mr. King was nominated to serve our Board of Directors shortly after our Company was formed.  As part of his experience in public accounting and, then, later as a financial advisor, Mr. King was involved in the issues of a newly formed public company  and also in the raising of capital in various industries.  The Board of Directors believed this background and experience would be a beneficial fit with the Company’s needs and would provide the company with an experienced individual to  analyze the Company’s operations.

Ambassador GREGORY J. NEWELL has served as a Director of the Company since June 13, 2002. Ambassador Newell is an international business development strategist and former: U.S. Ambassador; U. S. Assistant Secretary of State; and White House Commissioned Officer, having served under four U.S. Presidents. From 1992 to the present, Ambassador Newell has served as President of International Commerce Development Corporation in Provo, Utah, an international business-consulting firm. From 1989 to 1991, Ambassador Newell served as President and International Development Strategist of Dow, Lohnes & Albertson International, a subsidiary of one of Washington, D.C.’s oldest and largest law firms. Ambassador Newell was U.S. Ambassador to Sweden from 1985 to 1989. Prior to that he was U.S. Assistant Secretary of State for International Organizational Affairs serving as the senior U.S. government official responsible for the formulation and execution of U.S. multilateral foreign policy in 96 international organizations including the United Nations, where he served as senior advisor to the 37th, 38th, 39th and 40th United Nations General Assemblies. He served as Director of Presidential Appointments and Scheduling and Special Assistant to President Ronald Reagan and Staff Assistant to President Gerald R. Ford. Ambassador Newell has also served on the boards of the Landmark Legal Foundation, Sutherland Institute and the Swedish-American Chamber of Commerce.

Mr. Newell was nominated to serve our Board of Directors at a time when the Company was attempting to expand its market presence.  His background includes an emphasis on marketing activities in government as well as private industry.  As a result, he provides not only knowledge of product and service marketing but also brings business insight into the governmental regulatory environment.
 
 
JOHN E. SCATES , a garage door industry engineer and consultant, was appointed to the Company’s Board of Directors on June 27, 2002. From June 1997 to the present, Mr. Scates has been President and Owner of Scates, Inc., a product design and failure analysis consultancy in Carrollton, Texas. From May 1993 to May 1997, Mr. Scates served as Manager of Research and Development for Windsor Door, Little Rock, Arkansas. From February 1985 to May 1993, Mr. Scates served as Manager of Structures at Overhead Door R & D/engineering, Dallas, Texas. Mr. Scates earned a BS Degree in Mechanical Engineering, Summa Cum Laude from Texas A & M University in 1979. Mr. Scates is licensed as a Professional Engineer in Texas, Florida and North Carolina.

Mr. Scates was nominated to serve on our Board of Directors at such time when we were seeking to expand our product offerings.   He is knowledgeable of the powered gate industry and brings experience in research and manufacturing.

Significant Employees

At December 31, 2009 we had no full time employees.  Our Chief Financial Officer, who also serves as our Acting President, is employed on a part-time basis.  We support operations by using consultants and contract piece workers as required. 

Compensation Committee and Compensation of Directors

Messrs., Newell and Scates serve on the Compensation Committee, which determines the compensation amounts to be paid to our directors, officers and employees.

Report of the Audit Committee
 
The Audit Committee is composed of two independent directors and operates under a written charter adopted by the Board of Directors. A copy of the Audit Committee Charter (as amended) is filed herewith as exhibit 10.58.  As described above, the Audit Committee is responsible for appointing and replacing our independent accountants; reviewing the results and scope of the independent accountants’ audit and the services provided by the independent accountants; reviewing compliance with legal and regulatory requirements; evaluating our audit and internal control functions; and ensuring the integrity of our financial statements. In fulfilling its oversight responsibilities, the Audit Committee reviewed the audited financial statements in the Annual Report with management, including a discussion of the quality, not just the acceptability, of the accounting principles, the reasonableness of significant judgments, and the clarity of disclosures in the financial statements.
 
The Audit Committee reviewed with the independent auditors, who are responsible for expressing an opinion on the conformity of those audited financial statements with generally accepted accounting principles, their judgments as to the quality, not just the acceptability, of our accounting principles, and such other matters as are required to be discussed with the Committee in accordance with the standards of the Public Company Accounting Oversight Board (United States). In addition, the Audit Committee has discussed with the independent auditors the auditors’ independence from management and the Company, including the matters in the written disclosures required by the Independence Standards Board and considered compatibility of non-audit services with the auditors’ independence .
 
The Audit Committee discussed with our independent auditors the overall scope and plans for their audit. The Committee meets with the independent auditors, with and without management present, to discuss the results of their examination, and the overall quality of our financial reporting. The Audit Committee held 4 meetings during 2009.
 
In reliance on the reviews and discussions referred to above, the Audit Committee recommended to our Board of Directors, and the Board approved, that the audited financial statements be included in our Annual Report on Form 10-K for the 2009 fiscal year for filing with the Securities and Exchange Commission. The Audit Committee and the Board of Directors have also recommended the selection of our independent auditors.
 
THE AUDIT COMMITTEE
 
Gregory Newell, Chairman
John Scates
 
 
Board Meetings and Independence
 
During the year ended December 31, 2009, the Board of Directors of the Company held   4   telephonic meetings.   Each director attended at least 75% of the aggregate of (1) the total number of meetings of the Board (held during the period for which he has been a director) and (2) the total number of meetings held by all committees of the Board on which he served (during the periods that he served).
 
Compliance with Section 16(a) of the Exchange Act

Section 16(a) of the Securities Exchange Act of 1934, as amended, requires the Company’s directors and executive officers to send reports of their ownership of the equity securities of the Company and of changes in such ownership to the SEC. SEC regulations also require the Company to identify in this Annual Report on Form 10-K any person subject to this requirement who failed to file any such report on a timely basis, including the following:  Edmund C. King, John E. Scates and Gregory J Newell.

Code of Ethics

Our board of directors has adopted a Code of Business Conduct and Ethics and Compliance Program which is applicable to Invisa, Inc. and to all our directors, officers and employees, including Invisa, Inc.’s principal executive officer and principal financial officer, principal accounting officer or comptroller, or other persons performing similar functions.

A copy of the Company’s Code of Ethics may be obtained free of charge by making the request to the Company in writing.

Director Compensation

We do not have a formal plan for compensating our directors but during the 2009 fiscal year each of our Directors were granted 125,000 shares, respectfully, of the Company’s common stock.
 
Our bylaws provide for us to indemnify our directors and officers to the extent permitted by Nevada law, with respect to actions taken by them on our behalf. We maintain a policy of directors’ and officers’ liability insurance for this purpose.
 
Compensation Committee Interlocks and Insider Participation
 
We have no interlocking director relationships. None of our executive officers is a member of the Compensation Committee of any company in which any director or executive officer is a member of our board of directors.
 
EXECUTIVE COMPENSATION
 
Compensation Discussion & Analysis
 
Overview.
 
This Compensation Discussion and Analysis is intended to describe the material factors underlying the compensation policies and decisions of the Company with regard to compensation paid to our executive officers in 2008 and 2009. The Compensation Committee oversees the Company’s executive compensation in accordance with its Charter and recommends to the Board of Directors compensation for the named executive officers. The Compensation Committee receives input and recommendations when requested from our executive officers.
 
Our only named executive officer at the end of fiscal 2009, Mr. Edmund King, does not have a written employment agreement and works on a part-time basis for the Company. Mr. King received no salary or other cash compensation during fiscal 2009 but did receive 125,000 shares of the Company’s common stock. However the Company charged $36,000 to operations for the value of his services.
 
 
Our compensation philosophy for our executive officers has been shaped by our lack of long-term financing and our severe shortage of operating capital. Accordingly, our compensation decisions and particularly our approach to allocating compensation between cash and non-cash elements of the compensation package reflect our goal to preserve cash whenever possible. In fiscal 2007 our compensation decisions for our executive officers emphasized option grants which we believe support our goals with regard to both retention and motivation of our executive officers. In making our compensation decisions, we strive to be aware of the level of compensation which is paid to executive officers of various companies that we consider to be comparable to us in size. Our goal is for the compensation paid to our named executive officers to be at or below the fiftieth percentile of the companies that we have identified as being comparable companies.
 
Base Salaries .
 
Mr. King did not receive any base salary in fiscal 2009; however, a proforma amount of $36,000 has been charged to operations and credited to additional paid in capital.

Option Grants.
 
 N o Options were granted in fiscal year 2009.

Perquisites .
 
Consistent with our philosophy to preserve cash, we have sought to limit perquisites. Perquisites paid to our named executive officers are discussed as footnotes to the following Summary Compensation Table. Our current policy for paying medical and dental insurance is not to pay insurance premiums. Our policy is not to pay for life insurance, long-term and short-term disability insurances and accidental death and dismemberment insurance. Our policy with regard to unused vacation for our executive group is to pay at the base salary rate for vacation not used during the calendar year of termination.
 
Change in Control Severance Policy.
 
None.
 
REPORT OF COMPENSATION COMMITTEE
 
The Compensation Committee of the Board of Directors has reviewed the Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K and discussed it with the Company’s management. Based on the Compensation Committee’s review and discussions with management, the Compensation Committee recommends to the Board of Directors that the Compensation Discussion and Analysis be included in the Company’s Annual Report on Form 10-K for fiscal 2009.
 
   
John E Scates, Chairman
Gregory J Newell
 
 
DIRECTOR COMPENSATION
FOR THE THREE YEARS ENDED DECEMBER 31, 2009
Name
 
Fees Earned
or Paid in
Cash ($)
Stock
Awards
($)
Option
Awards
($) 
Non-Equity
Incentive
Plan
Compensation
($)
Change in Pension
Value and Non Qualified
Deferred Compensation
Earnings ($)
All Other
Compensation
($)
Total
($) 
Edmund C. King -    
 2007
----
----
20,000
----
----
----
----
                                 
 2008
----
----
----
----
----
----
----
                                  
 2009
----
1,000
----
----
----
----
----
Greg Newell -           
 2007
----
----
----
----
----
----
----
                                  
 2008
----
----
----
----
----
----
----
                                  
 2009
----
1,000
----
----
----
----
----
John Scates -             
 2007
----
----
----
----
----
----
----
                                  
 2008
----
----
----
----
----
----
----
                                  
 2009
----
1,000
----
----
----
----
----
 
 
Employment Agreements with Executives
 
We have no written employment agreements .

Equity Incentive Plans
 
We have five stock plans as listed below:
 
Plan
Shares
Authorized
for Issuance
2000 Plan
1,200,000
2002 Plan
1,500,000
2003 Plan
1,500,000
2003A Plan
        3,500,000
2006 Plan
        2,500,000
 
      10,200,000
 
All of the Plans have been approved by the Board of Directors and all, except for the 2006 Plan, have been approved by the Shareholders.  All of the plans authorize awards of incentive stock options or non-qualified stock options to employees, directors, and consultants of our company and affiliates. The purposes of the Plans are as follows: to encourage and enable employees, directors, and consultants to acquire a proprietary interest in the growth and performance of our company; to generate an increased incentive for key employees and directors to contribute to our future success and prosperity, thus enhancing the value of our company for the benefit of our stockholders; and to enhance the ability of our company to attract and retain key employees and directors who are essential to progress, growth, and profitability.
 
The Plans are administered by the Compensation Committee of our Board (the “Administrator”). All members of our Compensation Committee are non-employee directors and outside directors, as defined in the Plans. Subject to the limitations set forth in the Plans, the administrator has the authority to grant options, to determine the purchase price of the shares of our common stock covered by each option, to establish the term of each option, to determine the number of shares of our common stock to be covered by each option, to establish vesting schedules, to designate options as incentive stock options or non-qualified stock options, and to determine the persons to whom grants are to be made.
 
The Administrator establishes the option exercise price, which in the case of incentive stock options, must be at least the market price (as such term is defined in the Plans) of our common stock on the date of the grant or, with respect to optionees who own at least 10% of the total combined voting power of all classes of our stock (a “10% Stockholder”), 110% of the market price on the date of the grant.
 
Options granted under the Plans are generally not transferable by the optionee except by will or the laws of descent and distribution, or pursuant to written agreement approved by the administrator relating to any non-qualified stock options in any manner authorized under applicable law. Except as provided in the applicable stock option agreement, options must be exercised within 90 days of termination for any reason other than disability, retirement, or death, within one year of termination by disability or retirement, or by a designated beneficiary within two years of death.
 
Except as provided to the contrary in the option agreement, options granted under the Plans vest in one-third annual increments, beginning on the grant date of the option. In no event may an incentive stock option be granted more than 10 years from the effective date of the plan or be exercised after either the expiration of 10 years from the grant date, or five years from the grant date in the case of a 10% Stockholder.
 
Incentive stock options may not vest for the first time with the respect to any optionee in a calendar year with a market price exceeding $100,000. Any option grants that exceed that amount shall be automatically treated as non-statutory stock options.
 
The Plans may be suspended, terminated, modified, or amended by our board, but no such suspension, termination, modification, or amendment may adversely affect the terms of any option previously granted without the consent of the affected optionee, and any amendment will be subject to stockholder approval to the extent required by applicable law, rules, or regulations.
 
We, from time to time, grant to our directors, executive officers and employees options to purchase our common stock under the Plans. As of December 31, 2009, Invisa had no options to purchase shares of common stock outstanding or exercisable.
 
 
401(k) Savings Plan
 
We do not have a 401(k) savings plan.
 
Limitation of Liability and Indemnification of Officers and Directors; Insurance
 
Our Officers and Directors are indemnified to the fullest extent provided by Nevada law.
 
We maintain a policy of directors’ and officers’ liability insurance to indemnify our directors and officers with respect to actions taken by them on our behalf.
 
Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers, or persons controlling our company pursuant to the foregoing provisions, we have been informed that, in the opinion of the Securities and Exchange Commission, such indemnification is against public policy as expressed in such Act and is therefore unenforceable.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.
 
The following table sets forth the beneficial ownership of shares of our common stock as of December 31, 2009 for:
 
 
each person (or group of affiliated persons) known by us to beneficially own more than 5% of our common stock;
 
 
each of our directors;
 
 
each named executive officer; and
 
 
all of our directors and executive officers as a group.
 
Information with respect to beneficial ownership has been furnished by each director, officer or beneficial owner of more than 5% of our common stock. Beneficial ownership is determined in accordance with the rules of the SEC and generally requires that such person have voting or investment power with respect to securities. In computing the number of shares beneficially owned by a person listed below and the percentage ownership of such person, shares of common stock underlying options, warrants or convertible securities held by each such person that are exercisable or convertible within 60 days of December 31, 2009 are deemed outstanding, but are not deemed outstanding for computing the percentage ownership of any other person.
 
Except as otherwise noted below, and subject to applicable community property laws, the persons named have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them.
 
Name and Address of Beneficial Owner (1)
Reporting Status
Aggregate
Number of Shares
Beneficially
Owned (2)
Percentage
of Shares
Beneficially
Owned
Stephen A. Michael  
5% Stockholder
3,939,261
10.08%
Michael R. Ries (Trustee)
5% Stockholder
1,864,584
  5.04
Frank A Ficarra (Trustee)
5% Stockholder
1,864,584
  5.04
Samuel S Duffey
5% Stockholder
5,082,740   (3)
12.63
Edmund C. King  
Acting President, CFO, Director
1,201,772   (4)
  3.31
Gregory J. Newell  
Director
   328,565
  0.93
John E. Scates  
Director
   328,565
  0.93
All officers and directors as a group
 
 1,858,902
  5.02 %
 
(1)
Unless otherwise provided herein all addresses are C/O Invisa, Inc., 1800 2 nd Street, Suite 965 Sarasota, FL 34236. The address for Mr. Ries is 4837 Swift Road, Suite 210, Sarasota, Florida 34231; for Mr. Ficarra is 4837 Swift Road, Suite 210, Sarasota, Florida 34231;

(2)
The percentage calculations are based on 35,156,081 shares that were outstanding as of December 31, 2009 plus the respective beneficial shares owned by each selling stockholder. Beneficial ownership is determined in accordance with rules of the Securities and Exchange Commission and includes voting power and/or investment power with respect to securities. Shares of common stock subject to options or warrants currently exercisable or exercisable within 60 days of December 31, 2009 are deemed outstanding for computing the number, and the percentages of outstanding shares beneficially owned by the person holding such options, but are not deemed outstanding for computing the percentage beneficially owned by any other person.
 
 
  (3)        
Includes 4,528,666 shares held in the name of Friday Harbour and 554,074 in Mr. Duffey’s name.

(4)
Includes 1,196,792 shares held in Mr. King’s name, and 5,000 shares held in the name of the King Family Trust.
 

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
 
Other than the compensation discussed herein, we had no items to disclose hereunder for 2009 except Mr. King had loaned  $20,124 to the Company during 2007 and an additional $136 in 2008 aggregating $20,260. The loans were not secured and are interest free; they remain outstanding and unpaid at December 31, 2009 and on the date hereof
 
PRINCIPAL ACCOUNTANT FEES AND SERVICES
 
During 2009 and 2008, annual fees approved for the year-end audit and interim reviews aggregated approximately   $32,000   for each year.    In addition, during 2009 and 2008 tax-related fees approved for compliance aggregated, approximately, $4,000 and $4,000 respectively.
 
The Audit Committee has established its pre-approval policies and procedures, pursuant to which the Audit Committee approved the foregoing audit services, provided by Stark, Winter Schenkein & Co., LLP in and 2008 and 2009 and Kingery & Crouse, PA in 2010. Consistent with the Audit Committee’s responsibility for engaging the Company’s independent auditors, all audit and permitted non-audit services require pre-approval by the Audit Committee. The full Audit Committee approves proposed services and fee estimates for these services. The Audit Committee chairperson or its designee has been designated by the Audit Committee to approve any services arising during the year that were not pre-approved by the Audit Committee. Services approved by the Audit Committee chairperson are communicated to the full Audit Committee at its next regular meeting and the Audit Committee reviews services and fees for the year at each such meeting.

Effective January 2010, Stark, Winter Schenkein & Co., LLP was replaced by Kingery & Crouse, PA as the Company’s independent auditors.
 
 
 
 
PART IV
 
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
 
(a) The following documents are filed as part of this Report:
 
Exhibits
 
The following exhibits are filed as part of, or incorporated by reference into, this amendment to annual report on Form 10-K/A:
 
INDEX TO EXHIBITS

ITEM NO.
DESCRIPTION
2.1 1
Agreement of Merger and Plan of Reorganization dated 2/25/02 by and among SmartGate Inc., SmartGate/RadioMetrix Acquisition Corp. and Radio Metrix Inc., Letter of Clarification, and Amendment dated as of April 24, 2003
   
10.1 1
Quarterly Revenue Based Payment Agreement by and among the Company and Stephen A. Michael, Spencer Charles Duffey Irrevocable Trust u/a/ d July 29, 1998, Elizabeth Rosemary Duffey Irrevocable Trust u/a/d July 29, 1998, Robert T. Roth, William W. Dolan dated as of February 25, 2002; and Amendment dated as of April 24, 2003
   
10.2 1
Promissory Note, Security Agreement, and Escrow Agreement - Re: Daimler Capital Partners, Ltd. - loan and stock options; Stock Option Agreement with Daimler Capital Partners, Ltd. - October 28, 2002; Stock Option Agreement with Daimler Capital Partners, Ltd. - February 28, 2003
   
10.3 1
Form of Plan 2003 Option Agreement with Joseph F. Movizzo - May 13, 2003 (including form of Letter of Investment Intent)
   
10.4 1
Consulting Agreement - March 2003 between Crescent Fund, Inc. and the Company
   
10.5 1
Agreement dated as of April 24, 2003 between Alan A. Feldman and the Company
   
10.6 1
Financing Agreement dated as of May 9, 2003 between BarBell Group, Inc. and the Company
   
10.7 1
Series 2003A 7% Convertible Note Due June 9, 2004, dated May 9, 2003 from the Company to BarBell Group, Inc.
   
10.8 1
Investment Agreement dated as of May 9, 2003 between BarBell Group, Inc. and the Company
   
10.9 1
Warrant to Purchase Shares of Common Stock dated as of May 9, 2003, issued by the Company to BarBell Group, Inc.
   
10.10 1
Registration Rights Agreement dated as of May 9, 2003 between the Company and BarBell Group, Inc.
   
10.11 1
Broker-Dealer Placement Agent Selling Agreement - May 2003 between Capstone Partners LC and the Company
   
10.12 2
Amended and Restated Regulation S Subscription Agreement - July 22, 2003 between Capstone Partners LC and the Company
   
10.13 2
Amended and Restated Regulation S Subscription Agreement - July 22, 2003 executed by Nautilus Technologies, Ltd. - subscribing for 125,000 Units
  
 
10.14 2
Amended and Restated Regulation S Subscription Agreement - July 22, 2003 executed by GM Capital Partners, Ltd. - subscribing for 50,500 Units
   
 
 
10.15 2
Amended and Restated Regulation S Subscription Agreement - July 22, 2003 executed by Kallur Enterprises, Ltd. - subscribing for 50,000 Units
   
10.16 2
Publicity Agreement - July 2003 between Capital Financial Media, Inc. and the Company
 
10.17 2
Consulting Agreement - July 2003 between National Financial Communications Corp. and the Company
   
10.18 2
Agreement - July 2003 between Brooks Houghton & Company, Inc. and the Company
   
10.19 2
Non-Exclusive Financial Advisor Agreement - July 2003 between Source Capital Group, Inc. and the Company
   
10.20 2
Consulting Agreement - July 2003 between Patrick W.H. Garrard d/b/a The Garrard Group of West Redding, CT and the Company
   
10.21 2
Investment Agreement Modification I dated as of July 21, 2003 by and among Invisa, Inc. and BarBell Group, Inc.
   
10.22 2
Joint Development Agreement - July 2003 between Dominator International Ltd. And SmartGate, L.C.
   
10.23 3
Engagement Agreement dated September 9, 2003 between G.M. Capital Partners, Ltd and Invisa, Inc.
   
10.24 4
Employment Agreement dated November 6, 2003 between Herb Lustig and Invisa, Inc.
   
10.25 4
Severance Agreement dated November 13, 2003 between Samuel S. Duffey and Invisa, Inc.
   
10.26 4
Agreement dated November 13, 2003 between Invisa, Inc. and the Duffey related shareholders
   
10.27 5
SDR Metro Inc. letter extension agreement
   
10.28 5
SDR Metro Inc. confirmation letter agreement
   
10.29 5
Severance Agreement dated January 26, 2004 between Stephen A. Michael and Invisa, Inc.
   
10.30 5
Consulting Agreement dated January 26, 2004 between Stephen A. Michael and Invisa, Inc.
   
10.31 5
Severance Agreement dated December 31, 2003 between William W. Dolan and Invisa, Inc.
   
10.32 5
Agreement dated February 11, 2004 between The Video Agency, Inc. and Invisa, Inc.
   
10.33 5
Employment Agreement dated March 2004 between Charles Yanak and Invisa, Inc.
   
10.34 5
2003-A Employee, Director, Consultant and Advisor Stock Compensation Plan.
   
10.35 5
First Amendment to Invisa, Inc., 2003 Incentive Plan Date As of November 6, 2003
   
10.36 5
Stock Option Agreement for Herb M. Lustig dated November 6, 2003
   
10.37 6
Subscription Agreement for issuance of 22,000 shares of Series A Convertible Preferred Stock and Common Stock Warrants
   
10.38 6
Registration Rights Agreement
     
10.39 6
Warrants to Purchase Common Stock (Mercator Momentum Fund, LP, Mercator Advisory Group, LLC, and Monarch Pointe Fund, Ltd.)
 
     
 10.40 6
Certificate of Designations of Preferences and Rights of Series A Convertible Preferred Stock.


   
10.41 7
Marketing Agreement between Aurelius Consulting Group and Invisa, Inc.
   
10.42 7
Lease Agreement among HAR-WAL ASSOCIATES, INC. and WR-I ASSOCIATES, LTD. and Invisa, Inc. dated September dated September 23, 2004
   
10.43 11
Business consulting agreement
   
10.44 11
Opinion of counsel regarding legality of Common Stock
   
10.45 
Consent of Aidman, Piser and Company, PA
   
10.46 11
Consent of Legal Counsel
   
10.47 11
Power of Attorney relating to subsequent amendments
   
10.48 9
Promissory note agreements dated October 10, 2006 by and between Invisa, Inc. and M.A.G. Capital, LLC; Mercator Momentum Fund III, LP and Monarch Pointe Fund, Ltd. Borrowing Certificates and Forms of Assignments
   
10.49 9
Warrant Agreement dated October 10, 2006 by and between Invisa, Inc. and Ocean Park Advisors, LLP
     
10.50 9
UCC Financing Statements
 
     
10.51 9
Schedule of Advances: Permitted Payments
 
     
10.52 10
Business Consulting Agreement dated August 14, 2006 between Invisa, Inc. and John Anderson
 
     
10.53 17
Carl A. Parks Employment agreement
 
     
10.54 16
Forbearance and Modification agreement dated July 27, 2007
 
     
10.55 16
Promissory Note dated July 25, 2007
 
     
10.56 15
Promissory Note dated March 6, 2007
 
     
10.57 16
Forbearance and Modification Agreement
 
     
10.58 18
Audit Committee Charter
 
     
10.59 18
Senior Secured Promissory Note date March 28, 2008
 
     
10.60 18
Forbearance and Modification Agreement dated March 28, 2008
 
     
10.61 18
Extension of Promissory Note dated April 11, 2008
 
     
10.62 19
Senior Secured Promissory Note dated July 1, 2008
 
     
10.63 19
Forbearance and Modification Agreement dated June 1, 2008
 
     
10.64  20
Note and Share Exchange Agreement dated July 31, 2008
 
     
10.65 20
Certificate of Designations of Preferences and Rights dated December 22, 2008.
 
     
10.66 8
Senior Secured Promissory Note dated March 24, 2010.
 
     
 
 
10.67 8
Senior Secured Promissory Note (Line of Credit) dated March 24, 2010.
     
         
10.68 8
Note Extension Agreement dated March 24, 2010.
     
         
10.69 8
Note Extension Agreement dated March 24, 2010.
     
         
10.70 8
Note Extension Agreement dated March 24, 2010.
     
         
10.71 8
Note Extension Agreement dated March 24, 2010.
     
         
10.72 8
Note Extension Agreement dated March 24, 2010.
     
         
10.73 8
Terms of Exchange dated January 11, 2010.
     
         
10.74 8
Amended and Restated  Certificate of Designations of Preferences and Rights of Series B of Convertible Preferred Stock of Invisa, Inc. dated January 11, 2010.
     
         
10.75 8
Letter Term Sheet and Consent Documents dated January 11, 2010.
     
         
10.76 8
Share Exchange Agreement dated January 11, 2010.
     
         
10.77 8
Property Lease dated February 8, 2010.
     
         
31.1 8
Chief Executive Officer Certification Pursuant to Securities Exchange Act Rules 13a-14 and 15d-14 as Adopted Pursuant to the Section 302 of the Sarbanes-Oxley Act of 2002.
     
         
31.2 8
Chief Financial Officer Certification Pursuant to Securities Exchange Act Rules 13a-14 and 15d-14 as Adopted Pursuant to the Section 302 of the Sarbanes-Oxley Act of 2002.
     
         
32.1 8
Certification Pursuant to 18 U.S.C. Section 1350.
     
         
32.2 8
Certification Pursuant to 18 U.S.C. Section 1350.
     
         
1
Previously filed on June 23, 2003 with Invisa’s Form 10-KSB for the year ended December 31, 2002 and are incorporated by reference.
     
         
2
Previously filed on August 1, 2003 with Invisa’s Form 10-QSB for the quarter period ended June 30, 2003 and are incorporated by reference.
   

3
Previously filed on September 17, 2003 with Invisa’s Form 8-KA (Amendment No. 1) dated September 9, 2003 and is incorporated by reference.

4
Previously filed on November 14, 2003 with Invisa’s Form 8-K dated November 6, 2003 and are incorporated by reference.

5
Previously filed on April 14, 2004 with Invisa Form 10-KSB for the year ended December 31, 2003 and incorporated herein by reference.

6
Previously filed on August 18, 2004 with Invisa Form 10-QSB and incorporated herein by reference.

7
Previously filed on February 7, 2005 with Invisa Form 10-KSB for the year ended December 31, 2004 and incorporated herein by reference.

8
Filed herewith.
   
9
Previously filed on October 10, 2006 with Invisa Form 8-K/A dated October 10, 2006 and are incorporated by reference.
 
 
10
Previously filed on August 17, 2006 with Invisa Form 8-K dated August 14, 2006 and are incorporated by reference.
   
11
Previously filed on August 14, 2006 with Invisa Form S-8 dated August 14, 2006 and are incorporated by reference
   
12
Previously filed on April 14, 2007 with Invisa For 10-KSB and incorporated herein by reference.
   
13
Previously filed on August 1, 2007 with Invisa’s Form 8-K and incorporated herein.
   
14
Previously filed on July 26, 2007 with Invisa’s Form 8-K and incorporated herein.
   
14  1
Code of Business Conduct and Ethics and Compliance Program
   
15
Previously filed on March 6, 2007 with Invisa’s Form 8-K and incorporated herein.
   
16
Previously filed on November 14, 2007 with Invisa Form 10-QSB and incorporated herein by reference.
   
17
Previously filed on April 18, 2007 with Invisa Form 10-KSB and incorporated herein by reference.
   
18
Previously filed on April 14, 2008 with Invisa Form 10-KSB and incorporated herein by reference.
   
19
Previously filed on July 30, 2008 with Invisa Form 8-K and incorporated herein by reference.
   
20
Previously filed on January 13, 2009 with Invisa Form 8-K and incorporated herein by reference.
 
 
 
26

 
SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
     
 
INVISA, INC.
     
Dated:   March 31,  2010
By:  
/s/ Edmund C. King
 
Edmund C. King
 
Acting President
     
   
     
Dated:   March 31 , 20010
By:  
/s/ Edmund C King
 
Edmund C King
 
Chief Financial Officer
 
 
 
 
NOW ALL PERSONS BY THESE PRESENTS , that each of the undersigned hereby constitutes and appoints Edmund C. King as his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him and on his behalf to sign, execute and file this annual report on Form 10-K and any or all amendments without limitation to this annual report, and to file the same, with all exhibits thereto and any and all documents required to be filed with respect therewith, with the Securities and Exchange Commission or any regulatory authority, granting unto such attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith and about the premises in order to effectuate the same as fully to all intents and purposes as he might or could do if personally present, hereby ratifying and confirming all that such attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done.

In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


Dated:   March 31 , 20010
/s/ Edmund C. King
 
 
Edmund C. King, Acting President
   
Dated:   March 31 , 20010
/s/ Edmund C. King
 
 
Edmund C. King, Chief Financial Officer, Director
   
Dated:   March 31 , 20010
/s/ Gregory J. Newell
 
 
Gregory J. Newell, Director
   
Dated:   March 31 , 20010
/s/ John E. Scates
 
 
John E. Scates, Director
 
 
 

Report of Independent Registered Certified Public Accounting Firm


Board of Directors and Stockholders
Invisa, Inc.

We have audited the accompanying balance sheets of Invisa, Inc. (the “Company”) as of December 31, 2008 and 2009, and the related statements of operations, stockholders’ (deficit), and cash flows for the years then ended. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with standards of the Public Company Accounting Oversight Board (United States of America). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Invisa, Inc. as of December 31, 2008 and 2009, and the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America.

/s / Kingery & Crouse, PA
 
Kingery & Crouse, PA
Certified Public Accountants
    Tampa, Florida
    March 31, 2010
 

Invisa, Inc.
BALANCE SHEETS
 

 
December 31,
 
   
2008
   
2009
 
ASSETS
           
Current assets:
           
Cash and cash equivalents
  $ ----     $ 157  
Accounts receivable
    6,498       6,187  
Inventories
    35,115       15,724  
Prepaids and other assets
    5,366       5,158  
Total current assets
    46,979       27,226  
                 
Furniture, fixtures and equipment, net of $39,718 and $40,130, respectively of accumulated depreciation
    2,800       2,389  
Total assets
  $ 49,779     $ 29,615  
                 
LIABILITIES AND STOCKHOLDERS’ DEFICIT
               
                 
Current liabilities:
               
Bank overdraft
  $ 191     $ ----  
Accounts payable, trade
    118,410       98,108  
Accrued interest expense
    30,377       92,376  
Due to stockholders and officers
    105,334       105,334  
Notes Payable
    494,030       ----  
Preferred dividends payable
    261,375       315,720  
                 
Total current liabilities
    1,009,717       611,538  
                 
Notes Payable
    ----       563,400  
                 
Stockholders’ Deficit
               
Convertible Preferred Stock, 5 million shares authorized ($0.001 par value):
               
Series A, 14,500 and 9,715, respectively, shares issued and outstanding
    798,500       798,500  
Series B, 10,000 and 9,000, respectively, shares issued and outstanding
    900,000       900,000  
Series C, 6,668 and 6,668, respectively, shares issued and outstanding
    654,907       654,907  
Common Stock; 95,000,000 shares authorized ($.001 par value), 34,781,081and 35,156,081, respectively, shares issued and outstanding
    34,781       35,156  
Additional paid-in capital
    31,975,470       32,016,025  
Accumulated deficit
    (35,323,596 )     (35,549,911 )
                 
Total stockholders’ deficit
    (959,938 )     (1,145,323 )
                 
Total liabilities and stockholders’ deficit
  $ 49,779     $ 29,615  

 
See notes to financial statements.
 
 
Invisa, Inc.
STATEMENTS OF OPERATIONS
 
   
Years Ended December 31,
 
   
2008
   
2009
 
             
Net sales
  $ 102,297     $ 147,589  
Other operating revenues
    ----       ----  
      102,297       147,589  
Costs and expenses:
               
Cost of goods sold
    60,558       64,113  
Selling, general and administrative expenses
    256,999       219,533  
                 
Loss from operations
    (215,260 )     (136,057 )
                 
Other income (expense):
               
   Interest (expense)and other, net
    (56,348 )     (62,202 )
Debt extinguishment gain
    377,454       24,714  
Other
    ----       1,575  
      321,106       (35,913 )
Income (Loss) before income tax            
    105,846       (171,970 )
Income tax
    ----       ----  
                 
Net Income (Loss)
    105,846       (171,970 )
                 
Preferred Stock dividends
    (87,750 )     (54,345 )
Net Income (Loss) applicable to Common Stockholders
  $ 18,096     $ (226,315 )
                 
Net Income (Loss) per share applicable to Common Stockholders:
               
Basic and diluted
  $ 0.00     $ (0.00 )
                 
Weighted average Common Stock shares outstanding:
Basic and diluted
    33,230,793       34,875,602  
 
See notes to financial statements.
 
 
Invisa, Inc.
STATEMENTS OF STOCKHOLDERS’ (DEFICIT)
 
 
   
Convertible Preferred
Stock
   
Common Stock
   
Additional
paid –
in capital
   
Accumulated
Deficit
   
Total
 
   
Shares
   
Amount
   
Shares
   
Amount
                   
BALANCE AT DECEMBER 31, 2007     24,500     $ 2,277,000       25,066,126     $ 25,066     $ 31,797,807     $ (35,341,692 )   $ (1,241,820 )
                                                         
Employee share-based compensation
    ----       ----       2,667,361       2,667       24,006       ----       26,674  
Pro Forma officer compensation
    ----       ----       ----       ----       35,500       ----       35,500  
Shares issued for settlement of debt                          
    ----       ----       7,047,594       7,048       62,709       ----       69,757  
Contribution to capital
    ----       ----       ----       ----       55,448       ----       55,448  
Preferred Stock Series B dividend
    ----       ----       ----       ----       ----       (87,750 )     (87,750 )
Preferred Series C Stock (6,185 shares) issued for settlement of debt, dividends and Preferred Series A and B Stock (4,785 shares and 1,000 shares, respectively)
    400       35,541       ----       ----       ----       ----       35,541  
Preferred Series C Stock issued for settlement of debt
    483       40,866       ----       ----       ----       ----       40,866  
Net Income
    ----       ----       ----       ----       ----       105,846       105,846  
BALANCE AT DECEMBER 31, 2008
    25,383       2,353,407       34,781,081       34,781       31,975,470       (35,323,596 )     (959,938 )
Pro Forma officer compensation
    ----       ----       ----       ----       36,000       ----       36,000  
Shares issued for settlement of debt                          
    ----       ----       ----       ----       1,930       ----       1,930  
Preferred Stock Series B dividend
    ----       ----       ----       ----       ----       (54,345 )     (54,345 )
Issuance of Common Stock to Board Members
    ----       ----       375,000       375       2,625               3,000  
Preferred Series C Stock issued for settlement of debt
    ----       ----       ----       ----       ----       ----       ----  
Net Income
    ----       ----       ----       ----       ----       (171,970 )     (171,970 )
BALANCE AT DECEMBER 31, 2009
    25,383     $ 2,353,407       35,156,081     $ 35,156     $ 32,016,025     $ (35,549,911 )   $ (1,145,323 )

See notes to financial statements.


Invisa, Inc.
STATEMENTS OF CASH FLOWS
   
Years Ended December 31,
 
   
2008
   
2009
 
             
Cash flows from operating activities:
           
Net income (loss)
  $ 105,846     $ (171,970 )
Adjustments to reconcile net income (loss) to net cash used in operating activities:
               
Depreciation and amortization
    515       411  
Share Based Compensation and Proforma officer compensation
    62,174       39,000  
Debt extinguishment gain
    (377,454 )     (24,714 )
Changes in operating assets and liabilities:
               
Accounts receivable
    12,827       311  
Inventories
    (14,663 )     19,391  
Prepaids and other assets
    (1,068 )     209  
Accounts payable, trade
    (53,276 )     6,341  
Accrued expenses
    ----       61,999  
Net cash used in operating activities
    (265,099 )     (69,022 )
                 
Cash flows from investing activities:
               
Purchases of furniture, fixtures and equipment
    (103 )     ----  
Net cash used in investing activities
    (103 )     ----  
                 
Cash flows from financing activities:
               
Proceeds from notes payable
    262,730       69,370  
Bank overdraft
    191       (191 )
Net cash provided by financing activities
    262,921       69,179  
                 
Net (decrease) increase in cash
    (2,281 )     157  
Cash at beginning of period
    2,281       ----  
Cash (overdraft) at end of period
  $ ----     $ 157  

See notes to financial statements.
 
 
Invisa, Inc.

STATEMENTS OF CASH FLOWS - CONTINUED
 
   
Year Ended December 31,
 
   
2008
   
2009
 
             
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
           
Cash paid for interest
  $ 37,132     $ 203  
                 
Cash paid for Income Taxes
  $ ----     $ ----  
                 
Non-cash financing and investing activities:
               
                 
Exchange of liabilities for Common Stock
  $ 69,757     $ -----  
                 
Preferred dividends accrued as liabilities
  $ 87,750     $ 54,345  
                 
Exchange of liabilities for Preferred Stock and dividends paid in Preferred Stock
  $ 76,407     $ ----  
 
 
 See notes to financial statements.

 
Invisa, Inc.
NOTES TO FINANCIAL STATEMENTS

NOTE A - DESCRIPTION OF ORGANIZATION AND BUSINESS

Invisa, Inc., (the “Company” or “Invisa”) is an enterprise that incorporates safety system technology and products into automated closure devices, such as parking gates, sliding gates, overhead garage doors and commercial overhead doors. Invisa has also demonstrated production-ready prototypes of security products for the museum and other markets.   The Company is currently manufacturing and selling powered closure safety devices.

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates

In preparing the financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expense during the reporting period. Actual results could differ from those estimates.

 Cash and Cash Equivalents

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash and cash equivalents at a major commercial bank. Such amounts are occasionally in excess of the maximum federally insured amounts.

Accounts Receivable, Major Customer Information and Export Sales

Accounts receivable are due primarily from companies in the gate manufacturing industry located throughout the United States and the United Kingdom. Credit is extended based on an evaluation of the customers’ financial condition and, generally, collateral is not required. Account balances are evaluated for collectability based on the condition of the customers’ credit including repayment history and trends and relative economic and business conditions. Bad debts have not been significant.  During 2008, Magnetic Automation Corp. was our largest customer, comprising approximately 21% of our product revenues. During 2009, Automatic Systems America was our largest customer, comprising approximately 11% of our product revenues.

Inventories

Inventories are stated at the lower of cost or market.  Cost is determined using an averaging method, which approximates   the first-in, first-out method.  Inventory consists principally of finished goods and raw materials.

Furniture, Fixtures and Equipment

Furniture, fixtures, and equipment are stated at cost and are depreciated on a straight-line basis over their estimated useful lives, principally five years. Leasehold improvements are amortized over the term of the lease or the estimated useful lives, whichever is shorter.   Depreciation expense was $515 and   $411 for 2008 and 2009 respectively.

Revenue

In general, the Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured.

Product sales under fixed price arrangements are recognized as revenue upon shipment of product (when title transfers to the purchaser) and collectability is assured. Other operating revenues relate to services and are recorded when services are complete.
 
 
Shipping costs

Shipping and handling costs are included in cost of sales in the accompanying statements of operations.

Research and Development Costs

Research and development costs consist of direct costs that are associated with the development of the Company’s technology. These costs are expensed as incurred.  During the years 2008 and 2009, the Company did not incur research and development expense.

Advertising Costs

The Company’s policy is to expense advertising costs as incurred.

Warranty Costs

The Company warrants its products for ninety days. Estimated warranty costs are recognized in the period product is shipped. However, there have been no significant warranty costs incurred through December 31, 2009, nor are any significant amounts expected to occur subsequently. Accordingly, no warranty liability has been recognized for any period presented.

Income Taxes

The Company follows ASC 740 Income Taxes for recording the provision for income taxes. Deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expenses or benefits are based on the changes in the asset or liability each period. If available evidence suggests that it is more likely than not that some portion or all of the deferred tax assets will not be realized, a valuation allowance is required to reduce the deferred tax assets to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income taxes in the period of change.
 
Beginning January 1, 2007, we adopted ASC 740-10-05 Accounting for Uncertainty in Income Taxes . The Interpretation prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement.

Financial Instruments

The Company’s financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, notes payable and due to stockholders. The carrying amounts of these financial instruments approximate their fair value, due to the short-term nature of these items and the use of market rates of interest.  The carrying value of the Company’s long-term debt approximates fair value based on the terms and conditions of similar debt instruments.

Derivative Financial Instruments

The Company generally does not use derivative financial instruments to hedge exposures to cash-flow risks or market-risk that may affect the fair values of its financial instruments. However, certain other financial instruments, such as warrants and embedded conversion features that are indexed to the Company’s common stock, are classified as liabilities when either (a) the holder possesses rights to net cash settlement or (b) physical or net-share settlement is not within the control of the Company. In such instances, net-cash settlement is assumed for financial accounting and reporting, even when the terms of the underlying contracts do not provide for net-cash settlement. Such financial instruments are initially recorded at fair value and subsequently adjusted to fair value at the close of each reporting period.

Impairment of Long-Lived Assets

The Company evaluates the recoverability of its long-lived assets or asset groups, annually; or whenever adverse events or changes in business climate indicate that the expected undiscounted future cash flows from the related asset may be less than previously anticipated. If the net book value of the related asset exceeds the undiscounted future cash flows of the asset, the carrying amount would be reduced to the present value of its expected future cash flows and an impairment loss would be recognized. There were no impairments in 2008 or 2009.

 
Income (Loss) per Share

Basic earnings (loss) per share are calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period.  Diluted earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares and dilutive common stock equivalents outstanding. During periods in which the Company incurs losses common stock equivalents, if any, are not considered, as their effect would be anti dilutive.

At December 31, 2009 the preferred stock was convertible into 20,757,500   shares of common stock, which has not been considered in the calculation of diluted loss per share since the effect would be anti-dilutive.

  Equity-Based Compensation

The Company accounts for stock based compensation in accordance with ASC 718 Stock Compensation. This Statement requires that the cost resulting from all share-based transactions be recorded in the financial statements. The Statement establishes fair value as the measurement objective in accounting for share-based payment arrangements and requires all entities to apply a fair-value-based measurement in accounting for share-based payment transactions with employees. The Statement also establishes fair value as the measurement objective for transactions in which an entity acquires goods or services from non-employees in share-based payment   transactions.

Recent Accounting Pronouncements
 
Recently Issued Accounting Pronouncements
 
Adoption of New Accounting Standards
 
Accounting Standards Codification
 
In June 2009, the FASB issued Statement of Financial Accounting Standards (“SFAS”) No. 168, The FASB Accounting Standards Codification and the Hierarchy of Generally Accepted Accounting Principles  (the “Codification”). This standard replaces SFAS No. 162, The Hierarchy of Generally Accepted Accounting Principles, and establishes only two levels of U.S. generally accepted accounting principles (“GAAP”), authoritative and nonauthoritative. The FASB ASC has become the source of authoritative, nongovernmental GAAP, except for rules and interpretive releases of the SEC, which are sources of authoritative GAAP for SEC registrants. All other nongrandfathered, non-SEC accounting literature not included in the Codification will become nonauthoritative. This standard is effective for financial statements for interim or annual reporting periods ending after September 15, 2009. The adoption of the Codification changed the Company’s references to GAAP accounting standards but did not impact the Company’s results of operations, financial position or liquidity.
 
Participating Securities Granted in Share-Based Transactions
 
Effective January 1, 2009, the Company adopted a new accounting standard included in ASC 260, Earnings Per Share (formerly FASB Staff Position (“FSP”) Emerging Issues Task Force (“EITF”) 03-6-1, Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities).  The new guidance clarifies that non-vested share-based payment awards that entitle their holders to receive nonforfeitable dividends or dividend equivalents before vesting should be considered participating securities and included in basic earnings per share. The Company’s adoption of the new accounting standard did not have a material effect on previously issued or current earnings per share.
 
 
Business Combinations and Noncontrolling Interests
 
Effective January 1, 2009, the Company adopted a new accounting standard included in ASC 805, Business Combinations (formerly SFAS No. 141(R), Business Combinations).  The new standard applies to all transactions or other events in which an entity obtains control of one or more businesses. Additionally, the new standard requires the acquiring entity in a business combination to recognize all (and only) the assets acquired and liabilities assumed in the transaction; establishes the acquisition-date fair value as the measurement date for all assets acquired and liabilities assumed; and requires the acquirer to disclose additional information needed to evaluate and understand the nature and financial effect of the business combination. The Company’s adoption of the new accounting standard did not have a material effect on the Company’s consolidated financial statements.
 
Effective January 1, 2009, the Company adopted a new accounting standard included in ASC 810, Consolidations (formerly SFAS 160, Noncontrolling Interests in Consolidated Financial Statements).  The new accounting standard establishes accounting and reporting standards for the noncontrolling interest (or minority interests) in a subsidiary and for the deconsolidation of a subsidiary by requiring all noncontrolling interests in subsidiaries be reported in the same way, as equity in the consolidated financial statements. As such, this guidance has eliminated the diversity in accounting for transactions between an entity and noncontrolling interests by requiring they be treated as equity transactions. The Company’s adoption of this new accounting standard did not have a material effect on the Company’s consolidated financial statements.
 
Fair Value Measurement and Disclosure
 
Effective January 1, 2009, the Company adopted a new accounting standard included in ASC 820, Fair Value Measurements and Disclosures (“ASC 820”) (formerly FASB FSP No 157-2, Effective Date of FASB Statement No. 157), which delayed the effective date for disclosing all non-financial assets and non-financial liabilities, except for items that are recognized or disclosed at fair value on a recurring basis (at least annually). This standard did not have a material impact on the Company’s consolidated financial statements.
 
In April 2009, the FASB issued new guidance for determining when a transaction is not orderly and for estimating fair value when there has been a significant decrease in the volume and level of activity for an asset or liability. The new guidance, which is now part of ASC 820 (formerly FSP 157-4, Determining Fair Value When the Volume and Level of Activity for the Asset or Liability Have Significantly Decreased and Identifying Transactions That Are Not Orderly), requires disclosure of the inputs and valuation techniques used, as well as any changes in valuation techniques and inputs used during the period, to measure fair value in interim and annual periods. In addition, the presentation of the fair value hierarchy is required to be presented by major security type as described in ASC 320, Investments — Debt and Equity Securities . The provisions of the new standard were effective for interim periods ending after June 15, 2009. The adoption of the new standard on April 1, 2009 did not have a material on the Company’s consolidated financial statements.
 
In April 2009, the Company adopted a new accounting standard included in ASC 820, (formerly FSP 107-1 and Accounting Principles Board (“APB”) 28-1, Interim Disclosures about Fair Value of Financial Instruments).  The new standard requires disclosures of the fair value of financial instruments for interim reporting periods of publicly traded companies in addition to the annual disclosure required at year-end. The provisions of the new standard were effective for the interim periods ending after June 15, 2009. The Company’s adoption of this new accounting standard did not have a material effect on the Company’s consolidated financial statements.
 
In August 2009, the FASB issued new guidance relating to the accounting for the fair value measurement of liabilities. The new guidance, which is now part of ASC 820, provides clarification that in certain circumstances in which a quoted price in an active market for the identical liability is not available, a company is required to measure fair value using one or more of the following valuation techniques: the quoted price of the identical liability when traded as an asset, the quoted prices for similar liabilities or similar liabilities when traded as assets, or another valuation technique that is consistent with the principles of fair value measurements. The new guidance clarifies that a company is not required to include an adjustment for restrictions that prevent the transfer of the liability and if an adjustment is applied to the quoted price used in a valuation technique, the result is a Level 2 or 3 fair value measurement. The new guidance is effective for interim and annual periods beginning after August 27, 2009. The Company’s adoption of the new guidance did not have a material effect on the Company’s consolidated financial statements.
 
 
Derivative Instruments and Hedging Activities
 
Effective January 1, 2009, the Company adopted a new accounting standard included in ASC 815, Derivatives and Hedging (SFAS No. 161, Disclosures about Derivative Instruments and Hedging Activities, an amendment of SFAS No.133). The new accounting standard requires enhanced disclosures about an entity’s derivative and hedging activities and is effective for fiscal years and interim periods beginning after November 15, 2008. Since the new accounting standard only required additional disclosure, the adoption did not impact the Company’s consolidated financial statements.
 
Other-Than-Temporary Impairments
 
In April 2009, the FASB issued new guidance for the accounting for other-than-temporary impairments. Under the new guidance, which is part of ASC 320, Investments — Debt and Equity Securities (formerly FSP 115-2 and 124-2, Recognition and Presentation of Other-Than-Temporary Impairments), and other-than-temporary impairment is recognized when an entity has the intent to sell a debt security or when it is more likely than not that an entity will be required to sell the debt security before its anticipated recovery in value.  The new guidance does not amend existing recognition and measurement guidance related to other-than-temporary impairments of equity securities and is effective for interim and annual reporting periods ending after June 15, 2009. The Company’s adoption of the new guidance did not have a material effect on the Company’s consolidated financial statements.
 
Subsequent Events
 
I n May 2009, the FASB issued new guidance for subsequent events. The new guidance, which is part of ASC 855, Subsequent Events  (formerly SFAS No. 165,  Subsequent Events)  is intended to establish general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued or are available to be issued. Specifically, this guidance sets forth the period after the balance sheet date during which management of a reporting entity should evaluate events or transactions that may occur for potential recognition or disclosure in the financial statements, the circumstances under which an entity should recognize events or transactions occurring after the balance sheet date in its financial statements, and the disclosures that an entity should make about events or transactions that occurred after the balance sheet date. The new guidance is effective for fiscal years and interim periods ended after June 15, 2009 and will be applied prospectively. The Company’s adoption of the new guidance did not have a material effect on the Company’s consolidated financial statements. The Company evaluated subsequent events through the date the accompanying financial statements were issued, which was March 31, 2010.
 
Accounting Standards Not Yet Effective
 
Accounting for the Transfers of Financial Assets
 
In June 2009, the FASB issued new guidance relating to the accounting for transfers of financial assets. The new guidance, which was issued as SFAS No. 166, Accounting for Transfers of Financial Assets,  an amendment to SFAS No.  140, was adopted into Codification in December 2009 through the issuance of Accounting Standards Updated (“ASU”) 2009-16. The new standard eliminates the concept of a “qualifying special-purpose entity,” changes the requirements for derecognizing financial assets, and requires additional disclosures in order to enhance information reported to users of financial statements by providing greater transparency about transfers of financial assets, including securitization transactions, and an entity’s continuing involvement in and exposure to the risks related to transferred financial assets. The new guidance is effective for fiscal years beginning after November 15, 2009. The Company will adopt the new guidance in 2010 and is evaluating the impact it will have to the Company’s consolidated financial statements.
 
Accounting for Variable Interest Entities
 
In June 2009, the FASB issued revised guidance on the accounting for variable interest entities. The revised guidance, which was issued as SFAS No. 167, Amending FASB Interpretation No. 46(R), was adopted into Codification in December 2009 through the issuance of ASU 2009-17. The revised guidance amends FASB Interpretation No. 46(R), Consolidation of Variable Interest Entities, in determining whether an enterprise has a controlling financial interest in a variable interest entity. This determination identifies the primary beneficiary of a variable interest entity as the enterprise that has both the power to direct the activities of a variable interest entity that most significantly impacts the entity’s economic performance, and the obligation to absorb losses or the right to receive benefits of the entity that could potentially be significant to the variable interest entity. The revised guidance requires ongoing reassessments of whether an enterprise is the primary beneficiary and eliminates the quantitative approach previously required for determining the primary beneficiary. The Company does not expect that the provisions of the new guidance will have a material effect on its consolidated financial statements.
 
 
Revenue Recognition
 
In October 2009, the FASB issued ASU 2009-13, Multiple-Deliverable Revenue Arrangements. The new standard changes the requirements for establishing separate units of accounting in a multiple element arrangement and requires the allocation of arrangement consideration to each deliverable based on the relative selling price. The selling price for each deliverable is based on vendor-specific objective evidence (“VSOE”) if available, third-party evidence if VSOE is not available, or estimated selling price if neither VSOE or third-party evidence is available. ASU 2009-13 is effective for revenue arrangements entered into in fiscal years beginning on or after June 15, 2010. The Company does not expect that the provisions of the new guidance will have a material effect on its consolidated financial statements.

NOTE C - COMMON AND PREFERRED STOCK
 
In September 2004, the Company issued 22,000 shares of Series A Convertible Preferred Stock in the face amount of $2,200,000 for $1,937,000 (net of $263,000 transaction expenses) which was paid in the respective amounts of $1,158,200 and $778,800 at closing. Additionally, the transaction included:

 
Issuance of Detachable Warrants to acquire up to 1,500,000 shares of the Company’s Common Stock at $1.00 per share. The Warrants expire on August 16, 2007.  The terms of these Warrants were revised in August 2007 to extend the expiration date to August 2010 however the warrants were cancelled in 2008.

 
In addition to the transaction costs referred to above, the Company granted 162,500 shares of Common Stock and Detachable Warrants to acquire up to 162,500 shares of the Company’s Common Stock at $1.00 per share to a broker. The term of the Warrants was three years.

 
The Preferred Stock is non-voting, entitled to dividends only when, or if, declared by the Board of Directors and has preference over the Common Stock in the event of the Company’s liquidation. The Preferred Stock is convertible into Common Stock at the option of the holder. The conversion price is equal to 80% of the market price at the time of conversion, subject to a floor of $0.50 per share and a ceiling of $1.17 per share. During 2005, the floor was modified to $0.12 per share as an inducement to execute the Series B Convertible Preferred Stock transaction discussed below.

The Company accounted for the host instrument as equity under the ASC guidance and accounted for both the beneficial conversion feature and the warrants as equity as well.

In August 2005, the Company issued 10,000 shares of Series B Convertible Preferred Stock in the face amount of $1,000,000 for $878,000 (net of $122,000 transaction expenses) which was paid in the respective amounts of $378,000 and $500,000 at closing. Additionally, the transaction included:

 
Detachable warrants to acquire up to 2,500,000 shares of the Company’s Common Stock at $0.30 per share. The warrants expire on August 31, 2010 and are subject to call by the Company upon the Common Stock trading at a price of $0.60, a minimum trading volume of 60,000 shares for 20 consecutive days and the registration statement being effective.
     
 
In addition to the transaction costs referred to above, the Company granted warrants to acquire up to 666,667 shares of the Company’s Common Stock at $0.16 per share to a broker. The term of the warrants was three years.
     
 
The Preferred Stock is non-voting and is entitled to receive dividends at an annual rate equal to the lower of the Prime Rate plus 3.5% or 9%. The dividend may either be paid in cash or registered shares of the Company’s Common Stock, subject to certain limitations. The Preferred Stock is convertible into Common Stock at the option of the holder. The conversion price is equal to 80% of the market price at the time of conversion, subject to a floor of $0.12 per share and a ceiling of $0.275 per share.
 
The Series B Preferred Stock and Series A Preferred Stock as amended permit the Company, in its discretion, to redeem part or all of the outstanding Preferred A and B Stock at 125 percent of par value per share until August 2007 and thereafter at 150 percent of par value, plus any accrued dividends.

The Company accounted for the host instrument as equity under ASC guidance and accounted for both the beneficial conversion feature and the warrants as equity as well.
 
 
In 2007,  20,000,000 and in 2008 an additional 33,333,333 shares of the Company’s authorized but unissued common stock were delivered by the Company to an escrow agent to hold as security for certain short term note obligations of the Company. The aggregate 53,333,333 shares are not being treated as outstanding and will only be considered as being issued and outstanding if and when the shares are released by the escrow agent and delivered to the lender as a result of a default under the promissory notes and related security agreement.

In 2008 the Company issued 9,714,955 shares of Common stock in exchange for the redemption of 12,989,167 outstanding warrants and options and settlement of certain debt totaling $341,071.

In 2008 the Company also issued 6,205 shares of its Series C Convertible Preferred stock in exchange for 4,785 and 1,000 shares, respectively of its Series A and Series B Convertible Preferred stock.  In addition, the Company issued 483 shares of its Preferred C stock for settlement of debt.  The C preferred stock is (i) non voting, (ii) entitled to receive dividends, when, and/if declared by the Board of Directors, (iii) senior to the common stock in liquidation and (iv) convertible into common stock at $0.12 per common share at the option of the holder and under certain conditions at the option of the Company.

In 2009 the Company’s Board authorized the grant of 375,000 shares of its common stock to its Directors as compensation.  Value of the shares was based on the market price at date of grant aggregated $3,000.

NOTE D- STOCK OPTION AND WARRANT ACTIVITY

The Company has five stock-based compensation plans which provides for the granting of options to purchase the Company’s Common Stock to employees, directors, consultants and advisors. The options granted are subject to a vesting schedule as set forth in each individual option agreement.

   
Maximum
Shares
 
   
of Common
Stock
 
Plan
 
which can be
issued
 
2000 Plan
    1,200,000  
2002 Plan
    1,500,000  
2003 Plan
    1,500,000  
2003A Plan
    3,500,000  
2006 Plan
    2,500,000  
      10,200,000  

Activity with respect to the stock-based compensation plans is summarized as follows:

 
Shares
Range of
Exercise
Prices
Weighted-
average Option
per price per
share
Outstanding at December 31, 2007
5,840,000
$0.11
$0.11
Options Granted
----
----
----
Options Canceled/Expired
(5,840,000)
$0.11
$0.11
Options Outstanding  at December 31, 2008 and 2009
----
----
----


Aggregate intrinsic value of options outstanding at December 31, 2009 is $0.00.

The total intrinsic value of options exercised during 2008 and 2009 was $0.00 and $0.00, respectively.
 
 
Activity with respect to warrants for common stock is as follows:

 
Shares
Range of
Exercise
Prices
Weighted-
average Option
per price per
share
Outstanding at December 31, 2007
7,149,167
0.62
0.62
Warrants canceled/expired
(7,149,167)
0.62
0.62
Outstanding at December 31, 2008
----
 
----


As of December 31, 2009, there was no unrecognized compensation cost related to non-vested share-based compensation arrangements.

NOTE E - COMMITMENT AND CONCENTRATIONS

Operating Leases

In February 2010, the Company began occupying space in a building in Sarasota, Florida under a lease with a one year term expiring February 28, 2010, and annual lease payments of approximately $23,208. Rent expense for the years ended December 31, 2008 and 2009, was $8,535 and $5,530, respectively.

Concentrations

  During 2008, one customer comprised approximately 21% of total sales revenue.

 During 2009, one customer comprised approximately 11% of our total sales revenue.

NOTE F - DUE TO STOCKHOLDERS AND OFFICERS

Due to stockholders and officers consists of the following at December 31, 2008 and 2009:

Monarch Point Fund, Ltd
 
$
85,074
 
Edmund C. King  
   
20,260
 
Total                                                                                                              
 
 $
105,334
 
                                                                
These advances are due on demand and bear interest at 10% to Monarch Point Fund, Ltd. and no interest is due on the remaining note of $20,260.
 
NOTE G - LINES OF CREDIT

The Company has four lines of credit with a private investor.  The credit facilities allow for advances up to $500,000, bear interest at 10% and have a first security interest in all of the Company’s assets.  Additionally the credit facilities are secured by a security interest in 53,333,333 shares of the Company’s common stock which are held in escrow.  Because the credit facilities are not in default the shares are not treated as issued and outstanding.  At December 31, 2009, $563,400 is outstanding.  The Notes were due December 31, 2009, but under an oral understanding had been held in abeyance while discussions are in progress for anticipated additional financing under proposed terms consistent with the existent notes.  Accrued interest under these obligations totaled $64,920 at December 31, 2009; interest expense was $56,348 and $62,202 during 2008 and 2009, respectively.  (See Note J)
 
 
NOTE H – GAIN ON THE SETTLEMENT OF DEBT

During 2008 and 2009 the Company recorded a gain on the settlement of debt as follows:

Cash:
 
2008
   
2009
 
Amount of debt settled
  $ 190,955     $ 24,714  
                 
Cash payments
    (84,815 )     ----  
Gain
    106,140       24,714  
                 
Common stock:
               
Amount of debt settled
    341,071       ----  
Fair value of common shares issued
    (69,757 )     ----  
Gain
    271,314       ----  
    $ 377,454     $ 24,714  
 
NOTE I - INCOME TAXES

Deferred taxes are recorded for all the tax effects of existing temporary differences in the Company’s assets and liabilities for income tax and financial reporting purposes. Due to the valuation allowance for deferred tax assets, as noted below, there was no net deferred tax benefit or expense for the years ended December 31, 2008 or 2009.

Reconciliation of the federal statutory income tax rate of 34.0% to the effective income tax rate is as follows at December 31:
 
   
2008
 
2009
 
Federal statutory income tax rate
   
(34.0)%
   
(34.0)%
 
State income taxes, net of federal tax benefit
   
(3.5)%
   
(3.5)%
 
Deferred tax asset valuation allowance
   
37.5%
   
37.5%
 
     
-0-%
   
-0-%
 

ASC guidance requires that a deferred tax asset be reduced by a valuation allowance if, based on the weight of available evidence it is more likely than not (a likelihood of more than 50 percent) that some portion or all of the deferred tax assets will not be realized. The valuation allowance should be sufficient to reduce the deferred tax asset to the amount that is more likely than not to be realized. As a result the Company recorded a valuation allowance with respect to all the Company’s deferred tax assets.

The Company has a federal net operating loss carryforward of approximately $16.9 million as of December 31, 2009 which expire through 2029. Under Section 382 and 383 of the Internal Revenue Code, if an ownership change occurs with respect to a “loss corporation”, as defined, there are annual limitations on the amount of the net operating loss and other deductions, which are available to the Company. The Company has not determined the impact of these limitations at this time.
 
Since inception, we have been subject to tax by both federal and state taxing authorities. Until the respective statutes of limitations expire, we are subject to income tax audits in the jurisdictions in which we operate. We are no longer subject to U.S. federal tax examinations for fiscal years prior to 2005, and we are not subject to audits prior to the 2005 fiscal year for the state jurisdiction.

 NOTE J: SUBSEQUENT EVENTS

In March 2010, the Company’s senior lender agreed to extend the maturity dates of the outstanding Senior Secured Promissory Notes aggregating $628,320 (including $64,920 accrued interest) at December 31, 2009 until March 1, 2012.  Terms and provisions of the notes otherwise remained unchanged.

The Senior Lender also established a $150,000 Revolving Line of Credit to finance operations of the Company through December 31, 2010.  The Revolving Line has similar terms and provisions to the previous notes between the Company and the Senior Lender and is due and payable March 1, 2012.

In January 2010, the Company commenced an exchange offer, which remains open, of Series B Preferred Stockholders to convert their shares into shares of Series C Preferred Stock.  In conjunction with the January 2010 offer, the Company has restated its Series B Stock Certificate of Designation to eliminate any further accrual of dividends and provide that the Company may satisfy its obligation with respect to accrued but unpaid dividends either (a) in cash, (b) by issuance of its additional Series B Stock or (c) by issuance of common stock of the Company.
 
F-15

 
 
Exhibit 10.66
 
SENIOR SECURED PROMISSORY NOTE
 
$ 128,319.10 
March 24, 2010
Sarasota, Florida  
                                                                                          
FOR VALUE RECEIVED, the undersigned, INVISA, INC. , a Nevada corporation (“ Borrower ”) having an address at 1800 2 nd Street, Suite 965, , Sarasota, Florida, 34236 promises to pay to the order of Centurian Investors, Inc, a Delaware corporation (“ Lender ”), having an office at 1800 2 nd Street, Suite 970, Sarasota, Florida 34236, or such other place as the Lender may designate in writing, the principal amount up to and not to exceed ONE HUNDRED TWENTY EIGHT THOUSAND THREE HUNDRED NINETEEN United States Dollars and TEN cents (U.S. $128,319.10), to the extent advanced hereunder and then outstanding, with interest on the unpaid principal balance from the date of this Senior Secured Promissory Note (this “ Promissory Note ”), until paid, at the Interest Rate (as hereinafter defined) provided herein.
 
1.            Rate of Interest .  The outstanding principal balance of this Promissory Note shall bear interest at ten percent (10%) per annum (the “ Interest Rate ”).
 
                        2.            Date and Time of Payment .  The outstanding principal balance of this Promissory Note, together with all accrued and unpaid interest,  shall be paid in full on earlier to occur of (a) the Maturity Date or (b) the date of termination of this Promissory Note, whether by its terms, by prepayment, or by acceleration.  All amounts outstanding hereunder shall constitute Borrower’s obligations hereunder, and such obligations include without limitation all principal, interest (including all interest which accrues after the commencement of any case or proceeding by or against Borrower in bankruptcy whether or not allowed in such case or proceeding), expenses, attorneys’ fees and any other sum chargeable to Borrower hereunder and owing to Lender under this Promissory Note (all such obligations and all other obligations of Borrower under this Promissory Note ,(the “ Obligations ”).
 
                        3.            Default Rate .  Notwithstanding Section 1 , after the occurrence of any Event of Default and for so long as such Event of Default continues, and in any event from and after the Maturity Date, all principal, interest and other amounts payable under this Promissory Note shall bear interest until paid in full at a rate of interest equal to four percent (4%) above the per annum rate otherwise applicable hereunder (the “ Default Rate ”).
 
                        4.            Computation of Interest .  Interest on the principal amount hereof and all other Obligations shall be computed on the basis of a 360-day year, and shall be charged for the actual number of days elapsed during any month or other accrual period.
 
                        5.            Manner of Payment .  All payments by Borrower in respect of any Obligations shall be made without deduction, defense, set off or counterclaim, free and clear of all taxes delivered to Lender.
 
                        6.            Maturity .  To the extent not sooner due and payable in accordance with this Promissory Note, the Obigations  shall be due and payable on  March 1, 2012 (the “ Maturity Date ”).
 
1

 
7.            Application of Payments .  All payments shall be applied to amounts then due and payable in the following order:  (a) to Lender’s costs and expenses reimbursable in connection herewith; (b) to interest accrued on the outstanding principal balance of this Promissory Note; (c) to the principal amount hereof; and (d) to all other Obligations, or in such other manner as Lender shall determine in its sole and exclusive discretion.
 
8.           [Intentionally Deleted]
 
9.            Security .   This Promissory Note shall be secured by (i) Seventeen Million, Sixty Six Thousand Six Hundred Sixty Eight (17,066,668) shares of common stock of Borrower to be issued as of the date hereof or when available, or the equivilant thereof, in a form of preferred stock or other security to be designated by Borrower  with such terms and conditions as are acceptable to the Lender, and held in escrow and a continuing first priority security interest in all of Borrower’s right, title, and interest in and to, all property of Borrower (collectively, the “ Collateral ”), as more specifically set forth in the Security Agreement executed by Borrower in favor of Lender dated as of February 28, 2007.  (the “Security Agreement”).
 
10.           Priority   This Promissory Note shall be a senior obligation of Borrower, and for so long as this Promissory Note shall be outstanding, (i) Borrower shall be prohibited from incurring any and all future indebtedness without the prior written consent of Lender and (ii) any and all future indebtedness approved by Borrower in writing shall be deemed subordinate and inferior to, all respective right, title and interest of Lender, in, to and under this Promissory Note, this Security Agreement and any and all documents and instruments evidencing, securing or otherwise relating to this Promissory Note.
 
                        11.          Representations and Warranties .   Borrower makes the following representations and warranties to Lender, which representations and warranties shall be true, correct, and complete as of the date hereof and shall survive the execution and delivery of this Promissory Note.
 
(a)          Due Organization and Qualification .  Borrower is duly organized and validly existing and in good standing under the laws of the jurisdiction of its organization and qualified to do business in any jurisdiction where it is required to be so qualified, and has all requisite power and authority to (i) own its assets and carry on its business, and (ii) execute, deliver and perform its Obligations.
 
(b)          Due Authorization; No Conflict .  The execution, delivery, and performance by Borrower of this Promissory Note has been duly authorized by all necessary action on the part of Borrower.  This Promissory Note has been duly executed and delivered by Borrower.  The execution, delivery, and performance by Borrower of this Promissory Note and the consummation of the transactions contemplated hereby, do not and will not (i) violate in any material respect any provision of federal, state, provincial or local law or regulation applicable to Borrower, its organizational documents, or any order, judgment, or decree of any court or other governmental authority, (ii) conflict with, result in a breach or termination of, or constitute (with due notice or lapse of time or both) a default under any material contractual obligation of Borrower, (iii) result in or require the creation or imposition of any lien of any nature whatsoever upon any properties or assets of Borrower, other than liens or security interests in favor of Lender, or (iv) require any approval of any of Borrower’s stockholders or any approval or consent of any other person or entity, other than consents or approvals that have been obtained and that are still in force and effect.  The execution, delivery, and performance by Borrower of this Promissory Note do not and will not require any registration with, consent, or approval of, or notice to, or other action with or by, any governmental authority, other than consents or approvals that have been obtained and that are still in force and effect.  This Promissory Note when executed and delivered by Borrower will be the legally valid and binding obligation of Borrower, enforceable against Borrower in accordance with its term, except as enforcement may be limited by equitable principles or by bankruptcy, insolvency, reorganization, moratorium, or similar laws relating to or limiting creditors’ rights generally.
 
2

 
        (c)          No Litigation .  No litigation, investigation or proceeding of or before any arbitrator or government authority is (i) pending or, to the knowledge of Borrower, threatened with respect to this Promissory Note or the Collateral or any of the transactions contemplated hereby or (ii) pending or, to the knowledge of Borrower, threatened by or against Borrower, its properties or revenues which, if adversely determined, would have a material adverse effect on its business, operations, property or financial condition, when taken as a whole.
 
 (d)         No Default .  Borrower is not in default under or with respect to any contractual obligation and no event of default has occurred or is continuing with respect to Borrower.
 
 (e)         Taxes .   Borrower has filed or caused to be filed all tax returns required to be filed by it and has paid all taxes due and payable on said returns or on any assessments made against Borrower or any of its property.   All other taxes, fees or other charges on Borrower or any of its property by any governmental authority have been paid and no tax liens have been filed.
 
12.   Covenants of Borrower.   As of the date hereof and so long as the Obligations hereunder shall be outstanding:
 
(a)  Borrower will preserve and keep in force and effect, its corporate existence and all licenses and permits necessary to the proper conduct of its business;

(b)  Borrower will promptly pay and discharge, all lawful taxes, assessments, charges or levies imposed upon Borrower, or upon or in respect of all or any part of the property or business of Borrower, all trade accounts payable in accordance with usual and customary business terms and all claims for work, labor or materials, which if unpaid might become a lien or charge upon any property of Borrower; provided , Borrower shall not be required to pay such tax, assessment, charge, levy, account payable or claim if (i) the validity, applicability or amount thereof is being contested in good faith by appropriate action or proceeding which will prevent the forfeiture or sale of any property of Borrower, and (ii) Borrower shall set aside on its books, reserves deemed by it to be adequate with respect thereto;

(c)  Borrower will promptly comply with all laws, ordinances or governmental rules and regulation to which it is subject, the violations of which would materially or adversely affect its properties, business, prospects, profits or condition or would result in any material lien or charge upon any property of Borrower;
 
3

 
(d)  Borrower will maintain, preserve and keep its properties which are used or useful in the conduct of its business in good repair and working order;

(e)  Borrower will not create, assume or incur or in any manner become liable with respect of any indebtedness except this Promissory Note and any indebtedness of Borrower incurred prior to the date hereof.

(f)  Borrower will not create or incur any mortgage, pledge, security interest, encumbrance, lien or charge of any kind (a “Lien”) on its or its property or assets, whether now owned or hereinafter acquired, or upon any income or profits therefrom  except

(i)           Liens for property taxes and assessments or levies and liens that are not yet due and payable;

(ii)          Liens of or resulting from any judgment or award, the time for appeal or petition for rehearing of which shall not have expired or in respect of which the Company shall in good faith be prosecuting an appeal or proceeding for a review and in respect of which a stay of execution pending such appeal or proceeding for review shall have been secured; or

(iii)         Liens or priority claims (A) incidental to the conduct of business, (B) created by any material agreement of Borrower entered into prior to and currently in effect as of the date hereof or (C) the ownership or lease of properties and assets and not in connection with the borrowing of money, provided , in each case, the obligation secured is not overdue, or if overdue, is being contested in good faith by appropriate actions or proceedings and provided , further that Borrower shall have received the prior written consent of Lender to any Lien described in (A) or (C) above; or

13.           Events of Default; Remedies; Acceleration .  (a) The occurrence of any one or more of the following events (regardless of the reason therefor) shall constitute an “ Event of Default ” hereunder:
 
                        (i) Borrower fails to make any payment of outstanding principal balance of this Promissory Note , or interest thereon, or any of the other Obligation when due and payable;
 
                                (ii) Any representation or warranty of Borrower made in this Promissory Note, the Security Agreeent,  or any other document made by or on behalf of Borrower in connection herewith and the transactions contemplated hereby proves to have been false or incorrect in any material respect or Borrower shall fail to comply in all respects with any covenant herein or therein;
 
(iii) Borrower shall violate any provision of this Promissory Note, the Security Agreement or any other document made by or on behalf of Borrower in connection herewith and the transactions contemplated hereby, including, without limitiation, failure to comply with the terms and provisions of Section 8 of this Promissory Note;
 
4

                         
    (iv) A case or proceeding is commenced against Borrower seeking a decree or order (i) under Title 11 of the United States Bankruptcy Code (11 U.S.C. §§101 et seq. , as amended, and any successor statute, the “ Bankruptcy Code ”), or any other applicable federal, state or foreign bankruptcy or other similar law, rule or regulation, (ii) appointing a custodian, receiver, liquidator, assignee, trustee or sequestrator (or similar official) for Borrower or for any substantial part of Borrower’s assets, or (iii) ordering the winding-up or liquidation of the affairs of s Borrower, and such case or proceeding shall remain undismissed or unstayed for sixty (60) days or more or a decree or order granting the relief sought in such case or proceeding shall be entered by a court of competent jurisdiction;
 
                                (v) Borrower, without the prior written consent of Lender (A) files a petition seeking relief under the Bankruptcy Code, or any other applicable federal, state or foreign bankruptcy or other similar law, rule or regulation, (B) consents to or fails to contest in a timely and appropriate manner the institution of proceedings thereunder or the filing of any such petition or the appointment of or taking possession by a custodian, receiver, liquidator, assignee, trustee or sequestrator (or similar official) for Borrower or for any substantial part of Borrower’s assets, (C) makes an assignment for the benefit of creditors, (D) takes any action in furtherance of any of the foregoing; or (E) admits in writing its inability to, or is generally unable to, pay its debts as such debts become due;
 
                                (vi)  If this Promissory Note, the Security Agreement, or any financing statement, document or other instrument executed, delivered or filed in connection herewith or with the security interest granted to Lender hereunder, shall, for any reason, fail or cease to create a valid and perfected lien on or security interest in any or all of the Collateral or the Collateral shall be compromised, encumbered or, in the case of the common stock, invalid, cancelled or otherwise rescinded;
 
(vi) If Borrower shall default on any material obligations of Borrower or an event of default shall occur with respect to any material agreement of Borrower, whether such agreement shall be in effect or effective subsequent to this Promissory Note.
 
(b)         Immediately upon the occurrence of any Event of Default,   Lender may (i) proceed to protect and enforce Lender’s rights by suit in equity, action at law and/or other appropriate proceeding, either for specific performance of any covenant or condition contained in this Promissory Note, the Security Agreement, or in any instrument or document delivered to Lender pursuant to this Promissory Note , or in aid of the exercise of any power granted in this Promissory Note or any such instrument or document, and (ii) proceed to enforce payment of the Obligations in such manner as Lender may elect , including the foreclosure of the Collateral in accordance with the terms of the Security Agreement, and to realize upon any and all rights of Lender hereunder.  Upon the occurrence of any Event of Default under Section 13(a)(iv) and (v), Lender shall have a right to immediately enforce its rights hereunder and proceed against or foreclose upon the Collateral without regard to the 45 day period set forth in this Section 13(b) To the extent not prohibited by applicable law which cannot be waived, all of Lender’s rights hereunder shall be cumulative.  Lender shall have all other rights and remedies not inconsistent herewith as provided under applicable law or in equity, and no exercise by Lender of one right or remedy shall be deemed an election, and no waiver by Lender of any Event of Default shall be deemed a continuing waiver.   No delay by Lender shall constitute a waiver, election or acquiescence by it.
 
5

 
(c) In the event that the Obligations hereunder shall be paid in full by or on behalf of Borrower, after the Acceleration of this Promissory Note but prior to the Final Payment Date, then this Promissory Note shall be deemed paid in full, Lender shall promptly release any lien of Lender on the Collateral, and each Lender Nominee shall immediately resign from the Board of Directors of Borrower.
 
                           14.         Certain   Rights and Waivers .  To the extent not prohibited by the provisions of applicable law, Borrower hereby expressly waives: (a) all presentments, demands for performance, notices of nonperformance (except to the extent required by this Note), protests, notices of protest and notices of dishonor; (b) any requirement of diligence or promptness on the part of Lender in the enforcement of its rights under this Note; (c) any and all notices of every kind and description which may be required to be given by any statute or rule of law; and (d) any defense (other than indefeasible payment in full) which it may now or hereafter have with respect to its liability under this Note.
 
15.           Assignments .  Borrower may not assign or transfer any of its rights or obligations hereunder without the express, written consent of Lender.  Any such purported assignment or transfer by Borrower without the express, written consent of Lender shall be null and void ab initio .
 
 
16.           Costs and Expenses .  Borrower agrees to pay all costs and expenses of Lender, including without limitation all fees and disbursements of counsel, advisors, consultants, examiners and appraisers for Lender, in connection with (a) the issuance of this Promissory Note and advancement of principal amount hereunder (which fees and disbursements associated with the origination of this Promissory Note shall not exceed $3,500.00), (b) any enforcement (whether through negotiations, legal process or otherwise) of this Promissory Note, (c) any workout or restructuring of this Promissory Note during the pendency of one or more Events of Default, (d) any bankruptcy case or proceeding of Borrower or any appeal thereof, and (e) upon the occurrence and during the continuance of an Event of Default, any efforts to verify, protect, evaluate, assess, appraise, collect, sell, liquidate or otherwise dispose of any of the Collateral.
 
6

          
    17.        CHOICE OF LAW .    THE VALIDITY OF THIS NOTE, THE CONSTRUCTION, INTERPRETATION, AND ENFORCEMENT HEREOF, AND THE RIGHTS OF THE BORROWER AND LENDER WITH RESPECT TO ALL MATTERS ARISING HEREUNDER OR RELATED HERETO SHALL BE DETERMINED UNDER, GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF FLORIDA, WITHOUT REFERENCE TO CONFLICTS OF LAW PRINCIPLES EXCEPT TO THE EXTENT NECESSARY TO ENFORCE THIS CHOICE OF LAW PROVISION.
 
18.   Notices .  All communications hereunder shall be in writing and shall be deemed to be duly given and received (a) upon delivery if delivered personally or upon confirmed transmittal if by facsimile, (b) on the next Business Day if sent by overnight courier, or (c) four (4) Business Days after mailing if mailed by prepaid registered mail, return receipt requested, in each case to the appropriate notice address or facsimile number.
 
19.   Independent Arms Length Transaction .  It is understood and agreed that this Promissory Note, the Security Agreement and the transactions contemplated hereby and thereby were negotiated in an arms length transacton separate and distinct from any other transaction or contractual obligations and are independent of any transaction or transactions between Borrower, on the one hand, and Lender and any of its affilates or related entitles on the other hand.   Borrower further agrees that the contractual obligations of Borrower hereunder are in no way dependent or conditioned upon any other agreements, contracts or transactions whatsoever unless expressly stated herein.
 
 
 
7

 
IN WITNESS WHEREOF, the undersigned has executed this Promissory Note as of the date first written above.
 
 
INVISA, INC.
 
By:  __________________________
Name:   Edmund C. King
Title:   Chief Financial Officer
 
   
 
 
8

Exhibit 10.67
 
SENIOR SECURED PROMISSORY NOTE
 
 $ 150,000.00   March 24, 2010
Sarasota, Florida
 
FOR VALUE RECEIVED, the undersigned, INVISA, INC. , a Nevada corporation (“ Borrower ”) having an address at 1800 2 nd Street, Suite 965, , Sarasota, Florida, 34236 promises to pay to the order of Centurian Investors, Inc, a Delaware corporation (“ Lender ”), having an office at 1800 2 nd Street, Suite 970 Sarasota, Florida 34236, or such other place as the Lender may designate inwriting, the principal amount up to and not to exceed ONE HUNDRED FIFTY THOUSAND United States Dollars (U.S. $150,000.00), to the extent advanced hereunder and then outstanding, with interest on the unpaid principal balance from the date of this Senior Secured Promissory Note (this “ Promissory Note ”), until paid, at the Interest Rate (as hereinafter defined) provided herein.
 
1.            Rate of Interest .  The outstanding principal balance of this Promissory Note shall bear interest at ten percent (10%) per annum (the “ Interest Rate ”).
 
2.            Date and Time of Payment .  The outstanding principal balance of this Promissory Note, together with all accrued and unpaid interest,  shall be paid in full on earlier to occur of (a) the Maturity Date or (b) the date of termination of this Promissory Note, whether by its terms, by prepayment, or by acceleration.  All amounts outstanding hereunder shall constitute Borrower’s obligations hereunder, and such obligations include without limitation all principal, interest (including all interest which accrues after the commencement of any case or proceeding by or against Borrower in bankruptcy whether or not allowed in such case or proceeding), expenses, attorneys’ fees and any other sum chargeable to Borrower hereunder and owing to Lender under this Promissory Note (all such obligations and all other obligations of Borrower under this Promissory Note ,(the “ Obligations ”).  Any principal amount of this Note paid or prepaid may be reborrowed prior to the Maturity Date.
 
 3.            Default Rate .  Notwithstanding Section 1 , after the occurrence of any Event of Default and for so long as such Event of Default continues, and in any event from and after the Maturity Date, all principal, interest and other amounts payable under this Promissory Note shall bear interest until paid in full at a rate of interest equal to four percent (4%) above the per annum rate otherwise applicable hereunder (the “ Default Rate ”).
 
4.            Computation of Interest .  Interest on the principal amount hereof and all other Obligations shall be computed on the basis of a 360-day year, and shall be charged for the actual number of days elapsed during any month or other accrual period.
 
5.            Manner of Payment .  All payments by Borrower in respect of any Obligations shall be made without deduction, defense, set off or counterclaim, free and clear of all taxes delivered to Lender.
 
6.            Maturity .  To the extent not sooner due and payable in accordance with this Promissory Note, the Obigations  shall be due and payable on December 31, 2010 (the “ Maturity Date ”).
 
1

 
7.            Application of Payments .  All payments shall be applied to amounts then due and payable in the following order:  (a) to Lender’s costs and expenses reimbursable in connection herewith; (b) to interest accrued on the outstanding principal balance of this Promissory Note; (c) to the principal amount hereof; and (d) to all other Obligations, or in such other manner as Lender shall determine in its sole and exclusive discretion.
 
8.            Procedure for Borrowing and Use of Proceeds .   The proceeds of this Promissory Note shall be funded in multiple advances (each, an “ Advance ”) by Lender to Borrower in the amounts and on such dates as determined by Lender based on requests from Borrower.  Borrower shall give Lender notice requesting that Lender make an Advance in accordance herewith specifying (a) the Borrowing Date, (b) the amount requested and (c) a detailed, itemized list of the use of such Advance.  Upon receipt of such notice from Borrower, Lender shall determine, in its sole and exclusive discretion, whether it shall make such amount available to Borrower on the Borrowing Date.  Upon each Advance, Lender shall record each Advance on Schedule I to this Promissory Note.  For purposes of this Section 8, the Borrowing Date shall mean any business day specified in the notice pursuant to this Section 8 as a date on which Borrower requests Lender to make a loan hereunder.    The obligation of Lender to make each subsequent Advance following the initial Advance hereunder is subject to the Lenders approval of the loan request made by Borrower in accordance with this Section 8 and shall be funded in the sole and exclusive discretion of Lender.  As of the date hereof, Borrower has received an aggregate Advance of ($___________________) Dollars  under this Note.
 
9.            Security .   This Promissory Note shall be secured by (i) up to Twenty Million, (20,000,000) shares of common stock of Borrower to be issued as of the date hereof or when available, or the equivilant thereof, in a form of preferred stock or other security to be designated by Borrower  with such terms and conditions as are acceptable to the Lender, and held in escrow and a continuing first priority security interest in all of Borrower’s right, title, and interest in and to, all property of Borrower (collectively, the “ Collateral ”), as more specifically set forth in the Security Agreement executed by Borrower in favor of Lender dated as of February 28, 2007.  (the “Security Agreement”).
 
10.           Priority   This Promissory Note shall be a senior obligation of Borrower, and for so long as this Promissory Note shall be outstanding, (i) Borrower shall be prohibited from incurring any and all future indebtedness without the prior written consent of Lender and (ii) any and all future indebtedness approved by Borrower in writing shall be deemed subordinate and inferior to, all respective right, title and interest of Lender, in, to and under this Promissory Note, this Security Agreement and any and all documents and instruments evidencing, securing or otherwise relating to this Promissory Note.
 
11.           Representations and Warranties .   Borrower makes the following representations and warranties to Lender, which representations and warranties shall be true, correct, and complete as of the date hereof and shall survive the execution and delivery of this Promissory Note.
 
(a)            Due Organization and Qualification .  Borrower is duly organized and validly existing and in good standing under the laws of the jurisdiction of its organization and qualified to do business in any jurisdiction where it is required to be so qualified, and has all requisite power and authority to (i) own its assets and carry on its business, and (ii) execute, deliver and perform its Obligations.
 
2

 
(b)    Due Authorization; No Conflict .  The execution, delivery, and performance by Borrower of this Promissory Note has been duly authorized by all necessary action on the part of Borrower.  This Promissory Note has been duly executed and delivered by Borrower.  The execution, delivery, and performance by Borrower of this Promissory Note and the consummation of the transactions contemplated hereby, do not and will not (i) violate in any material respect any provision of federal, state, provincial or local law or regulation applicable to Borrower, its organizational documents, or any order, judgment, or decree of any court or other governmental authority, (ii) conflict with, result in a breach or termination of, or constitute (with due notice or lapse of time or both) a default under any material contractual obligation of Borrower, (iii) result in or require the creation or imposition of any lien of any nature whatsoever upon any properties or assets of Borrower, other than liens or security interests in favor of Lender, or (iv) require any approval of any of Borrower’s stockholders or any approval or consent of any other person or entity, other than consents or approvals that have been obtained and that are still in force and effect.  The execution, delivery, and performance by Borrower of this Promissory Note do not and will not require any registration with, consent, or approval of, or notice to, or other action with or by, any governmental authority, other than consents or approvals that have been obtained and that are still in force and effect.  This Promissory Note when executed and delivered by Borrower will be the legally valid and binding obligation of Borrower, enforceable against Borrower in accordance with its term, except as enforcement may be limited by equitable principles or by bankruptcy, insolvency, reorganization, moratorium, or similar laws relating to or limiting creditors’ rights generally.
 
(c)    No Litigation .  No litigation, investigation or proceeding of or before any arbitrator or government authority is (i) pending or, to the knowledge of Borrower, threatened with respect to this Promissory Note or the Collateral or any of the transactions contemplated hereby or (ii) pending or, to the knowledge of Borrower, threatened by or against Borrower, its properties or revenues which, if adversely determined, would have a material adverse effect on its business, operations, property or financial condition, when taken as a whole.
 
(d)    No Default .  Borrower is not in default under or with respect to any contractual obligation and no event of default has occurred or is continuing with respect to Borrower.
 
(e)    Taxes .   Borrower has filed or caused to be filed all tax returns required to be filed by it and has paid all taxes due and payable on said returns or on any assessments made against Borrower or any of its property.   All other taxes, fees or other charges on Borrower or any of its property by any governmental authority have been paid and no tax liens have been filed.
 
12.   Covenants of Borrower.   As of the date hereof and so long as the Obligations hereunder shall be outstanding:
 
(a)  Borrower will preserve and keep in force and effect, its corporate existence and all licenses and permits necessary to the proper conduct of its business;
 
3

 
(b)  Borrower will promptly pay and discharge, all lawful taxes, assessments, charges or levies imposed upon Borrower, or upon or in respect of all or any part of the property or business of Borrower, all trade accounts payable in accordance with usual and customary business terms and all claims for work, labor or materials, which if unpaid might become a lien or charge upon any property of Borrower; provided , Borrower shall not be required to pay such tax, assessment, charge, levy, account payable or claim if (i) the validity, applicability or amount thereof is being contested in good faith by appropriate action or proceeding which will prevent the forfeiture or sale of any property of Borrower, and (ii) Borrower shall set aside on its books, reserves deemed by it to be adequate with respect thereto;

(c)  Borrower will promptly comply with all laws, ordinances or governmental rules and regulation to which it is subject, the violations of which would materially or adversely affect its properties, business, prospects, profits or condition or would result in any material lien or charge upon any property of Borrower;

(d)  Borrower will maintain, preserve and keep its properties which are used or useful in the conduct of its business in good repair and working order;

(e)  Borrower will not create, assume or incur or in any manner become liable with respect of any indebtedness except this Promissory Note and any indebtedness of Borrower incurred prior to the date hereof.

(f)  Borrower will not create or incur any mortgage, pledge, security interest, encumbrance, lien or charge of any kind (a “Lien”) on its or its property or assets, whether now owned or hereinafter acquired, or upon any income or profits therefrom  except

(i)           Liens for property taxes and assessments or levies and liens that are not yet due and payable;

(ii)          Liens of or resulting from any judgment or award, the time for appeal or petition for rehearing of which shall not have expired or in respect of which the Company shall in good faith be prosecuting an appeal or proceeding for a review and in respect of which a stay of execution pending such appeal or proceeding for review shall have been secured; or

(iii)         Liens or priority claims (A) incidental to the conduct of business, (B) created by any material agreement of Borrower entered into prior to and currently in effect as of the date hereof or (C) the ownership or lease of properties and assets and not in connection with the borrowing of money, provided , in each case, the obligation secured is not overdue, or if overdue, is being contested in good faith by appropriate actions or proceedings and provided , further that Borrower shall have received the prior written consent of Lender to any Lien described in (A) or (C) above; or

13.            Events of Default; Remedies; Acceleration .  (a) The occurrence of any one or more of the following events (regardless of the reason therefor) shall constitute an “ Event of Default ” hereunder:
 
4

 
(i) Borrower fails to make any payment of outstanding principal balance of this Promissory Note , or interest thereon, or any of the other Obligation when due and payable;
 
(ii) Any representation or warranty of Borrower made in this Promissory Note, the Security Agreeent,  or any other document made by or on behalf of Borrower in connection herewith and the transactions contemplated hereby proves to have been false or incorrect in any material respect or Borrower shall fail to comply in all respects with any covenant herein or therein;
 
(iii) Borrower shall violate any provision of this Promissory Note, the Security Agreement or any other document made by or on behalf of Borrower in connection herewith and the transactions contemplated hereby, including, without limitiation, failure to comply with the terms and provisions of Section 8 of this Promissory Note;
 
(iv) A case or proceeding is commenced against Borrower seeking a decree or order (i) under Title 11 of the United States Bankruptcy Code (11 U.S.C. §§101 et seq. , as amended, and any successor statute, the “ Bankruptcy Code ”), or any other applicable federal, state or foreign bankruptcy or other similar law, rule or regulation, (ii) appointing a custodian, receiver, liquidator, assignee, trustee or sequestrator (or similar official) for Borrower or for any substantial part of Borrower’s assets, or (iii) ordering the winding-up or liquidation of the affairs of s Borrower, and such case or proceeding shall remain undismissed or unstayed for sixty (60) days or more or a decree or order granting the relief sought in such case or proceeding shall be entered by a court of competent jurisdiction;
 
(v) Borrower, without the prior written consent of Lender (A) files a petition seeking relief under the Bankruptcy Code, or any other applicable federal, state or foreign bankruptcy or other similar law, rule or regulation, (B) consents to or fails to contest in a timely and appropriate manner the institution of proceedings thereunder or the filing of any such petition or the appointment of or taking possession by a custodian, receiver, liquidator, assignee, trustee or sequestrator (or similar official) for Borrower or for any substantial part of Borrower’s assets, (C) makes an assignment for the benefit of creditors, (D) takes any action in furtherance of any of the foregoing; or (E) admits in writing its inability to, or is generally unable to, pay its debts as such debts become due;
 
(vi)  If this Promissory Note, the Security Agreement, or any financing statement, document or other instrument executed, delivered or filed in connection herewith or with the security interest granted to Lender hereunder, shall, for any reason, fail or cease to create a valid and perfected lien on or security interest in any or all of the Collateral or the Collateral shall be compromised, encumbered or, in the case of the common stock, invalid, cancelled or otherwise rescinded;
 
(vi) If Borrower shall default on any material obligations of Borrower or an event of default shall occur with respect to any material agreement of Borrower, whether such agreement shall be in effect or effective subsequent to this Promissory Note.
 
5

 
(b)  Immediately upon the occurrence of any Event of Default, all of the Obligations of Borrower hereunder shall become immediately due and payable to Lender and the Obligations shall thereafter accrue interest at the Default Rate from the date of any Event of Default until such Obligations are paid in full (an “Accelleration”).  Promptly upon the occurrence of an Acceleration, Lender shall send Borrower written notice of the date upon which the Acceleration is effective and the names of  up to three (3) representatives of Lender (“Lender Nominees”) to be immediately appointed to the Board of Directors of Borrower (the “Default Notice”).  The Lender Nominees shall be appointed to the Board of Directors of Borrower not less than five days following the date of the Default Notice.  Except with respect to an Event of Default  under Section 13(a)(iv) and (v), Borrower shall have forty five (45) days (the forty fifth day hereinafter being the “Final Payment Date”) from the date of the Default Notice to pay Lender the total amount of the Obligations due and owning under this Promissory Note.  In the event that Borrower shall fail to satisfy in full all of the outstanding Obligations under this Promissory Note on or before the Final Payment Date, then Lender may (i) proceed to protect and enforce Lender’s rights by suit in equity, action at law and/or other appropriate proceeding, either for specific performance of any covenant or condition contained in this Promissory Note, the Security Agreement, or in any instrument or document delivered to Lender pursuant to this Promissory Note , or in aid of the exercise of any power granted in this Promissory Note or any such instrument or document, and (ii) proceed to enforce payment of the Obligations in such manner as Lender may elect, including the foreclosure of the Collateral in accordance with the terms of the Security Agreement, and to realize upon any and all rights of Lender hereunder.  Upon the occurrence of any Event of Default under Section 13(a)(iv) and (v), Lender shall have a right to immediately enforce its rights hereunder and proceed against or foreclose upon the Collateral without regard to the 45 day period set forth in this Section 13(b) To the extent not prohibited by applicable law which cannot be waived, all of Lender’s rights hereunder shall be cumulative.  Lender shall have all other rights and remedies not inconsistent herewith as provided under applicable law or in equity, and no exercise by Lender of one right or remedy shall be deemed an election, and no waiver by Lender of any Event of Default shall be deemed a continuing waiver.   No delay by Lender shall constitute a waiver, election or acquiescence by it.
 
(c) In the event that the Obligations hereunder shall be paid in full by or on behalf of Borrower, after the Acceleration of this Promissory Note but prior to the Final Payment Date, then this Promissory Note shall be deemed paid in full, Lender shall promptly release any lien of Lender on the Collateral, and each Lender Nominee shall immediately resign from the Board of Directors of Borrower.
 
14.   Certain   Rights and Waivers .  To the extent not prohibited by the provisions of applicable law, Borrower hereby expressly waives: (a) all presentments, demands for performance, notices of nonperformance (except to the extent required by this Note), protests, notices of protest and notices of dishonor; (b) any requirement of diligence or promptness on the part of Lender in the enforcement of its rights under this Note; (c) any and all notices of every kind and description which may be required to be given by any statute or rule of law; and (d) any defense (other than indefeasible payment in full) which it may now or hereafter have with respect to its liability under this Note.
 
15.   Assignments .  Borrower may not assign or transfer any of its rights or obligations hereunder without the express, written consent of Lender.  Any such purported assignment or transfer by Borrower without the express, written consent of Lender shall be null and void ab initio .
 
6

 
16.   Costs and Expenses .  Borrower agrees to pay all costs and expenses of Lender, including without limitation all fees and disbursements of counsel, advisors, consultants, examiners and appraisers for Lender, in connection with (a) the issuance of this Promissory Note and advancement of principal amount hereunder (which fees and disbursements associated with the origination of this Promissory Note shall not exceed $3,500.00), (b) any enforcement (whether through negotiations, legal process or otherwise) of this Promissory Note, (c) any workout or restructuring of this Promissory Note during the pendency of one or more Events of Default, (d) any bankruptcy case or proceeding of Borrower or any appeal thereof, and (e) upon the occurrence and during the continuance of an Event of Default, any efforts to verify, protect, evaluate, assess, appraise, collect, sell, liquidate or otherwise dispose of any of the Collateral.
 
17.   CHOICE OF LAW .    THE VALIDITY OF THIS NOTE, THE CONSTRUCTION, INTERPRETATION, AND ENFORCEMENT HEREOF, AND THE RIGHTS OF THE BORROWER AND LENDER WITH RESPECT TO ALL MATTERS ARISING HEREUNDER OR RELATED HERETO SHALL BE DETERMINED UNDER, GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF FLORIDA, WITHOUT REFERENCE TO CONFLICTS OF LAW PRINCIPLES EXCEPT TO THE EXTENT NECESSARY TO ENFORCE THIS CHOICE OF LAW PROVISION.
 
18.   Notices .  All communications hereunder shall be in writing and shall be deemed to be duly given and received (a) upon delivery if delivered personally or upon confirmed transmittal if by facsimile, (b) on the next Business Day if sent by overnight courier, or (c) four (4) Business Days after mailing if mailed by prepaid registered mail, return receipt requested, in each case to the appropriate notice address or facsimile number.
 
19.   Independent Arms Length Transaction .  It is understood and agreed that this Promissory Note, the Security Agreement and the transactions contemplated hereby and thereby were negotiated in an arms length transacton separate and distinct from any other transaction or contractual obligations and are independent of any transaction or transactions between Borrower, on the one hand, and Lender and any of its affilates or related entitles on the other hand.   Borrower further agrees that the contractual obligations of Borrower hereunder are in no way dependent or conditioned upon any other agreements, contracts or transactions whatsoever unless expressly stated herein.
 
 
7


 
IN WITNESS WHEREOF, the undersigned has executed this Promissory Note as of the date first written above.
 
 
INVISA, INC.
 
By:  __________________________
Name:   Edmund C. King
Title:   Chief Financial Officer
 
   
 
 
8

 
Exhibit 10.68
 
NOTE EXTENSION AGREEMENT
 
         This Note Extension Agreement (this "Extension Agreement"), by and between Invisa, Inc., a Nevada corporation, having a business at 1800 2 nd Street, Suite 965, Sarasota, Florida 34236 (the “Borrower”), and Centurian Investors, Inc., a Delaware corporation, having an address at 1800 2 nd Street Suite 970, Sarasota, Florida 34236 (the “Lender”) is entered into as of this 17th day of March, 2010 and shall be effective as of the date hereof (the “Effective Date”).

RECITALS:

WHEREAS, Borrower is indebted to Lender pursuant to that certain Promissory Note, dated February 28, 2007, in the principal amount of up to One Hundred Fifty Thousand ($150,000.00) (the “Note”),

WHEREAS, the Note is secured by (a) an aggregate of Twenty Million (20,000,000) shares of common stock of Borrower and (b) a first priority lien on all of the assets of Borrower as more specifically described in the Note and that certain General Security Agreement, dated February 28, 2007 (the “Security Agreement” the Notes and the Security Agreement, together with all documents executed in connection therewith being hereinafter referred to collectively as the “Loan Documents”); and

WHEREAS, the outstanding principal balance, together with accrued and unpaid interest, of the Note was due and payable on August 28, 2007; and

WHEREAS, Lender has periodically agreed to forebear with respect to certain provisions of the Notes; and

WHEREAS, Borrower has requested and Lender agreed to extend the maturity date of the Note, upon the terms and subject to the provisions set forth herein.

NOW THEREFORE, for ten ($10.00) Dollars, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

1.              Terms used herein which are defined in the Loan Documents shall have the same meanings when used herein unless otherwise provided herein.

2.              The Note is hereby amended to extend the Maturity Date of the Note from August 28, 2007 to March 1, 2012.

3.              Lender shall attach an executed copy of this Amendment to the original Note and all references hereafter to the Note shall be as amended hereby.

4.              No right of Lender with respect to the loan evidenced by the Loan Documents or any agreement, security agreement, financing statements or other documents, executed or delivered in connection  therewith are or will be in any manner, released, destroyed, diminished or otherwise adversely affected by this Agreement, except as expressly provided herein.
 
1

 
5.              Borrower understands and agrees that the remaining provisions of the Note shall remain in full force and effect without any changes or modification except as expressly stated herein.

6.              The provisions set forth herein are limited precisely as written and shall not be deemed to (a) be a consent to, or waiver or modification of, any other term or condition of the Loan Documents, or (b) except as expressly set forth herein, prejudice any right or rights which the Lender may now have or may have in the future under or in connection with the Loan Documents or any of the other documents referred to therein. Except as expressly modified hereby or by express written amendments thereof, the terms and provisions of the Loan Documents or any other documents or instruments executed in connection with any of the foregoing are and shall remain in full force and effect. In the event of a conflict between this Agreement and any of the foregoing documents, the terms of this Agreement shall be controlling. The representations and warranties made in each Loan Document are true and correct in all material respects on and as of the date of this Agreement.

7.              None of the provisions of this Agreement shall inure to the benefit of Borrower or any person other than Lender. Consequently, Borrower shall not be, and no person other than the Lender shall be, entitled to rely upon or raise a claim or defense, in any manner whatsoever, the failure of Lender to comply with the provisions of this Agreement.  Lender shall not incur any liability to Borrower or any other person for any act or omission  whatsoever.

8.              This Agreement and the documents referred to herein represent the entire understanding of the parties hereto regarding the subject matter hereof and supersede all prior and contemporaneous oral and written agreements of the parties hereto with respect to the subject matter hereof.

9.              This Agreement may be executed in any number of counterparts and by different parties on separate counterparts and all of such counterparts shall together constitute one and the same instrument. Complete sets of counterparts shall be lodged with the Borrower and the Lender.

IN WITNESS WHEREOF, this Agreement is executed as of the date first written above and shall be effective as of the Effective Date.

 
 
 INVISA, INC.       CENTURIAN INVESTORS, INC.
   
   
                                            
 Name:     Name:
 Title:     Title:
 
2

 
Exhibit 10.69
 
NOTE EXTENSION AGREEMENT

         This Note Extension Agreement (this "Extension Agreement"), by and between Invisa, Inc., a Nevada corporation, having a business at 1800 2 nd Street, Suite 965, Sarasota, Florida 34236 (the “Borrower”), and Centurian Investors, Inc., a Delaware corporation, having an address at 1800 2 nd Street Suite 970, Sarasota, Florida 34236 (the “Lender”) is entered into as of this 17th day of March, 2010 and shall be effective as of the date hereof (the “Effective Date”).

RECITALS:

WHEREAS, Borrower is indebted to Lender pursuant to that certain Promissory Note, dated June 1, 2008, in the principal amount of up to One Hundred  Thousand ($100,000.00) (the “Note”),

WHEREAS, the Note is secured by (a) an aggregate of Thirteen Million, Three Hundred Thirty Three Thousand, Three Hundred Thirty Four (13,333,334) shares of common stock of Borrower and (b) a first priority lien on all of the assets of Borrower as more specifically described in the Note and that certain General Security Agreement, dated February 28, 2007 (the “Security Agreement” the Notes and the Security Agreement, together with all documents executed in connection therewith being hereinafter referred to collectively as the “Loan Documents”); and

WHEREAS, the outstanding principal balance, together with accrued and unpaid interest, of the Note was due and payable on September 30, 2008; and

WHEREAS, Lender has periodically agreed to forebear with respect to certain provisions of the Notes; and

WHEREAS, Borrower has requested and Lender agreed to extend the maturity date of the Note, upon the terms and subject to the provisions set forth herein.

NOW THEREFORE, for ten ($10.00) Dollars, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

1.              Terms used herein which are defined in the Loan Documents shall have the same meanings when used herein unless otherwise provided herein.

2.              The Note is hereby amended to extend the Maturity Date of the Note from June 1, 2008 to March 1, 2012.

3.              Lender shall attach an executed copy of this Amendment to the original Note and all references hereafter to the Note shall be as amended hereby.

4.              No right of Lender with respect to the loan evidenced by the Loan Documents or any agreement, security agreement, financing statements or other documents, executed or delivered in connection  therewith are or will be in any manner, released, destroyed, diminished or otherwise adversely affected by this Agreement, except as expressly provided herein.
 
1

 
5.              Borrower understands and agrees that the remaining provisions of the Note shall remain in full force and effect without any changes or modification except as expressly stated herein.

6.              The provisions set forth herein are limited precisely as written and shall not be deemed to (a) be a consent to, or waiver or modification of, any other term or condition of the Loan Documents, or (b) except as expressly set forth herein, prejudice any right or rights which the Lender may now have or may have in the future under or in connection with the Loan Documents or any of the other documents referred to therein. Except as expressly modified hereby or by express written amendments thereof, the terms and provisions of the Loan Documents or any other documents or instruments executed in connection with any of the foregoing are and shall remain in full force and effect. In the event of a conflict between this Agreement and any of the foregoing documents, the terms of this Agreement shall be controlling. The representations and warranties made in each Loan Document are true and correct in all material respects on and as of the date of this Agreement.

7.              None of the provisions of this Agreement shall inure to the benefit of Borrower or any person other than Lender. Consequently, Borrower shall not be, and no person other than the Lender shall be, entitled to rely upon or raise a claim or defense, in any manner whatsoever, the failure of Lender to comply with the provisions of this Agreement.  Lender shall not incur any liability to Borrower or any other person for any act or omission  whatsoever.

8.              This Agreement and the documents referred to herein represent the entire understanding of the parties hereto regarding the subject matter hereof and supersede all prior and contemporaneous oral and written agreements of the parties hereto with respect to the subject matter hereof.

9.              This Agreement may be executed in any number of counterparts and by different parties on separate counterparts and all of such counterparts shall together constitute one and the same instrument. Complete sets of counterparts shall be lodged with the Borrower and the Lender.

IN WITNESS WHEREOF, this Agreement is executed as of the date first written above and shall be effective as of the Effective Date.



 INVISA, INC.       CENTURIAN INVESTORS, INC.
   
   
                                            
 Name:     Name:
 Title:     Title:
 
2

 
Exhibit 10.70
 
NOTE EXTENSION AGREEMENT

         This Note Extension Agreement (this "Extension Agreement"), by and between Invisa, Inc., a Nevada corporation, having a business at 1800 2 nd Street, Suite 965, Sarasota, Florida 34236 (the “Borrower”), and Centurian Investors, Inc., a Delaware corporation, having an address at 1800 2 nd Street Suite 970, Sarasota, Florida 34236 (the “Lender”) is entered into as of this 17th day of March, 2010 and shall be effective as of the date hereof (the “Effective Date”).

RECITALS:

WHEREAS, Borrower is indebted to Lender pursuant to that certain Promissory Note, dated March 28, 2008, in the principal amount of up to One Hundred Fifty Thousand ($150,000.00) (the “Note”),

WHEREAS, the Note is secured by (a) an aggregate of Twenty Million (20,000,000) shares of common stock of Borrower and (b) a first priority lien on all of the assets of Borrower as more specifically described in the Note and that certain General Security Agreement, dated February 28, 2007 (the “Security Agreement” the Notes and the Security Agreement, together with all documents executed in connection therewith being hereinafter referred to collectively as the “Loan Documents”); and

WHEREAS, the outstanding principal balance, together with accrued and unpaid interest, of the Note was due and payable on May 31, 2008; and

WHEREAS, Lender has periodically agreed to forebear with respect to certain provisions of the Notes; and

WHEREAS, Borrower has requested and Lender agreed to extend the maturity date of the Note, upon the terms and subject to the provisions set forth herein.

NOW THEREFORE, for ten ($10.00) Dollars, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

1.              Terms used herein which are defined in the Loan Documents shall have the same meanings when used herein unless otherwise provided herein.

2.              The Note is hereby amended to extend the Maturity Date of the Note from May 31, 2008 to March 1, 2012.

3.              Lender shall attach an executed copy of this Amendment to the original Note and all references hereafter to the Note shall be as amended hereby.

4.              No right of Lender with respect to the loan evidenced by the Loan Documents or any agreement, security agreement, financing statements or other documents, executed or delivered in connection  therewith are or will be in any manner, released, destroyed, diminished or otherwise adversely affected by this Agreement, except as expressly provided herein.
 
1

 
5.              Borrower understands and agrees that the remaining provisions of the Note shall remain in full force and effect without any changes or modification except as expressly stated herein.

6.              The provisions set forth herein are limited precisely as written and shall not be deemed to (a) be a consent to, or waiver or modification of, any other term or condition of the Loan Documents, or (b) except as expressly set forth herein, prejudice any right or rights which the Lender may now have or may have in the future under or in connection with the Loan Documents or any of the other documents referred to therein. Except as expressly modified hereby or by express written amendments thereof, the terms and provisions of the Loan Documents or any other documents or instruments executed in connection with any of the foregoing are and shall remain in full force and effect. In the event of a conflict between this Agreement and any of the foregoing documents, the terms of this Agreement shall be controlling. The representations and warranties made in each Loan Document are true and correct in all material respects on and as of the date of this Agreement.

7.              None of the provisions of this Agreement shall inure to the benefit of Borrower or any person other than Lender. Consequently, Borrower shall not be, and no person other than the Lender shall be, entitled to rely upon or raise a claim or defense, in any manner whatsoever, the failure of Lender to comply with the provisions of this Agreement.  Lender shall not incur any liability to Borrower or any other person for any act or omission  whatsoever.

8.              This Agreement and the documents referred to herein represent the entire understanding of the parties hereto regarding the subject matter hereof and supersede all prior and contemporaneous oral and written agreements of the parties hereto with respect to the subject matter hereof.

9.              This Agreement may be executed in any number of counterparts and by different parties on separate counterparts and all of such counterparts shall together constitute one and the same instrument. Complete sets of counterparts shall be lodged with the Borrower and the Lender.

IN WITNESS WHEREOF, this Agreement is executed as of the date first written above and shall be effective as of the Effective Date.
 


 INVISA, INC.       CENTURIAN INVESTORS, INC.
   
   
                                            
 Name:     Name:
 Title:     Title:
 
2

 

Exhibit 10.71
 
NOTE EXTENSION AGREEMENT

         This Note Extension Agreement (this "Extension Agreement"), by and between Invisa, Inc., a Nevada corporation, having a business at 1800 2 nd Street, Suite 965, Sarasota, Florida 34236 (the “Borrower”), and Centurian Investors, Inc., a Delaware corporation, having an address at 1800 2 nd Street Suite 970, Sarasota, Florida 34236 (the “Lender”) is entered into as of this 17th day of March, 2010 and shall be effective as of the date hereof (the “Effective Date”).

RECITALS:

WHEREAS, Borrower is indebted to Lender pursuant to that certain Promissory Note, dated July 25,  2007, in the principal amount of up to Fifty Thousand ($50,000.00) (the “Note”),

WHEREAS, the Note is secured by (a) an aggregate of Six Million Six Hundred Sixty Six Thousand, Six Hundred Sixty Six (6,666,666) shares of common stock of Borrower and (b) a first priority lien on all of the assets of Borrower as more specifically described in the Note and that certain General Security Agreement, dated February 28, 2007 (the “Security Agreement” the Notes and the Security Agreement, together with all documents executed in connection therewith being hereinafter referred to collectively as the “Loan Documents”); and

WHEREAS, the outstanding principal balance, together with accrued and unpaid interest, of the Note was due and payable on August 31, 2007; and

WHEREAS, Lender has periodically agreed to forebear with respect to certain provisions of the Notes; and

WHEREAS, Borrower has requested and Lender agreed to extend the maturity date of the Note, upon the terms and subject to the provisions set forth herein.

NOW THEREFORE, for ten ($10.00) Dollars, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

1.              Terms used herein which are defined in the Loan Documents shall have the same meanings when used herein unless otherwise provided herein.

2.              The Note is hereby amended to extend the Maturity Date of the Note from August 31, 2007 to March 1, 2012.

3.              Lender shall attach an executed copy of this Amendment to the original Note and all references hereafter to the Note shall be as amended hereby.

4.              No right of Lender with respect to the loan evidenced by the Loan Documents or any agreement, security agreement, financing statements or other documents, executed or delivered in connection  therewith are or will be in any manner, released, destroyed, diminished or otherwise adversely affected by this Agreement, except as expressly provided herein.
 
1

 
5.              Borrower understands and agrees that the remaining provisions of the Note shall remain in full force and effect without any changes or modification except as expressly stated herein.

6.              The provisions set forth herein are limited precisely as written and shall not be deemed to (a) be a consent to, or waiver or modification of, any other term or condition of the Loan Documents, or (b) except as expressly set forth herein, prejudice any right or rights which the Lender may now have or may have in the future under or in connection with the Loan Documents or any of the other documents referred to therein. Except as expressly modified hereby or by express written amendments thereof, the terms and provisions of the Loan Documents or any other documents or instruments executed in connection with any of the foregoing are and shall remain in full force and effect. In the event of a conflict between this Agreement and any of the foregoing documents, the terms of this Agreement shall be controlling. The representations and warranties made in each Loan Document are true and correct in all material respects on and as of the date of this Agreement.

7.              None of the provisions of this Agreement shall inure to the benefit of Borrower or any person other than Lender. Consequently, Borrower shall not be, and no person other than the Lender shall be, entitled to rely upon or raise a claim or defense, in any manner whatsoever, the failure of Lender to comply with the provisions of this Agreement.  Lender shall not incur any liability to Borrower or any other person for any act or omission  whatsoever.

8.              This Agreement and the documents referred to herein represent the entire understanding of the parties hereto regarding the subject matter hereof and supersede all prior and contemporaneous oral and written agreements of the parties hereto with respect to the subject matter hereof.

9.              This Agreement may be executed in any number of counterparts and by different parties on separate counterparts and all of such counterparts shall together constitute one and the same instrument. Complete sets of counterparts shall be lodged with the Borrower and the Lender.

IN WITNESS WHEREOF, this Agreement is executed as of the date first written above and shall be effective as of the Effective Date.



 INVISA, INC.       CENTURIAN INVESTORS, INC.
   
   
                                            
 Name:     Name:
 Title:     Title:
 
2

 



Exhibit 10.72
 
NOTE EXTENSON AGREEMENT

         This Note Extension Agreement (this "Extension Agreement"), by and between Invisa, Inc., a Nevada corporation, having a business at 1800 2 nd Street, Suite 965, Sarasota, Florida 34236 (the “Borrower”), and Centurian Investors, Inc., a Delaware corporation, having an address at 1800 2 nd Street Suite 970, Sarasota, Florida 34236 (the “Lender”) is entered into as of this 17th day of March, 2010 and shall be effective as of the date hereof (the “Effective Date”).

RECITALS:

WHEREAS, Borrower is indebted to Lender pursuant to that certain Promissory Note, dated November 9, 2007, in the principal amount of up to Fifty Thousand ($50,000.00) (the “Note”),

WHEREAS, the Note is secured by (a) an aggregate of Six Million Six Hundred Sixty Six Thousand, Six Hundred Sixty Six (6,666,666) shares of common stock of Borrower and (b) a first priority lien on all of the assets of Borrower as more specifically described in the Note and that certain General Security Agreement, dated February 28, 2007 (the “Security Agreement” the Notes and the Security Agreement, together with all documents executed in connection therewith being hereinafter referred to collectively as the “Loan Documents”); and

WHEREAS, the outstanding principal balance, together with accrued and unpaid interest, of the Note was due and payable on December 31, 2007; and

WHEREAS, Lender has periodically agreed to forebear with respect to certain provisions of the Notes; and

WHEREAS, Borrower has requested and Lender agreed to extend the maturity date of the Note, upon the terms and subject to the provisions set forth herein.

NOW THEREFORE, for ten ($10.00) Dollars, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

1.              Terms used herein which are defined in the Loan Documents shall have the same meanings when used herein unless otherwise provided herein.

2.              The Note is hereby amended to extend the Maturity Date of the Note from December 31, 2007 to March 1, 2012.

3.              Lender shall attach an executed copy of this Amendment to the original Note and all references hereafter to the Note shall be as amended hereby.

4.              No right of Lender with respect to the loan evidenced by the Loan Documents or any agreement, security agreement, financing statements or other documents, executed or delivered in connection  therewith are or will be in any manner, released, destroyed, diminished or otherwise adversely affected by this Agreement, except as expressly provided herein.
 
1


 
5.              Borrower understands and agrees that the remaining provisions of the Note shall remain in full force and effect without any changes or modification except as expressly stated herein.

6.              The provisions set forth herein are limited precisely as written and shall not be deemed to (a) be a consent to, or waiver or modification of, any other term or condition of the Loan Documents, or (b) except as expressly set forth herein, prejudice any right or rights which the Lender may now have or may have in the future under or in connection with the Loan Documents or any of the other documents referred to therein. Except as expressly modified hereby or by express written amendments thereof, the terms and provisions of the Loan Documents or any other documents or instruments executed in connection with any of the foregoing are and shall remain in full force and effect. In the event of a conflict between this Agreement and any of the foregoing documents, the terms of this Agreement shall be controlling. The representations and warranties made in each Loan Document are true and correct in all material respects on and as of the date of this Agreement.

7.              None of the provisions of this Agreement shall inure to the benefit of Borrower or any person other than Lender. Consequently, Borrower shall not be, and no person other than the Lender shall be, entitled to rely upon or raise a claim or defense, in any manner whatsoever, the failure of Lender to comply with the provisions of this Agreement.  Lender shall not incur any liability to Borrower or any other person for any act or omission  whatsoever.

8.              This Agreement and the documents referred to herein represent the entire understanding of the parties hereto regarding the subject matter hereof and supersede all prior and contemporaneous oral and written agreements of the parties hereto with respect to the subject matter hereof.

9.              This Agreement may be executed in any number of counterparts and by different parties on separate counterparts and all of such counterparts shall together constitute one and the same instrument. Complete sets of counterparts shall be lodged with the Borrower and the Lender.

IN WITNESS WHEREOF, this Agreement is executed as of the date first written above and shall be effective as of the Effective Date.



 INVISA, INC.       CENTURIAN INVESTORS, INC.
   
   
                                            
 Name:     Name:
 Title:     Title:
 
2

 


Exhibit 10.73
 
Terms of Exchange
 
 Invisa Inc.
 
EXCHANGE OF
SERIES B PREFERRED STOCK FOR SHARES OF SERIES C PREFERRED STOCK
 
AND
 
CONSENT SOLICITATION
 
 
THIS EXCHANGE EXPIRES AT 9:00 A.M., E.S.T., ON JANUARY 28, 2010,
UNLESS THE OFFER IS EXTENDED OR MODIFIED BY THE COMPANY.
 

 
        Invisa, Inc. (the "Company," "our," "we" or "us") is offering to exchange on a share for share basis, upon the terms and subject to the conditions set forth in this Terms of Exchange and in the related letters of transmittal and consent (the "Exchange"), all of our outstanding Series B Preferred Stock, par value $0.001 per share ("Series B Preferred Stock") for shares of Series C Preferred Stock, par value $0.001 per share ("Series C Preferred Stock" and together with Series B Preferred Stock, collectively hereinafter referred to as the "Preferred Stock").
 
        Concurrently with the Exchange, we are soliciting consents (the "Consent Solicitation") from holders of the Series B Preferred Stock to amend our Charter (the "Charter") to modify the preferential terms of the Series B Preferred Stock, including modifications to dividends and conversion, as described in this Terms of Exchange ("Proposed Amendments").
 
        If successfully completed, in the Exchange and Consent Solicitation you will receive one share of Series C Preferred Stock for each share of Series B Preferred Stock exchanged.  Any accumulated and unpaid dividends of the Series B Preferred Stock presented for exchange by any Holder shall be paid in equal shares of Series C Preferred Stock.
 
        Furthermore, holders representing a majority of the outstanding shares of Series B Preferred Stock, voting as a single class, must also approve the Proposed Amendments in order to affect the Proposed Amendments, which may be accomplished by submitting executed letter(s) of transmittal and consent and exchanging your shares of Series B Preferred Stock. You must validly exchange all shares of Series B Preferred Stock that you own and deliver your consent to the Proposed Amendments to the Charter to modify the terms of the Series B Preferred Stock in order to participate in the Exchange and Consent Solicitation.
 
         The Exchange and Consent Solicitation will expire at 9:00 a.m., Eastern Standard Time, on January 28, 2010, unless extended, modified or otherwise terminated by us. The term "expiration date" means 9:00 a.m., Eastern Standard Time, on January 28, 2010, unless we extend or modify the period of time for which the Exchange and Consent Solicitation are open, in which case the term "expiration date" means the latest time and date on which the Exchange and Consent Solicitation, as so extended, expire.
 
         The Exchange and Consent Solicitation and the securities to be issued in the Exchange and Consent Solicitation have not been approved or disapproved by the Securities and Exchange Commission (the "SEC"), any state securities commission, or the similar commission or governmental agency of any foreign jurisdiction, nor has the SEC, any state securities commission, or the similar commission or governmental agency of any foreign jurisdiction determined whether the information in this Terms of Exchange is truthful or complete. None of the SEC, any state securities commission or any similar commission or governmental agency of any foreign jurisdiction has passed upon the merits or fairness of the Exchange and Consent Solicitation, or passed upon the adequacy or accuracy of the disclosure contained in this Terms of Exchange. Any representation to the contrary is a criminal offense.
 
Page 1

 
        This Terms of Exchange is being mailed to holders of the Series B Preferred Stock on or around January 11, 2010.
 
        There are 9,000 shares of our Series B Preferred Stock and 6628 shares of our Series C Preferred Stock outstanding, each of which has a liquidation preference of $100.00 per share.
 
        We are seeking consents from holders of the Series B Preferred Stock to amend certain provisions (collectively, the "Proposed Amendments") applicable to the Series B Preferred Stock as described herein.  The affirmative vote of holders of outstanding shares of Series B Preferred Stock is necessary to approve the Proposed Amendments modifying the preferential terms of the Series B Preferred Stock.  The holders representing a majority of the outstanding shares of Series B Preferred Stock, voting as a single class, must approve the Proposed Amendments which may be accomplished by submitting executed letter(s) of transmittal and consent and validly exchanging your shares of Series B Preferred Stock. If we do not receive the requisite consent from the holders of the Series B Preferred Stock, the Company may or may not elect to exchange the Series B Preferred Stock presented for exchange together with accumulated and unpaid dividends on the Preferred Stock.
 
                None of our officers, employees, the Board, or any of our financial advisors is making a recommendation to any holder of Preferred Stock as to whether you should exchange shares in the Exchange and Consent Solicitation. You must make your own investment decision regarding the Exchange and Consent Solicitation based upon your own assessment of the value of the Series B Preferred Stock, the effect of holding shares of the Series B Preferred Stock upon the approval of the Proposed Amendments, your liquidity needs, your investment objectives and any other factors you deem relevant.
 
        In order to exchange shares in the Exchange and Consent Solicitation, you must consent to the Proposed Amendments by executing letters of transmittal and consent.  No meeting has been or is being held in conjunction with the Consent Solicitation. Consents may only be submitted on the terms set forth herein.
 
        Our officers, directors and employees may solicit exchanges from holders of our Preferred Stock and may answer inquiries concerning the Exchange and Consent Solicitation, but they will not receive additional compensation for soliciting exchanges or answering any such inquiries.
 
        The Company will act as its own agent for the Exchange and Consent Solicitation.
 
        Questions related to the terms of the Exchange and Consent Solicitation and requests for assistance or for additional copies of this Terms of Exchange, the letters of transmittal and consent or any other documents may be directed to the Company using its contact information set forth herein or by telephone at (941) 870-3950. Beneficial owners may also contact their custodian for assistance concerning the Exchange and Consent Solicitation.
 
Page 2

 
SUMMARY
 
         The Terms of Exchange and the related letters of transmittal and consent each contain important information that should be read carefully before any decision is made with respect to the Exchange and Consent Solicitation. The following summary is qualified in its entirety by the more detailed information appearing elsewhere in the Terms of Exchange and the related letters of transmittal and consent.
 
Invisa, Inc.
 
        Invisa Inc. is a corporation incorporated in Nevada.  Our management has been seriously challenged by the unprecedented economic turmoil.   One of our goals in this challenging market environment has been to align the costs of our operations to our cash flows. The acceptance of this Exchange and Consent Solicitation would reduce the Company's continuing obligation to pay or accumulate quarterly dividends on the Series B Preferred Stock, thereby allowing the Company to use or preserve cash for other purposes and would also allow the Company to elect to pay accrued but unpaid dividends in kind. The aggregate dividends on the outstanding Preferred Stock total approximately $ 300,533.00 as of September 30, 2009.
 
        We believe the elimination of the Series B Preferred Stock and the related dividends will give us the enhanced balance sheet flexibility to operate and grow our business. We additionally believe that with an improved capital structure there are multiple business opportunities we can pursue to enhance stockholder value that have not previously been feasible.
 
        If the Exchange and Consent Solicitation is not approved, there may be a near-term negative effect on our business, results of operations, and financial position, including the potential inability to satisfy our liabilities and the long-term dividend-related cash requirements of our Series B Preferred Stock. The Series B Preferred Stock will remain issued and outstanding, and entitled to all of the preferential rights associated with the Series B Preferred Stock, including the right to receive accumulated dividends.  If we do not successfully complete the Exchange and Consent Solicitation, we currently cannot make accumulated or future dividend payments on our Series B Preferred Stock, which could adversely affect our business. Furthermore, the Preferred Stock is entitled to receive $100.00 per share (before any payments are made to the holders of our Common Stock and any other junior stock) upon any voluntary or involuntary liquidation, dissolution or winding up of our affairs. However, if the Proposed Amendments are not approved, upon any voluntary or involuntary liquidation, dissolution or winding up of our affairs, the Series B Preferred Stock will also continue to be entitled to any accumulated and unpaid dividends (whether or not declared). Any liquidating distributions to capital stock are subject to payments on outstanding indebtedness. The Series B Preferred Stock will continue to rank senior to our Common Stock with respect to the payment of distributions and the distribution of assets upon liquidation, dissolution or winding up and be entitled to a larger amount of our assets. Our ability to make distributions to holders of Common Stock will remain limited.
 
        The Company cannot make any assurances that it will receive the requisite consents of the holders of the Preferred Stock and that all the conditions will be met to complete the Exchange and Consent Solicitation.
 
Page 3

 
Summary Description of the Exchange and Consent Solicitation
 
The Company
Invisa, Inc.
 
     
The Preferred Stock Subject to
the Exchange and Consent
Solicitation
All outstanding shares of our Series B Preferred Stock.
 
     
The Exchange
We are offering to exchange one share of Series B Preferred Stock for a newly issued shares of Series C Preferred Stock, for any and all of our shares of Series B Preferred Stock validly exchanged prior to the expiration of the Exchange and Consent Solicitation.
 
     
Consideration
 
In the Exchange and Consent Solicitation for each exchanged share of Series B Preferred Stock, the holder will receive one share of newly issued Series C Preferred Stock.  Any accumulated and unpaid dividends shall be converted into shares of Series C Preferred Stock at a rate of one share for each $100.00 of accumulated and unpaid dividends at the time of the exchange.
 
     
 
Aggregate Consideration
 
Assuming all shares of Preferred Stock are validly exchanged, we will cancel an aggregate of 9000 shares of Series B Preferred Stock and issue an aggregate of 9000 shares of Series C Preferred Stock, which does not include accrued and unpaid dividends.
 
 
 
     
     
     
 
Accumulated and Unpaid
Dividends
The aggregate accumulated and unpaid dividends on the Series B Preferred Stock as of September 30, 2009 is $300,533.00, which shall be converted into approximately 3005 shares of Series C Preferred Stock as of the expiration date.  Additional dividends due and payable through December 31, 2009 shall be calculated and converted at the same rate.
 
     
 
The Consent Solicitation
In order to exchange shares in the Exchange and Consent Solicitation, holders of our Series B Preferred Stock are required to consent (by executing the letters of transmittal and consent) to amend the Charter to modify the terms of the Series B Preferred Stock as set forth in Annex A .
 
 
Page 4

 
Expiration of the Exchange
and Consent Solicitation
The Exchange and Consent Solicitation will expire at 9:00 a.m., Eastern Standard Time, on January 28, 2010, unless extended or earlier terminated by us.
 
     
     
     
     
Risk Factors
You should consider carefully all of the information set forth in this Terms of Exchange before deciding whether to participate in the Exchange and Consent Solicitation.
   
   
   
Additional Documentation;
Further Information;
Assistance
Any requests for assistance concerning the Exchange and Consent Solicitation and requests for additional copies of this Terms of Exchange and the letters of transmittal and consent may be directed to the Company at the following address and telephone number: ­­­­­­­­PO Box 49376, Sarasota, Fl 34230 941-870-3950
 
QUESTIONS AND ANSWERS ABOUT
THE EXCHANGE AND CONSENT SOLICITATION
 
         The following are some questions regarding the Exchange and Consent Solicitation that you may have as a holder of the Series B Preferred Stock and the answers to those questions. We urge you to read carefully the entire Terms of Exchange, the related letters of transmittal and consent, our annual report on Form 10-K for the year ended December 31, 2008 (the "Annual Report") and our Quarterly Report on Form 10-Q for the period ended September 30, 2009 (the "Quarterly Report"). Additional important information is contained in the remainder of the Terms of Exchange.
 
         What is the purpose of the Exchange and Consent Solicitation?
 
       One of our goals in this challenging market environment has been to align the costs of our operations to our cash flows. The acceptance of this Exchange and Consent Solicitation would reduce the Company's continuing obligation to pay or accumulate quarterly dividends on the Series B Preferred Stock and allow the Company to pay accrued and unpaid dividends in kind, thereby allowing the Company to use or preserve cash for other purposes and improve its balance sheet. Currently, the aggregate dividends on the outstanding Preferred Stock total approximately $300,533.00 as of September 30, 2009.
 
        If we receive the requisite approval from the holders of the Series B Preferred Stock and the Exchange and Consent Solicitation is completed, then contemporaneously with the closing we will pay all accumulated and unpaid dividends on the Series B Preferred Stock through the issuance of additional shares of Series C Preferred Stock. Those holders who do not exchange their shares of Series B Preferred Stock, despite the completion of the Exchange and Consent Solicitation, will not be paid any cumulated dividends on the Series B Preferred Stock. Further, if the Exchange and Consent Solicitation is completed, our obligation to pay future accumulated and unpaid dividends on any remaining outstanding shares of Preferred Stock will be eliminated and future dividends, if any, will be eliminated.
 
        We believe the significant reduction or elimination of the outstanding Series B Preferred Stock and the elimination of the related dividends obligations will give us the enhanced balance sheet flexibility to operate and grow our business. We additionally believe that with an improved capital structure there are multiple business opportunities we can pursue to enhance stockholder value that have not previously been feasible.
 
Page 5

 
        If the Exchange and Consent Solicitation is not approved, there may be a near-term negative effect on our business, results of operations, and financial position, including the potential inability to satisfy our liabilities and the long-term dividend-related cash requirements of our Series B Preferred Stock and obligations pursuant to the terms of our remaining trust preferred securities. We currently have no present intention to pay accumulated or future dividends on the Series B Preferred Stock.
 
         What will I receive in the Exchange and Consent Solicitation if I exchange my shares of Preferred Stock and they are accepted?
 
        If successfully completed, for every one share of Series B Preferred Stock exchanged, you will receive one share of Series C Preferred Stock.  Additionally, any accrued and unpaid interest as of December 31, 2009, on the Series B Preferred Stock will be paid by the issuance of additional Series C Preferred Stock.
 
                  When will I receive my Series C Preferred Stock?
 
        If all terms and conditions for completion of the Exchange and Consent Solicitation are satisfied or waived, we will issue for all validly exchanged shares of Series B Preferred Stock for shares of Series C Preferred Stock as set forth herein promptly after the expiration date of the Exchange and Consent Solicitation. Unless otherwise indicated on the Letter of Transmittal and Consent, newly issued share certificates for Series C Preferred Stock shall be delivered to the address of the Holder on the books and records of the Company.
 
         What are the conditions to the closing of the Exchange and Consent Solicitation?
 
        We are not obligated to purchase any exchanged shares of Preferred Stock if (1) there is any litigation regarding the Exchange and Consent Solicitation challenging or seeking to make illegal, materially delay, restrain or prohibit the Exchange and Consent Solicitation; or which would have a material adverse effect on us; (2) the consummation of the Exchange and Consent Solicitation would violate any law, rule or regulation applicable to us; (3) any law, rule, regulation or governmental order becomes applicable to us that results, directly or indirectly, in the consequences described under paragraph 1 above; or (4) less than a majority of the outstanding shares of the Series B Preferred Stock, voting as a single class are exchanged (and thereby consent to the Proposed Amendments to our Charter) in the Exchange and Consent Solicitation.   We will, in our reasonable judgment, determine whether each of the Exchange and Consent Solicitation conditions have been satisfied and whether to waive any conditions that have not been satisfied.
 
         If the Exchange and Consent Solicitation is NOT successfully completed, what will be the consequences to the stockholders and the Company?
 
        If the Exchange and Consent Solicitation is not successfully completed, the Series B Preferred Stock will remain issued and outstanding, and entitled to all of the preferential rights associated with the Preferred Stock, including the right to receive dividends.  Given our current financial condition, we currently cannot pay dividends on the Series B Preferred Stock if the Exchange and Consent Solicitation is not successfully completed. If the Exchange and Consent Solicitation is not successfully completed, the Series B Preferred Stock will continue to rank senior to our Common Stock with respect to the payment of distributions and the distribution of assets upon liquidation, dissolution or winding up and be entitled to a larger amount of our assets. Plus, our ability to make distributions to holders of Common Stock will remain limited. Unless all of the cumulative dividends due and owing on the Series B Preferred Stock are paid in full, the Company will not be able to declare dividends or distributions on the Common Stock of the Company in the future.
 
Page 6

 
        There may be significant adverse consequences to the Company if the proposal to approve the Proposed Amendments is not approved by the holders of Series B Preferred Stock, including the potential inability to satisfy our liabilities and the long-term dividend-related cash requirements of our Series B Preferred Stock. The Company will continue to be obligated to pay accumulated dividends on the Series B Preferred Stock.
 
        In light of the continuing economic turmoil, our ability to continue our operations is dependent upon our ability to implement successfully our strategic initiatives and acquire new operations that contribute sufficient additional cash flow to enable us to meet our current and future expenses. Our future financial performance and success are dependent in large part upon our ability to implement our contemplated strategies successfully. To the extent that we are not successful in reducing our payment obligations, we would be unlikely to be able to continue our operations as planned, thereby requiring us to reduce our operating costs and expenses so that our income can cover those costs. As a result, we may not be able to accomplish our goals, rebuild our business, and, given the limited opportunities available in the financial market, we may be required to change our current plan of operations, which we cannot determine at this time, but could include a wind down of the Company.
 
         If I decide not to exchange my shares of Preferred Stock and the Exchange and the Consent Solicitation is completed, how will the completion of the Exchange and the Consent Solicitation affect my shares of Preferred Stock?
 
        If you decide not to exchange your shares of Preferred Stock and the Proposed Amendments take effect, the Series B Preferred Stock will no longer accrue dividends and any accrued and unpaid dividends may be satisfied by either (i) cash, (ii) in Series B Preferred Stock or (iii) in common stock of the Company, by the Company at its election.  In addition, the Company may convert your Series B Preferred Stock into common stock at its election at any time after the Proposed Amendments take effect.
 
 
 
         Am I required to exchange my shares of Preferred Stock in order to receive the accumulated and unpaid dividends on my shares of Preferred Stock?
 
        No. If the Exchange and Consent Solicitation is successfully completed, but you choose not to exchange your shares of Series B Preferred Stock, you will still be entitled to receive the accumulated and unpaid dividends on your shares of Series B Preferred Stock until such time as the Proposed Amendments become effective.  However, the Company does not have adequate funds to pay such dividends at this time and there can be no assurance that you will receive payment on the accumulated and unpaid dividends in the future.  In addition, the Proposed Amendments will permit the Company to satisfy any accumulated and unpaid dividends by issuing you additional shares of the Series B Preferred Stock in lieu of a cash payment.
 
         Will I receive accumulated and unpaid dividends if the Exchange and Consent Solicitation is NOT successfully completed?
 
         All dividends accrued as of the date of the Exchange shall remain an obligation of the Company; however, the Company is not able to pay any of the accumulated and unpaid dividends at this time and there can be no assurance that the Company will have the monetary resources to pay such dividends in the future.
 
         When will the Exchange and Consent Solicitation expire?
 
        The Exchange and Consent Solicitation is currently scheduled to expire at 9:00 a.m., Eastern Standard Time, on January 28, 2010.  We may, however, extend the Exchange and Consent Solicitation from time to time as necessary until all the conditions to the Exchange and Consent Solicitation have been satisfied or waived.
 
         Under what circumstances can the Exchange and Consent Solicitation be extended?
 
        We may extend the Exchange and Consent Solicitation for any period at our sole discretion to increase the time in which holders of the Series B Preferred Stock may exchange their shares. We will also extend the expiration date of the Exchange and Consent Solicitation if required by applicable law or regulation.  You should note that it is highly unlikely that the period of time for the exchange would be later than January28, 2010.
 
Page 7

 
         What happens to my exchanged shares if the Exchange and Consent Solicitation is terminated?
 
         If the Exchange and Consent Solicitation is terminated and you previously have exchanged shares, we will return certificates for such shares of Series B Preferred Stock exchanged as soon as practicable following the termination of the Exchange and Consent Solicitation without expense to the exchanging stockholder.         
 
         How will I be notified if the Exchange and Consent Solicitation is extended, amended or terminated?
 
        If the Exchange and Consent Solicitation is extended, amended or terminated, we will promptly notify all holders of the Series B Preferred at the address of record on the books of the Company.
 
         Will I have to pay any fees or commissions for participating in the Exchange and Consent Solicitation?
 
        No.
 
         May I exchange only a portion of the shares of Preferred Stock that I hold?
 
        No. You must exchange all of your shares of Series B Preferred Stock to participate in the Exchange and Consent Solicitation.
 
 
 
         How do I exchange my shares of Preferred Stock?
 
        If you hold physical share certificates and are the record owner of your shares, you must deliver the certificates representing your shares of Series B Preferred Stock, together with completed letters of transmittal and consent and any other documents required by the letters of transmittal and consent, to the Company, no later than the time the Exchange and Consent Solicitation expires.
 
         What is the Consent Solicitation?
 
        We are soliciting consents from holders of the Series B Preferred Stock to amend the Charter to modify the preferential terms of the Series B Preferred Stock including modifications to dividend.   Each share of Series B Preferred Stock (equal to each $100.00 of liquidation preference) will be entitled to one vote on the Consent Solicitation.
 
        In order to complete the purchase of the Series B Preferred Stock in the Exchange and Consent Solicitation, we must receive the requisite approvals of the Proposed Amendments from the holders of the Series B Preferred Stock.
 
         Do I have to deliver my consent in the Consent Solicitation in order to exchange my shares of Series B Preferred Stock validly in the Exchange and Consent Solicitation?
 
        Yes. You must consent to the Proposed Amendments in order to exchange your shares of Series B Preferred Stock in the Exchange and Consent Solicitation. Your participation in the Exchange and Consent Solicitation is conditioned on your execution of a written consent approving the Proposed Amendments, and our completion of the Exchange and Consent Solicitation is conditioned on obtaining consents from the requisite number of holders of the Preferred Stock (voting together as a single class) to the Proposed Amendments.  There is no record date for the Exchange and Consent Solicitation, and the holders of a majority of the outstanding shares of Series B Preferred Stock as of the expiration date will be required to consent to the Proposed Amendments pursuant to the terms set forth herein.
 
Page 8

 
         What vote is required to approve the Proposed Amendments?
 
     Holders representing a majority of the outstanding shares of Preferred Stock, voting as a single class, must approve the Proposed Amendments in order to affect the Proposed Amendments, which may be accomplished by submitting executed letter(s) of transmittal and consent and validly exchanging your shares of Series B Preferred Stock.
 
         May I deliver a consent to only some of the Proposed Amendments?
 
        No. You must consent to all of the Proposed Amendments affecting the Series B Preferred Stock you hold if you wish to validly exchange any of your shares of Preferred Stock.
 
         How do I deliver my consent to the Proposed Amendments?
 
        If you are a record holder of shares of Preferred Stock, by submitting executed letters of transmittal and consent and validly exchanging your shares of Series B Preferred Stock, you will be consenting to all of the Proposed Amendments to the terms of the Preferred Stock.
 
         When will the Proposed Amendments become effective?
 
        If we receive the requisite approval of the holders of the Series B Preferred Stock and all other conditions are met, the Proposed Amendments will become effective upon the filing by the Company of the Amendment to the Certificate of Designation of the Series B Preferred Stock with the Secretary of State of the State of Nevada  (the “Amendment”) or at a later date and time specified in the amendment.  The Company intends to file the Amendment promptly upon the earlier of receipt of a majority of the consents of the Series B Preferred Stock or, after the expiration of the Exchange and Consent Solicitation, but not later than January 31, 2009.
 
         Are you making a recommendation regarding whether I should exchange in the Exchange and Consent Solicitation?
 
        No. You must make your own investment decision regarding the Exchange and Consent Solicitation based upon your own assessment of the market value of the Series B Preferred Stock, the effect of holding shares of Series B Preferred Stock if the Proposed Amendments are approved, your liquidity needs, your investment objectives and any other factors you deem relevant.
 
         What are the tax consequences of the transaction to me?
 
        We urge you to consult with your own tax advisor as to the particular tax consequences to you of the Exchange and Consent Solicitation.
 
         Does the Company intend to remain a public company following the completion of the Exchange and Consent Solicitation?
 
        Yes. We intend to remain a public company.
 
         Whom do I call if I have any questions on how to exchange my shares of Preferred Stock or consent to the Proposed Amendments, or any other questions relating to the Exchange and Consent Solicitation?
 
Page 9

 
        Questions related to the terms of the Exchange and Consent Solicitation and requests for assistance, as well as for additional copies of this Terms of Exchange, the letters of transmittal and consent or any other documents, may be directed to the Company at its mailing address, PO Box 49376, Sarasota, Florida 34230 or by telephone at (941) 870-3750.
 
         Where can I find more information about Invisa, Inc.?
 
        For more information, see the Annual Report and the Quarterly Reports filed with the Securities and Exchange Commission at www.sec.gov .
 
Page 10

 
 

 
 

 
 

 
Exhibit 10.74
 
AMENDED AND RESTATED
CERTIFICATE OF DESIGNATIONS OF PREFERENCES AND RIGHTS
OF
SERIES B CONVERTIBLE PREFERRED STOCK
OF
INVISA, INC.,
a Nevada corporation

         The undersigned, Edmund C. King, certifies that:

                  1.  He is the duly acting President of Invisa, Inc., a corporation organized and existing under the Corporation Code of the State of Nevada (the "CORPORATION").

                  2. Pursuant to authority conferred upon the Board of Directors by the  Certificate of  Incorporation  of the Corporation,  and pursuant to the provisions  of the  Corporations  Code of the  State of  Nevada,  said  Board of Directors,  pursuant to a meeting  held on January 11,  2010,  adopted a  resolution amending and restating the rights,  preferences,  privileges and restrictions of, and the number of shares comprising,  the Corporation's  Series B Convertible  Preferred Stock, which resolution is as follows:

         RESOLVED,  that a series of Preferred Stock in the Corporation,  having the rights, preferences,  privileges and restrictions,  and the number of shares constituting such series and the designation of such series, authorized  by the  Board of  Directors  of the  Corporation pursuant to authority given by the Corporation's Certificate of Incorporation,  be, and hereby is, amended and restated as set forth below.

         NOW,  THEREFORE,  BE IT RESOLVED,  that the Board of  Directors  hereby amends and restates the rights,  preferences,  privileges  and  restrictions  relating to, the Series B Preferred Stock as follows:

         (a)  Determination.  The series of Preferred Stock is hereby designated Series B Convertible Preferred Stock (the "SERIES B PREFERRED STOCK").

         (b) Authorized Shares. The number of authorized shares constituting the Series B Preferred  Stock shall be Ten Thousand (10,000) shares of such series.

         (c)  Dividends.   On or after January 1, 2010, the holder of the Series B Preferred Stock shall be entitled to receive, when, as and if declared by the Board of Directors, out of any assets of the Corporation legally available therefor, such dividends as may be declared from time to time by the Board of Directors.  Nothing herein shall obligate or require the Board of Directors to declare a dividend for the Series B Preferred Stock on or after January 1, 2010. To the extent that any dividends accrued prior to January 1, 2010 and remain outstanding, such dividend may be paid in whole or in part by the delivery of (i) cash, (ii) shares of Series B Preferred Stock valued at $100.00 per share or (iii) shares of Common Stock at the Conversion Price (as hereinafter defined).  Payments of dividends with  Series B Preferred Stock may be made at any time and from time to time at the option of the Company, in its sole discretion.
 
         (d) Liquidation Preference.
 
1

 
                  (i) Preference upon Liquidation, Dissolution or Winding Up. In the event of any dissolution or winding up of the Corporation, whether voluntary or involuntary,  holders of each  outstanding  share of Series B Preferred Stock shall  be  entitled  to be  paid  first  out of the  assets  of the  Corporation available for  distribution  to  shareholders,  whether such assets are capital, surplus or earnings,  an amount equal to $100.00 (the "SERIES B PURCHASE PRICE") per share of Series B Preferred  Stock held (as adjusted  for any stock  splits, stock dividends or  recapitalizations of the Series B Preferred  Stock) and any declared but unpaid dividends on such share, before any payment shall be made to the holders of the Common Stock, or any other stock of the  Corporation  ranking junior to the Series B Preferred Stock with regard to any distribution of assets upon liquidation,  dissolution or winding up of the Corporation.  The holders of the Series B Preferred Stock shall be entitled to share ratably,  in accordance with  the  respective  preferential  amounts  payable  on  such  stock,  in  any distribution which is not sufficient to pay in full the aggregate of the amounts payable  thereon.  If, upon any  liquidation,  dissolution  or winding up of the Corporation,  the  assets  to be  distributed  to the  holders  of the  Series B Preferred Stock shall be insufficient to permit payment to such  shareholders of the  full  preferential  amounts  aforesaid,  then  all  of  the  assets  of the Corporation  available for distribution to shareholders  shall be distributed to the holders of Series B Preferred  Stock.  Each holder of the Series B Preferred Stock shall be entitled to receive that portion of the assets available for distribution as the number of outstanding shares of Series B Preferred Stock held by such holder bears to the total number of shares of Series B Preferred Stock.  Such payment shall constitute payment in full to the holders of the Series B Preferred Stock upon the liquidation, dissolution or winding up of the Corporation. After such payment shall have been made in full, or funds necessary for such payment shall have been set aside by the Corporation in trust for the account of the holders of Series B Preferred Stock, so as to be available for such payment, such holders of Series B Preferred Stock shall be entitled to no further participation in the distribution of the assets of the Corporation.

                  (ii)  Consolidation, Merger and Other Corporate Events.  A consolidation  or merger of the  Corporation  (except  into or with a subsidiary or affiliated corporation) or a sale, lease,  mortgage,  pledge,  exchange,  transfer or other disposition of all or substantially  all of the assets of the Corporation or any reclassification  of the stock of the  Corporation  (other  than a change in par  value or from no par to par,  or from par to no par or as the result of an event described in subsection  (iv), (v), (vi) or (viii) of paragraph (f)),  shall be regarded  as a  liquidation,  dissolution  or winding  up of the  affairs of the Corporation within the meaning of this paragraph (d), provided,  however, in the case of a  merger,  if (a) the  Corporation  is the  surviving  entity,  (b) the Corporation's  shareholders  hold a  majority  of the  shares  of the  surviving entity, and (c) the Corporation's  directors hold a majority of the seats on the board of  directors  of the  surviving  entity,  then such  merger  shall not be regarded as a liquidation,  dissolution or winding up within the meaning of this paragraph  (d). In no event shall the issuance of new classes of stock,  whether senior,  junior or on a parity with the Series B Preferred  Stock,  or any stock splits, or the issuance of common stock in connection with an acquisition of the securities, assets or business of another company, joint ventures, merger of a subsidiary and employee stock options be deemed a  "reclassification, merger or consolidation"  under or otherwise limited by the terms hereof.

                  (iii) Distribution of Cash and Other Assets. In the event of a liquidation,  dissolution  or winding  up of the  Corporation  resulting  in the availability  of assets other than cash for  distribution  to the holders of the Series B Preferred  Stock,  the holders of the Series B Preferred Stock shall be entitled  to a  distribution  of cash  and/or  assets  equal to the value of the liquidation  preference  stated in subsection  (i) of this  paragraph (d), which valuation shall be made solely by the Board of Directors, and provided that such Board of Directors was acting in good faith, shall be conclusive.
 
2

 
                  (iv)  Distribution  to  Junior  Security  Holders.  After  the payment or  distribution  to the holders of the Series B Preferred Stock of the full  preferential  amounts  aforesaid,  the holders of Series B Preferred Stock shall have no  further  rights in respect  at such  Series B Stock  which  shall become null and void, and the holders of the Common Stock then  outstanding,  or any  other  stock of the  Corporation  ranking  as to assets  upon  liquidation, dissolution  or winding up of the  Corporation  junior to the Series B Preferred Stock,  shall be entitled to receive ratably all of the remaining  assets of the Corporation.

                  (v)  Preference; Priority.  References  to a  stock  that  is "SENIOR"  to, on a "PARITY"  with or "JUNIOR"  to other stock as to  liquidation shall refer, respectively, to rights of priority of one series or class of stock over another in the  distribution of assets on any  liquidation,  dissolution or winding up of the  Corporation.  The Series B Preferred Stock shall be senior to the Common Stock of the  Corporation and junior to any subsequent  series of Preferred Stock issued by the Corporation.

         (e) Voting Rights.  Except as otherwise required by law, the holder of shares of Series B  Preferred  Stock shall not have the right to vote on matters that come before the shareholders.

         (f)  Conversion Rights.  The holders of Series B Preferred Stock will have the following conversion rights:

                  (i) Right to Convert.  Subject to and in  compliance  with the provisions of this paragraph (f), any issued and outstanding  shares of Series B Preferred  Stock shall, upon election in the discretion of the Corporation, be automatically converted by the Corporation, at any time or from time to time into fully paid and  non-assessable  shares of Common Stock at the conversion rate in effect at the time of conversion, determined as provided herein (the “Conversion Shares”);  provided,  that a holder of Series B  Preferred  Stock may at any given time be required to convert  up to that number of shares of Series B  Preferred  Stock so that, upon conversion, the aggregate  beneficial ownership of the Corporation's Common Stock (calculated  pursuant to Rule 13d-3 of the Securities  Exchange Act of 1934, as amended) of such holder and all persons  affiliated with such holder is not more than 9.99% of the Corporation's Common Stock then outstanding (the “Conversion Threshold”).

                  (ii)  Mechanics of Conversion.  Upon the determination by the Corporation that any holder has fallen below the Conversion Threshold, the Corporation may automatically convert such number of shares of the Series B Preferred Stock which may equal, but shall not exceed the Conversion Threshold, by the conversion of such number of Series B Preferred Stock, that equals such number of Common Stock as such holder shall be entitled.  Such conversion shall be automatically completed upon issuance by the Corporation of written Notice of Conversion mailed by regular US mail to the address of the record Holder of the Series B Preferred Stock as reflected on the books of the transfer agent or if no transfer agent the records of the Corporation (the “Notice of Conversion”). In issuing the Notice of Conversion and effecting the conversion, the Corporation may rely upon the records of the Company’s transfer agent, or if no transfer agent upon the Corporation’s books and records, as final and absolute proof of the identity of holder of record of the shares of Series B Preferred stock, the number of shares of Series B Preferred stock owned and the address of the Holder. Immediately upon issuance of such Notice of Conversion, the Holder shall be treated as a common stockholder for all purposes and such Holder shall have no continuing interest in or claim to Series B Preferred stock. Upon Notice of Conversion  by the Corporation , the Holder shall  surrender  the  certificate  or  certificates  therefor,  duly endorsed,  at the office of the  Corporation  or of any  transfer  agent for the Common Stock,  and the Corporation shall give written notice to the transfer agent to convert the same and shall state therein the number of shares of Series B Preferred Stock being converted.  Thereupon, the Corporation shall promptly issue and deliver to the record Holders address as reflected on the books of the transfer agent, or if no transfer agent the Corporation’s books, a certificate or certificates for the number of shares of Common Stock to which Holder shall be entitled, not to exceed the Conversion Threshold and, if applicable, a certificate or certificates for the number of shares of Series B Preferred Stock existing immediately after an automatic conversion.  The effectiveness of the Conversion shall not be affected by Holder’s failure to surrender or deliver the certificates for the Series B Preferred shares to the Corporation; however, Corporation shall have no obligation to deliver certificates for Conversion Shares until such surrender and delivery has been completed by Holder. Should it occur that a Holder of Series B Preferred stock transfers or assign shares of Series B Preferred stock without giving the transfer agent or the Corporation proper notice, the Holder shall be liable for any damage to the Corporation resulting therefrom and any Conversion Shares issued or to be issued to Holder based on the incorrect information on the Corporations books or the books of its transfer agent shall be voidable by the Corporation.
 
3

 
                  (iii)  Conversion Price.  The number of shares into which one share of Series B Preferred  Stock shall be  convertible shall be determined by dividing the Series B Purchase Price by $0.12 ( hereinafter, the “Conversion Price”)

                  (iv )  Adjustment for Stock Splits and Combinations.  If the Corporation shall at any time, or from time to time after the date shares of the Series B Preferred Stock are first issued (the "ORIGINAL ISSUE DATE"),  effect a subdivision of the outstanding  Common Stock,  the Conversion Price in effect  immediately  prior thereto shall be  proportionately  decreased,  and conversely,  if the Corporation shall at any time or from time to time after the Original Issue Date combine the  outstanding  shares of Common Stock,  the Conversion Price then in effect  immediately before the combination shall be proportionately  increased. Any adjustment under this paragraph (f)(iv) shall become  effective  at the  close of  business  on the date  the  subdivision  or combination becomes effective.

                  (v) Adjustment for Certain Dividends and Distributions. In the event the Corporation at any time, or from time to time after the Original Issue Date, shall make or issue, or fix a record date for the determination of holders of Common Stock entitled to receive, a dividend or other distribution payable in additional  shares of Common Stock,  then and in each such event the Conversion Price  then in effect  shall be  decreased  as of the time of such issuance  or, in the event such a record date shall have been  fixed,  as of the close of  business  on such  record  date,  by  multiplying  the Conversion Price then in effect by a fraction:

                           (A) the  numerator of which shall be the total number of shares of Common Stock issued and outstanding  immediately  prior to the time of such issuance or the close of business on such record date; and
 
4

 
                           (B) the  denominator  of  which  shall  be the  total number of shares of Common  Stock  issued and  outstanding  immediately prior to the time of such  issuance  or the close of  business  on such record  date plus the  number of shares  of Common  Stock  issuable  in payment of such dividend or distribution;  provided,  however,  if such record  date shall have been fixed and such  dividend is not fully paid or if such  distribution  is not fully made on the date fixed therefor, the Conversion Price shall be recomputed accordingly as of the close of business on such  record  date and  thereafter,  the Conversion Price shall be adjusted  pursuant to this  paragraph (f)(v)  as  of  the  time  of  actual  payment  of  such  dividends  or distributions.

                  (vi) Adjustments for Other Dividends and Distributions. In the event the  Corporation at any time or from time to time after the Original Issue Date shall make or issue, or fix a record date for the  determination of holders of Common Stock entitled to receive, a dividend or other distribution payable in securities of the  Corporation  other than shares of Common  Stock,  then and in each such event  provision  shall be made so that the  holders of such  Series B Preferred Stock shall receive upon conversion  thereof in addition to the number of shares of Common Stock receivable thereupon,  the amount of securities of the Corporation  that they would have  received had their  Series B Preferred  Stock been converted  into Common Stock on the date of such event and had  thereafter, during the period from the date of such event to and  including  the  conversion date,  retained  such  securities  receivable  by them as aforesaid  during such period giving application to all adjustments called for during such period under this  paragraph  (f) with  respect to the rights of the  holders of the Series B Preferred Stock.

                  (vii)    Adjustment   for    Reclassification    Exchange   or Substitution.  If the Common Stock  issuable upon the conversion of the Series B Preferred  Stock shall be changed into the same or a different  number of shares of  any  class  or  classes  of  stock,   whether  by  capital   reorganization, reclassification or otherwise (other than a subdivision or combination of shares or stock dividend provided for above, or a reorganization, merger, consolidation or sale of assets  provided for elsewhere in this  paragraph  (f)),  then and in each such event the holder of each share of Series B Preferred  Stock shall have the right thereafter to convert such share into the kind and amount of shares of stock and other  securities and property  receivable  upon such  reorganization, reclassification  or other change,  by holders of the number of shares of Common
Stock  into  which  such  shares of Series B  Preferred  Stock  might  have been converted immediately prior to such reorganization, reclassification, or change, all subject to further adjustment as provided herein.

                  (viii)  Reorganization, Mergers, Consolidations or Sales of Assets.  If at  any  time  or  from  time  to  time  there  shall  be a  capital reorganization  of the Common  Stock  (other  than a  subdivision,  combination, reclassification  or exchange of shares provided for elsewhere in this paragraph (f) or a  merger  or  consolidation  of the  Corporation  with or into  another corporation,  or  the  sale  of all or  substantially  all of the  Corporation's properties   and  assets  to  any  other  person,   then,  as  a  part  of  such reorganization,  merger,  consolidation or sale, provision shall be made so that the holders of the Series B  Preferred  Stock  shall  thereafter  be entitled to receive upon conversion of such Series B Preferred  Stock,  the number of shares of stock or other  securities or property of the Corporation or of the successor corporation  resulting  from such merger or  consolidation  or sale,  to which a holder of Common Stock  deliverable  upon conversion would have been entitled on such capital  reorganization,  merger,  consolidation or sale. In any such case, appropriate  adjustment  shall be made in the  application  of the provisions of this  paragraph  (f) with  respect to the rights of the  holders of the Series B Preferred Stock after the reorganization,  merger,  consolidation or sale to the end that the provisions of this paragraph (f) (including adjustment of the Conversion Price then in effect and the number of shares purchasable upon conversion of the Series B Preferred Stock) shall be applicable after that event as nearly equivalent as may be practicable.
 
5

 
                  (ix)  Sale of Common  Stock or  Securities  Convertible  Into Common Stock. In the event the Corporation sells or issues Common Stock or other securities  convertible  into or  exercisable  for  Common  Stock at a per share price,  exercise price or conversion  price lower than the Conversion Price then in effect  (other than in  connection  with an  acquisition  of the  securities, assets or  business  of  another  company,  licensing,  partnership,  technology transfer,  marketing alliance, joint ventures or employee, director, officer, or consultant issuances or stock options), the Conversion Price shall be subject to weighted average anti-dilution adjustments.

                  (x)  Certificate of Adjustment.  In each case of an adjustment or readjustment of the Conversion Price or the securities  issuable upon conversion of the Series B Preferred Stock,  the Corporation  shall compute such  adjustment or readjustment  in accordance  herewith and the  Corporation's Chief  Financial  Officer  shall  prepare and sign a  certificate  showing  such adjustment or readjustment, and shall mail such certificate by first class mail, postage  prepaid,  to each registered  holder of the Series B Preferred Stock at the holder's address as shown in the Corporation's  books. The certificate shall set forth such adjustment  or  readjustment,  showing in detail the facts upon which such adjustment or readjustment is based.

                  (xi) Notices of Record Date. In the event of (A) any taking by the  Corporation of a record of the holders of any class or series of securities for the purpose of determining  the holders  thereof who are entitled to receive any   dividend   or  other   distribution   or  (B)  any   reclassification   or recapitalization  of  the  capital  stock  of the  Corporation,  any  merger  or consolidation of the Corporation or any transfer of all or substantially  all of the assets of the Corporation to any other corporation, entity or person, or any voluntary  or  involuntary  dissolution,   liquidation  or  winding  up  of  the Corporation,  the  Corporation  shall mail to each  holder of Series B Preferred Stock at least 10 days  prior to the record  date  specified  therein,  a notice specifying  (1) the date on which any such record is to be taken for the purpose of  such  dividend  or  distribution  and a  description  of  such  dividend  or distribution,  (2) the date on which any such reorganization,  reclassification, transfer,  consolidation,  merger,  dissolution,  liquidation  or  winding up is expected to become effective and (3) the time, if any is to be fixed, as to when the holders of record of Common Stock (or other securities) shall be entitled to exchange their shares,  of Common Stock (or other  securities) for securities or other property deliverable upon such reorganization, reclassification, transfer, consolidation, merger, dissolution, liquidation or winding up.
 
(xii) Fractional Shares. No fractional shares of Common Stock shall be issued upon conversion of the Series B Preferred Stock. In lieu of any fractional  shares  to  which  the  holder  would  otherwise  be  entitled,  the Corporation shall round the shares up to the nearest whole number.
                  (xiii)  Reservation of Stock Issuable Upon  Conversion.  The Corporation  shall at all times reserve and keep available  not less than the aggregate number of authorized but unissued shares sufficient to effect the conversion of all then outstanding shares of Series B Preferred Stock and if at any time the number of authorized but unissued shares of Common Stock shall not be sufficient to effect the  conversion of all then  outstanding  shares of Series B Preferred Stock, the Corporation will take such corporate action as may, in the opinion of its counsel,  be necessary to increase  its  authorized  but unissued  shares of Common Stock to such number of shares as shall be sufficient for such purpose.
 
6

                  
                  (xiv) Notices. Any notice required by the provisions of this paragraph (f) to be given to the holders of shares of Series B Preferred Stock shall be deemed given (A) if deposited in the United States mail, postage prepaid, or (B) if given by any other reliable or generally accepted means (including by facsimile or by a nationally recognized overnight courier service), in each case addressed to each holder of record at his address (or facsimile number) appearing on the books of the Corporation.

                  (xv) Payment of Taxes.  The Corporation will pay all transfer taxes and other governmental charges that may be imposed in respect of the issue or delivery  of shares of Common  Stock upon  conversion  of shares of Series B Preferred Stock.
 
         (g) No Re-issuance of Preferred Stock. Except as otherwise expressly permitted herein with respect to dividends, any shares of Series B Preferred Stock acquired by the Corporation by reason of purchase, conversion or otherwise shall be canceled, retired and eliminated from the shares of Series B Preferred Stock that the Corporation shall be authorized to issue.  All such shares shall upon their cancellation become authorized but unissued shares of Preferred Stock and may be reissued as part of a new series of  Preferred  Stock  subject to the
conditions  and   restrictions   on  issuance  set  forth  in  the  Articles  of Incorporation  or in  any  certificate  of  designation  creating  a  series  of Preferred Stock or any similar stock or as otherwise required by law.

         (h) Severability.  If any right, preference or limitation of the Series B Preferred  Stock set forth  herein is invalid,  unlawful or incapable of being enforced  by reason  of any  rule,  law or  public  policy,  all  other  rights, preferences  and  limitations  set forth herein that can be given effect without the invalid,  unlawful or  unenforceable  right,  preference or limitation shall nevertheless  remain in full  force and  effect,  and no  right,  preference  or limitation  herein  shall  be  deemed  dependent  upon  any  other  such  right, preference or limitation unless so expressed herein.

         3.  The  number  of  authorized   shares  of  Preferred  Stock  of  the Corporation  is  5,000,000  and the number of shares of Series B Preferred Stock, 9,000 of which has been issued and outstanding, is 10,000.

        The  undersigned  declares  under  penalty of perjury  that the matters  set out in the  foregoing  Certificate  are true of his own  knowledge. Executed at Sarasota, Florida on this 11th day of January, 2010.


 
                       
Print Name:  Edmund C. King
Title:      Acting President and Chief Financial Officer
 
 
 
7

 

Exhibit 10.75
 
January 11, 2010

 
To Our Series B Preferred Stockholders:
 
                During the past few years, we have been seriously challenged by the unprecedented turmoil in the U.S. domestic economy.  One of our goals in this challenging market environment has been to align the costs of our operations to our cash flows. We believe the elimination of the Series B Preferred Stock (the “Series B Stock”) and the related dividends by exchanging the remaining outstanding Series B Stock for a recently created Series C Preferred Stock on a share for share basis (hereinafter, the “Exchange”) will help us achieve our goal of enhanced balance sheet flexibility which is instrumental to operate and grow our business. We are confident that with an improved capital structure, there are multiple business opportunities we can pursue to enhance stockholder value that would not have been previously feasible.  More importantly, our continued efforts to improve our balance sheet will position the Company to benefit in the anticipated economic recovery.  
 
If we cannot effectuate the Exchange of at least a majority of the Series B Holder, the continued accrual of dividends of the outstanding Series B Stock will continue to have a negative effect on the Company's business, results of operations, and financial position, including the potential inability to satisfy our liabilities and our cash requirements related to long-term dividend and interest obligations.
 
        Our Board of Directors (the "Board") took into account a number of factors in its decision to effectuate the Exchange, including the lack of liquidity and marketability of the Series B Stock and the present value of these the securities in a liquidation scenario. The Board's objective in its analysis was to further the best interests of stockholders and, toward that end, the Board would encourage the fullest participation in the Exchange by our Series B Stockholders.
 
        The success of the Exchange not only requires that the Series B Stock be surrendered and exchanged for Series C Stock, but also a valid consent from each Series B Stockholder to amend the Certificate of Designation to eliminate any further accrual of dividends, unless otherwise declared by the Company.  The Certificate of Designation will also provide that the Company may satisfy its obligations with respect to accrued but unpaid dividends either (a) in cash payment, (b) by issuance of additional Series B Stock or (c) in common stock of the Company.  Under the terms of the Exchange, you may not exchange your Series B Stock for Series C Stock without also consenting to the proposed amendment to the Series B Preferred Stock Certificate of Designation, a revised copy of which is provided herewith.
 
        The documents enclosed with this letter provide you with important information regarding the Exchange, the terms of the Exchange and the consent, procedures for exchanging your shares.
 
        Thank you for your ongoing support of and continued interest in Invisa, Inc.
 
 
Sincerely,
 

 
INVISA, INC.
 
LETTERS OF TRANSMITTAL AND CONSENT
 
Exchange of Series B Preferred Stock, par value $0.001 per share, for Series C Preferred Stock, par value $0.001 per share, on a share for share basis and Consent to Amendments to the Certificate of Designation of the Series B Preferred Stock  
 

        
The instructions contained within this LETTERS OF TRANSMITTAL and Consent should be read carefully before being completed.  This LETTERS OF TRANSMITTAL and Consent is only to be used by record holders of the Series B Preferred Stock.
 
 
 
DESCRIPTION OF SERIES B PREFERRED STOCK TENDERED BY HOLDER
 

 
Name(s) and Address(es of Registered Holder(s)
(Please fill in, if blank)(1)
 
Share Certificate(s) and Share(s) Tendered
(Please attach additional signed list, if necessary)
 

 
       
 
Series B Preferred
Stock Share
Certificate
Number(s)
 
Total Number of
Shares of Series B Preferred Stock Represented by
Share Certificate(s)
 
 
 
Number of Shares of Series B Preferred Stock Tendered
         
         
         
         
         
 

 
       
Total Shares Tendered
       

 
(1)
 
The names and addresses of the registered Holder of the Series B Preferred Stock should be printed, if not already printed above, exactly as they appear on the share certificates to be exchanged hereby.
     
(2)
 
Unless otherwise indicated, all Series B Preferred Stock represented by Share Certificates delivered to the Company will be deemed to have been exchanged. The LETTERS OF TRANSMITTAL requires that Holders submit all shares they own for exchange, and the Company is entitled to reject partial submissions. See Instruction 4 and 5.

 
o   Check here if share certificates have been lost or mutilated.
 

 
Ladies and Gentlemen:
 
        The undersigned hereby acknowledges that he or she has received and read the Terms of Exchange, dated January 11, 2009 (the "Term Sheet"), of the Company and this Letter of Transmittal and Consent (the "Consent"), which together constitutes the terms and conditions upon which the Company shall exchange (the "Exchange") all of the Company's outstanding Series B Preferred Stock, $0.001 par value per share (together with all accrued and unpaid interest, the "Series B Preferred Stock") for Series C Preferred Stock, $0.001par value per share ("Series C Preferred Stock," and collectively with the Series B Preferred Stock, the "Preferred Stock"), upon the terms and subject to the conditions specified in the Term Sheet. The Company is also soliciting consents (the "Consent Solicitation") from holders of the Series B Preferred Stock (each, a "Holder" and collectively, the "Holders") to amend our charter (the "Charter") to modify the terms of the Series B Preferred Stock to, among other things, terminate future dividends (the “Proposed Amendments”).         
 
        Holders who desire to exchange their shares of Series B Preferred Stock for Series C Preferred Stock are required to consent to the Proposed Amendments. The execution and delivery of this Consent will constitute a Holder's consent to the Proposed Amendments. A Holder of shares of Series B Preferred Stock may not exchange Series B Preferred Stock without delivering its consent to the Proposed Amendments with respect to all shares of Series B Preferred Stock owned by such Holder.
 
        The Company reserves the right, at any time or from time to time, to extend the time to Exchange the Series B Preferred Stock, in which event the term "Expiration Date" shall mean the latest time and date that the Company will honor the exchange requests of the Holders.  The Company shall notify the Holders of the Series B Preferred Stock of any extension as promptly as practicable.          
 
        None of the Company's board of directors (the "Board"), the officers or employees of the Company, or any of the Company's financial advisors is making a recommendation to any Holder of Series B Preferred Stock as to whether you should exchange your shares for Series C Preferred Stock. You must make your own investment decision regarding the Exchange based upon your own assessment of the market value of the Series B Preferred Stock, the effect of holding shares of the Preferred Stock upon approval of the Proposed Amendments, your liquidity needs, your investment objectives and any other factors you deem relevant.
 

 
        Upon acceptance by the Company and subject to the terms and conditions herein set forth, the undersigned hereby submits its shares of Series B Preferred Stock set forth in the box above entitled "Description of Series B Preferred Stock" to be exchanged for shares of Series C Preferred Stock in accordance herewith.    
 
        The undersigned understands that the Company is also soliciting consents from Holders of the Series B Preferred Stock to approve the Proposed Amendments. The undersigned understands and agrees that exchange of shares of the Series B Preferred Stock requires that the Holder execute and deliver a written consent approving the Proposed Amendments with respect to the shares of Series B Preferred Stock.  The undersigned further understands that Holders of shares of Series B Preferred Stock may not exchange shares of Series B Preferred Stock without executing and delivering a written consent to the Proposed Amendments to the Company.
 
        The undersigned understands that, if successfully completed, the undersigned will receive one share of Series C Preferred Stock for each share of Series B Preferred Stock exchanged.   
 
      Capitalized terms used but not defined herein have the meaning given to them in the Term Sheet.
 
        The undersigned hereby represents and warrants that (i) the undersigned has full power and authority to, sell, assign and transfer the Series B Preferred Stock exchanged hereby and to grant the consent and the power of attorney set forth herein, (ii) the undersigned is exchanging all and not less than all of the Series B Preferred Stock owned by the undersigned, and (iii) when exchanged, the Company will acquire good and unencumbered title thereto, free and clear of all liens, restrictions, charges and encumbrances and not subject to any adverse claim when the same are accepted by the Company.
 
        The undersigned further represents and warrants that the undersigned has read and agrees to all of the terms and conditions the Exchange. All authority herein conferred or agreed to be conferred shall survive the death or incapacity of the undersigned, and any obligation of the undersigned hereunder shall be binding upon the heirs, executors, administrators, personal representatives, trustees in bankruptcy, successors and assigns of the undersigned. This exchange and authorization to consent are irrevocable and once the Series B Preferred Stock submitted to and accepted by the Company for exchange such submission may not be withdrawn, nor the corresponding consent be revoked. The undersigned understands that, if the Company receives the requisite approvals of the Proposed Amendments from the Holders of the Series B Preferred Stock, the Company intends to execute and file Amendment to the Certificate of Designation immediately thereafter and that, once effective, such amendments will be binding upon each Holder of each series of Series B Preferred Stock, whether or not such Holder consents.
 
        Subject to, and effective upon, the acceptance of the requisite documents by the Company, the undersigned hereby tenders, sells, assigns and transfers to or upon the order of the Company, all right, title and interest in and to the shares of Series B Preferred Stock exchanged hereby and releases and discharges the Company from any and all claims the undersigned may have now, or may have in the future, arising out of, or related to, the shares of Series B Preferred Stock. The undersigned hereby acknowledges that it has reviewed the Proposed Amendment, a draft of which has been provided herewith, and consents to and approves the Proposed Amendments, as described herein and in the Term Sheet, acknowledges receipt of the Term Sheet, the terms of which are incorporated herein by reference, and revokes any proxy heretofore given with respect to the Proposed Amendments. The undersigned hereby irrevocably constitutes and appoints the Company as its agent and attorney-in-fact, with full power and authority in its name, place and stead, with respect to the exchanged shares of Series B Preferred Stock, with full power of substitution, such power of attorney being deemed to be an irrevocable power to effectuate the exchange of the Series B Preferred Stock for newly issued shares of Series C Preferred Stock as contemplated herein and to do and perform each and every act and thing whether necessary or desirable to be done, as fully as the undersigned might or could do if personally present at a meeting of stockholders of the Company or otherwise. That the foregoing power of attorney shall terminate upon the consummation of the exchange of the Preferred stock as contemplated herein.  
 
       The undersigned will, upon request, execute and deliver any additional documents deemed by the Company to be necessary or desirable to complete (i) the sale, assignment and transfer of the Series B Preferred Stock exchanged hereby and the issuance of the Series C Preferred Stock in exchange therefore, (ii) the execution and delivery of the written consent to approve the Proposed Amendments. All authority conferred or agreed to be conferred herein and every obligation of the undersigned hereunder shall be binding upon the successors, assigns, heirs, executors, administrators, trustees in bankruptcy and legal representatives of the undersigned and shall not be affected by, and shall survive, the death or incapacity of the undersigned.
 

 
         THE UNDERSIGNED, BY COMPLETING THE ABOVE "DESCRIPTION OF SERIES B PREFERRED STOCK " BOX AND SIGNING THIS LETTER, WILL BE DEEMED TO HAVE EXCHANGED THEIR DESIGNATED SHARES OF SERIES B PREFERRED STOCK AS SET FORTH IN SUCH BOX ABOVE.
 
         BY EXCHANGING SHARES OF SERIES B PREFERRED STOCK IN ACCORDANCE HEREWITH, THE UNDERSIGNED ALSO CONSENTS TO AND APPROVES THE PROPOSED AMENDMENTS.
 

 

 
IMPORTANT
 
PLEASE SIGN HERE
 
             This Letter of Transmittal and Consent must be signed by the Holder(s) of the shares of Series B Preferred Stock being exchanged exactly as his, her, its or their name(s) appear(s) on certificate(s) for such shares of Series B Preferred Stock. If signature is by a trustee, executor, administrator, guardian, attorney-in-fact, officer or other person acting in a fiduciary or representative capacity, such person must set forth his or her full title below under "Capacity" and submit evidence satisfactory to the Company of such person's authority to so act. See Instruction 5.
 
 
Signature(s) of Holders
 
   
Dated:
 
 
Name(s)
 
 
Capacity (full title)
 
 
Address
 
 
Area Code and Telephone Number
 
  
 
PLEASE READ THE INSTRUCTIONS ON THE FOLLOWING PAGES CAREFULLY BEFORE COMPLETING THE EXCHANGE AND CONSENT FORM
 

 
INSTRUCTIONS FOR COMPLETING THE EXCHANGE AND CONSENT FORM
 
 
1.   Signatures.     Signatures of all holders of the Series B Preferred must be presented to effectuate the exchange and consent contemplated hereunder in accordance with Section 5 below.   The Company may, in its sole and exclusive discretion, request additional documentation as it deems necessary to consummate the transactions contemplated hereby.
 
2.     Delivery of this Consent and Consent and Certificates for Series B Preferred Stock or Book-Entry Confirmations; Guaranteed Delivery Procedures.     This Letters of Transmittal and Consent is to be used by each Holder of the Series B Preferred Stock and submitted with the physical delivery of the original share certificate representing the B Preferred Stock being exchanged by such Holder.  All documentation shall be delivered by certified, return receipt requested or overnight mail or courier service to the Company at PO Box 49376, Sarasota, Fl 34230, such documents to be received by the Company on or before the Expiration Date.
 
        3.     Consenting to the Proposed Amendments.     By exchanging your shares of Series B Preferred Stock in accordance with the procedures described herein, you also consent to and approve the Proposed Amendments, acknowledge receipt of the Term Sheet and revoke any proxy heretofore given with respect to the Proposed Amendments. You irrevocably constitute and appoint the Company as your agent and attorney-in-fact, with full power and authority in your name, place and stead, with full knowledge that the Company, as your true and lawful representative, attorney-in-fact and agent with respect to the exchanged shares of Series B Preferred Stock, with full power of substitution, such power of attorney being deemed to be an irrevocable power coupled with an interest, to transfer the exchanged Series B Preferred Stock on the account books and records of the Company the shares of Series B Preferred Stock tendered, consent to and approve the Proposed Amendments on your behalf, and to do and perform each and every act and thing whether necessary or desirable to be done, as fully as you might or could do if personally present at a meeting of stockholders of the Company or otherwise.
 
         4.     No Partial Exchange Accepted.     If fewer than all the shares represented by any certificate of Series B Preferred Stock delivered to the Company presented for exchange or if fewer than all of the shares of Preferred Stock owned by a Holder are exchanged, the Company will be entitled to reject in its entirety any exchange requested by such Holder. All Series B Preferred Stock represented by certificates delivered to the Company will be deemed to have been tendered.
 
        5.     Signatures on this Consent and Consent; Stock Powers and Endorsements.     If this Letter of Transmittal and Consent is signed by the registered Holder(s) of the shares of Series B Preferred Stock referred to herein, the signature(s) must correspond with the name(s) as written on the face of the share certificates without alteration, enlargement or any change whatsoever.
 
        If any of the shares of Series B Preferred Stock exchanged are held of record by two or more persons, all such persons must sign the Letter of Transmittal and Consent.
 
        If any of the shares of Series B Preferred Stock tendered are registered in different names or different share certificates, it will be necessary to complete, sign and submit as many separate Letters of Transmittals and Consents as there are different registrations or share certificates.
 
        The Holder must either properly endorse the share certificates for shares of Series B Preferred Stock exchanged or transmit a separate properly completed stock power with this Letter of Transmittal and Consent, in either case, executed exactly as the name(s) of the Holder(s) appear(s) on such shares of Series B Preferred Stock, with the signature on the endorsement or stock power guaranteed by an Eligible Institution, unless such certificates or stock powers are executed by an Eligible Institution. See Instruction 1.
 
        If this Letter of Transmittal and Consent is signed by a person other than the registered Holder(s) of the Series B Preferred Stock tendered hereby, certificates must be endorsed or accompanied by appropriate stock powers, in either case, signed exactly as the name(s) of the registered Holder(s) appear(s) on the certificates for such Series B Preferred Stock.
 
        If either the Letter of Transmittal and Consent or any certificate or stock power is signed by a trustee, executor, administrator, guardian, attorney-in-fact, officer of a corporation or other person acting in a fiduciary or representative capacity, such person should so indicate when signing, and proper evidence satisfactory to the Company and the Depositary of the authority of such persons to act must be submitted.
 

 
        Endorsements on share certificates for Series B Preferred Stock and signatures on stock powers provided in accordance with this Instruction 5 by Holders not executing this Letter of Transmittal and Consent must be guaranteed by an Eligible Institution. See Instruction 1.
 
        6.     Special Issuance and Special Delivery Instructions.      Holders submitting their shares for exchange should indicate in the applicable box or boxes the name and address to which the shares of Series C Preferred Stock are to be issued or sent, if different from the name and address of the Holder signing this Letter of Transmittal and Consent. In the case of issuance in a different name, the taxpayer identification or social security number of the person named must also be indicated. If no instructions are given, the shares of Series C Preferred Stock will be returned to the Holder of the shares of Series B Preferred Stock exchanged.
 
        7.     Transfer Taxes.     The Company will pay all transfer taxes, if any, applicable for the exchange of the Preferred Stock.        
 
        8.     Requests for Assistance or Additional Copies.     Any questions or requests for assistance and additional copies of the Term Sheet, this Letter of Transmittal and Consent or other information concerning the exchange of the Series B Preferred should be directed to the Company at PO Box 49376, Sarasota, Fl 34230, (941) 870-3950.
 
        9.     Irregularities.     All questions as to the form of documents and the validity, eligibility (including the time of receipt), acceptance for the exchange of the Series B Preferred Stock will be determined by the Company, in its sole discretion, and its determination will be final and binding. The Company reserves the absolute right to reject any and all exchange of Series B Preferred Stock that it shall determine are not in proper form or the acceptance of or purchase for which may, in the opinion of the Company's counsel, be unlawful. The Company also reserves the absolute right to waive any defect or irregularity in any exchange of any shares of Series B Preferred Stock. No exchange of shares of Series B Preferred Stock will be deemed to have been made until all defects and irregularities in the exchange of such shares have been cured or waived. Neither the Company nor any other person authorized to act on behalf of the Company will be under any duty to give notice of any defect or irregularity in exchanges of shares of Series B Preferred Stock, nor shall any of them incur any liability for failure to give any such notice. The Company's interpretation of the terms of conditions of the Terms of Exchange and Letter of Transmittal and Consent will be final and binding.
 
        10.     Inadequate Space.     If the space provided in the above "Description of Series B Preferred Stock" box is inadequate, the number of shares of Series B Preferred Stock and any other required information should be listed on a separate signed schedule and attached to this Letter of Transmittal and Consent.
 
        11.     Lost, Destroyed or Stolen Certificates.     If any certificate(s) representing shares of Series B Preferred Stock have been lost, stolen or destroyed, please contact the Company at PO Box 49376, Sarasota, Fl 34230, (941) 870-3950. The Holder may need to complete an Affidavit of Loss with respect to the lost certificate(s) (which will be provided by the Company) and payment of an indemnity bond premium fee may be required.
 
        Any questions and requests for assistance may be directed to the Company at the address and telephone numbers set forth below. Additional copies of the Term Sheet and the Letter of Transmittal and Consent may be obtained from the Company at PO Box 49376, Sarasota, Fl 34230, (941) 870-3950..
 
 
 

 
Exhibit 10.76
SHARE EXCHANGE AGREEMENT
 

   
      THIS SHARE EXCHANGE AGREEMENT (the " Agreement ") is entered into as of January 11, 2010, by and between Invisa, Inc., a Nevada corporation (the " Company "), and the shareholder set forth on the signature page hereto. (hereinafter “ Holder ”)
 
RECITALS
 
         WHEREAS, as of the date hereof, the Holder is the owner of record of ____shares of Series B Preferred Stock. ( the “Series B Shares ”); and
 
         WHEREAS, the Company and the Holder desire to exchange the Series B Shares for shares of Series C Convertible Preferred Stock, of the Company (the " Series C Preferred Stock ").
 
         NOW, THEREFORE, in consideration of the foregoing recitals and the mutual promises hereinafter set forth, and intending to be legally bound thereby, the parties hereto agree as follows:
 
1.     Definitions.
 
        The following terms used in this Agreement shall have the following meanings (unless otherwise expressly provided herein):
 
        " Entity " shall mean any corporation (including any non-profit corporation), general partnership, limited partnership, limited liability partnership, joint venture, estate, trust, cooperative, foundation, society, political party, union, company (including any limited liability company or joint stock company), firm or other enterprise, association, organization or entity.
 
        " Governmental Body " shall mean any: (a) nation, principality, state, commonwealth, province, territory, county, municipality, district or other jurisdiction; (b) federal, state, local, municipal or foreign government (including any agency, department, bureau, division, or other administrative body thereof); or (c) governmental or quasi-governmental authority of any nature.
 
        " Person " shall mean any individual, Entity or Governmental Body.
 
        " Proceeding " shall mean any action, suit, litigation, arbitration, or investigation (including any civil, criminal or administrative) commenced, brought, conducted or heard by or before, or otherwise involving, any Governmental Body or any arbitrator or arbitration panel.           
 
2.     Exchange. Subject to the terms and conditions set forth in this Agreement, effective at the Closing, the Holder will transfer and convey to the Company the Series B Shares held by the Holder.   In consideration of the transfer and conveyance of Series B Shares referred to in the immediately preceding sentence, at the Closing, the Company shall issue and deliver to the Holder and the Holder shall accept and receive from the Company, the whole number of fully paid and non-assessable shares of Series C Preferred Stock set forth opposite such Holder name on the signature page hereto.
 
1

 
3.     Closing and Delivery.
 
        3.1    Closing.     The closing of the Exchange (the " Closing ") shall take place, at the offices of the Company on such date and time as the parties shall agree but not later January 28, 2010 (the " Closing Date ").
 
        3.2    Delivery.     Subject to the terms and conditions hereof, upon the surrender of the certificate or certificates representing the Series B Shares, the Company shall issue and deliver to Holder such number of Series C Preferred Stock at the Closing, indicated on the signature page hereto by the delivery of a certificate or certificates evidencing the shares of the Series C Preferred Stock to which Holder is entitled, free and clear of all liens, claims, and encumbrances (collectively, an " Encumbrance ").
 
4.     Representations and Warranties of the Holder.
 
        Holder hereby represents and warrants to the Company as follows:
 
        4.1    Requisite Power; Authorization; Binding Obligations.      Holder has all requisite power and authority to execute and deliver this Agreement and to carry out the provisions of this Agreement. All action on Holder's part necessary for the authorization, execution and delivery of this Agreement, the consummation of the transactions contemplated hereby, and the performance of all obligations of Holder hereunder has been or will be taken prior to the Closing. This Agreement, when executed and delivered, will be valid and binding obligations of Holder enforceable against it in accordance with their terms, except as limited by (a) applicable bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement of creditors' rights, and (b) general principles of equity that restrict the availability of equitable remedies.
 
        4.2    Investment Representations.      Holder understands that neither the shares of the Series C Preferred Stock, nor the Common Stock to which it is convertible into, have been registered under the Securities Act of 1933, as amended (the "Securities Act"). Holder also understands that the shares of Series C Preferred Stock are being offered pursuant to an exemption from registration contained in the Securities Act based in part upon such Holder's following representations and warranties:
 
        (a)     Holder Bears Economic Risk.      Holder has substantial experience in evaluating and investing in private placement transactions of securities in companies similar to the Company so that it is capable of evaluating the merits and risks of its investment in the Company and has the capacity to protect its own interests. Holder understands that it must bear the economic risk of this investment indefinitely unless the shares of Series C Preferred Stock are registered pursuant to the Securities Act, or an exemption from registration is available. Holder understands that the Company has no present intention of registering the shares of Series C Preferred Stock or any shares of its Common Stock to which it converts. Holder also understands that there is no assurance that any exemption from registration under the Securities Act will be available and that, even if available, such exemption may not allow such Holder to transfer all or any portion of the shares of Series C Preferred Stock under the circumstances, in the amounts or at the times Holder might propose.
 
2

 
        (b)     Acquisition for Own Account.      Holder is acquiring the shares of Series C Preferred Stock for its own account for investment only, and not with a view towards their distribution.
 
        (c)      Holder Can Protect Its Interest.      Holder represents that by reason of its, or of its management's, business or financial experience, Holder has the capacity to protect its own interests in connection with the transactions contemplated in this Agreement. Further, Holder is aware of no publication of any advertisement in connection with the transactions contemplated in this Agreement.
 
        (d)     Accredited or Regulation S Eligible Investor.      Holder is an "accredited investor" within the meaning of Regulation D under the Securities Act, or is not a "U.S. Person" within the meaning of Regulation S under the Securities Act.
 
        (e)     Company Information.      Holder has had an opportunity to discuss the Company's business, management and financial affairs with directors, officers and management of the Company and has had the opportunity to review the Company's operations and facilities and public filings. Holder has also had the opportunity to ask questions of and receive answers from the Company and its management regarding the terms and conditions of this investment.
 
        4.3    Ownership of Series B Shares.      Holder represents that the Series B Shares held by Holder are owned of record and beneficially by Holder, free and clear of any Encumbrances, and Holder has the full and unrestricted right, power and authority to transfer such holdings to the Company.
 
5.     Representations and Warranties of the Company.
 
        The Company hereby represents and warrants to each Holder as of the date of this Agreement and the Closing Date as follows:
 
        5.1    Requisite Power; Authorization; Binding Obligations.     The Company has all requisite power and authority to execute and deliver this Agreement and to carry out the provisions of this Agreement. All corporate action on the part of the Company, its officers, directors and Holder necessary for the authorization, execution and delivery of this Agreement, the consummation of the transactions contemplated hereby, and the performance of all obligations of the Company hereunder has been or will be taken prior to the Closing. This Agreement, when executed and delivered, will be valid and binding obligations of the Company enforceable against it in accordance with their terms, except as limited by (a) applicable bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement of creditors' rights, and (b) general principles of equity that restrict the availability of equitable remedies.
 
        5.2    Valid Issuance.     When issued at the Closing in accordance with the provisions of this Agreement and the Certificate of Designation, the shares of Series C Preferred Stock will be duly authorized, validly issued, fully paid and non-assessable, will be delivered free and clear of any Encumbrances, and will have the rights, preferences, privileges and restrictions set forth in the Certificate of Designation; provided, however, that such shares of Series C Preferred Stock may be subject to restrictions on transfer under state or federal securities laws or as otherwise required by such laws at the time a transfer is proposed.
 
3

 
6.     Conditions to Closing.
 
        6.1    Conditions to Obligation of Each Holder.     Each Holder's obligation to accept the issuance of the shares of Series C Preferred Stock and to deliver the Series B Shares at the Closing is subject to the satisfaction, at or prior to the Closing Date, of the following conditions:
 
        (a)     Performance of Obligations.     The Company shall have performed all obligations and conditions herein required to be performed or observed by it on or prior to the Closing Date.
 
        (b)     Representations and Warranties True.     The representations and warranties made by the Company in Section 5 hereof shall be true and correct in all material respects as of the Closing Date with the same force and effect as if they had been made on and as of the Closing Date.
 
(c)    Execution of the Exchange Documents and Consent.   Holder shall have executed and delivered all documentation required in connection with the exchange of the Series B Shares, including, but not limited, the Letter of Transmission and Consent as set forth in the Terms of Exchange (the “Exchange Documents”), all of which being previously delivered to Holder.       
 
        6.2    Conditions to Obligations of the Company.     The Company's obligation to issue and deliver the shares of Series C Preferred Stock for the Series B Shares at the Closing is subject to the satisfaction, at or prior to the Closing Date, of the following conditions:
 
(a)     Performance of Obligations.     Each Holder shall have performed all obligations and conditions herein required to be performed or complied with by it on or prior to the Closing Date.
 
(b)     Representations and Warranties True.     The representations and warranties made by each Holder in Section 4 hereof shall be true and correct in all material respects as of the Closing Date with the same force and effect as if they had been made on and as of the Closing Date.
 
(c)     Receipt of Exchange Documents.   The Company shall have received fully executed Exchange Documents from Holder, in such form as required by the Company in its sole discretion.
 
4

 
7.     Miscellaneous.
 
        7.1    Governing Law.     This Agreement shall be construed in accordance with, and governed in all respects by, the internal laws of the State of Nevada (without giving effect to principles of conflicts of laws).
 
        7.2    Survival.     The representations, warranties, covenants and agreements made herein shall survive any investigation made by Holder and the closing of the transactions contemplated hereby. All statements as to factual matters contained in any certificate or other instrument delivered by or on behalf of the Company pursuant hereto in connection with the transactions contemplated hereby shall be deemed to be representations and warranties by the Company hereunder solely as of the date of such certificate or instrument.
 
        7.3    Successors and Assigns; Assignment.     Each and all of the covenants, terms, provisions, and agreements contained in this Agreement shall be binding upon and inure to the benefit of the parties hereto and, to the extent permitted by this Agreement, their respective successors and assigns. Neither the Company nor Holder may assign their respective rights or obligations under this Agreement (by operation of law or otherwise) to any Person without the prior written consent of the parties.
 
        7.4    Entire Agreement.     This Agreement and the exhibits hereto, and the other documents delivered pursuant hereto constitute the full and entire understanding and agreement between the parties with regard to the subjects hereof, and no party shall be liable or bound to any other in any manner by any representations, warranties, covenants and agreements except as specifically set forth herein and therein.
 
        7.5    Severability.     In the event that any provision of this Agreement, or the application of any such provision to any Person or set of circumstances, shall be determined to be invalid, unlawful, void or unenforceable to any extent, the remainder of this Agreement, and the application of such provision to entities or circumstances other than those as to which it is determined to be invalid, unlawful, void or unenforceable, shall not be impaired or otherwise affected and shall continue to be valid and enforceable to the fullest extent permitted by law.
 
        7.6    Amendment.     This Agreement may not be amended, modified, altered or supplemented without the written consent of the Company and Holder.
 
        7.7    Waiver.     
 
        (a)   No failure on the part of any Person to exercise any power, right, privilege or remedy under this Agreement, and no delay on the part of any Person in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of such power, right, privilege or remedy; and no single or partial exercise of any such power, right, privilege or remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy.
 
        (b)   No Person shall be deemed to have waived any claim arising out of this Agreement, or any power, right, privilege or remedy under this Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such Person; and any such waiver shall not be applicable or have any effect except in the specific instance in which it is given.
 
5

 
        7.8    Notices.     All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified; (b) when sent by confirmed telex or facsimile if sent during normal business hours of the recipient, if not, then on the next business day; (c) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (d) one business day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the addresses set forth below:
 
 
  If to the Company:    Invisa, Inc., PO Box 49376, Sarasota, FL 34230
    (941) 870-3950
   
 If to Holder:               At the address set forth following the signature below.
 
        7.9    Remedies Cumulative; Specific Performance.     The rights and remedies of the parties hereto shall be cumulative (and not alternative). The parties hereto agree that: (a) in the event of any breach or threatened breach by any party of any covenant, obligation or other provision set forth in this Agreement, the other parties shall be entitled (in addition to any other remedy that may be available to it) to (i) a decree or order of specific performance or mandamus to enforce the observance and performance of such covenant, obligation or other provision, and (ii) an injunction restraining such breach or threatened breach; and (b) such other parties shall not be required to provide any bond or other security in connection with any such decree, order or injunction or in connection with any related action or Proceeding.
 
        7.10    Further Assurances.     
 
        Each party hereto shall execute and/or cause to be delivered to each other party hereto such instruments and other documents, and shall take such other actions, as such other party may reasonably request (prior to, at or after the Closing) for the purpose of carrying out or evidencing any of the transactions contemplated hereby.
 
        7.11    Construction; Interpretation.     For purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include the masculine and feminine genders.
 
        (b)   The parties hereto agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be applied in the construction or interpretation of this Agreement.
 
6

 
        (c)   All monetary amounts referenced herein are denominated in United States Dollars.
 
        (d)   As used in this Agreement, the words "include" and "including," and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words "without limitation."
 
        (e)   Except as otherwise indicated, all references in this Agreement to " Sections " and " Exhibits " are intended to refer to Sections of this Agreement and Exhibits to this Agreement.
 
        7.12    Counterparts.     This Agreement may be executed in any number of counterparts, each of which shall be an original, but all of which together shall constitute one instrument.
 
         IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date set forth in the first paragraph hereof.
 
 
INVISA, INC.
 
HOLDER
     
By:_____________________
                                               
By:_________________________
     
   
Name: ______________________
     
   
Title:________________________
     
   
Address: ____________________
     
   
Telephone: ___________________
     
   
SSN: _________________________
 
 
 
7

 
EXHIBIT 31.1
CERTIFICATIONS

I, Edmund C. King, certify that:

1.     I have reviewed this Annual Report on Form 10-K of Invisa, Inc.;

2.      Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;

3.      Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of and for the periods presented in this report;

4.      The small business issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the small business issuer and have:

(a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)  Evaluated the effectiveness of the small business issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

(d)  Disclosed in this report any change in the small business issuer’s internal control over financial reporting that occurred during the small business issuer’s most recent quarter (the small business issuer’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer’s internal control over financial reporting.

5.    The small business issuer’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuer’s auditors and the audit committee of the small business issuer’s board of directors (or persons performing the equivalent functions):

(a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer’s ability to record, process, summarize and report financial information; and

(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer’s internal control over financial reporting.


   
Dated:  March 31, 2010
  
/s/ Edmund C. King
 
Acting President
 
 
 

EXHIBIT 31.2
CERTIFICATIONS

I, Edmund C. King, Chief Financial Officer, certify that:

1.     I have reviewed this Annual Report on Form 10-K of Invisa, Inc.;

2.      Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;

3.      Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of and for the periods presented in this report;

4.      The small business issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the small business issuer and have:

(a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared

(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)  Evaluated the effectiveness of the small business issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

(d)  Disclosed in this report any change in the small business issuer’s internal control over financial reporting that occurred during the small business issuer’s most recent quarter (the small business issuer’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer’s internal control over financial reporting.

5.    The small business issuer’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuer’s auditors and the audit committee of the small business issuer’s board of directors (or persons performing the equivalent functions):

(a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer’s ability to record, process, summarize and report financial information; and

(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer’s internal control over financial reporting.
 
Dated:  March 31, 2010
  
/s/ Edmund C. King
    Edmund C. King, Chief Financial Officer
       
 
 

EXHIBIT 32.1

INVISA, INC.
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of Invisa, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Edmund C. King, Acting President and Acting Chief Operating Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1.    The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Edmund C. King
________________________________
Edmund C. King
Acting President
March 31, 2010
 
 
 
 
 

EXHIBIT 32.2

INVISA, INC.
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of Invisa, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Edmund C. King, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1.    The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.    The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


/s/ Edmund C. King
__________________________________
Edmund C. King
Chief Financial Officer
March 31, 2010